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Background:  As mobile phone ownership levels grow globally, opportunities to target 
hard-to-reach populations through mobile-health technologies become more realistic. In a 
rural Kenyan population, this dissertation seeks to assess the magnitude and risk factors 
of immunization timeliness and coverage, to determine the readiness of a community for 
mHealth interventions by assessing prevalence and risk factors for mobile phone 
ownership and SMS utilization, and to assess the effect of the Mobile Solutions for 
Immunization (M-SIMU) cluster randomized controlled trial.  
Methods:  A cross-sectional survey of Kenyan caregivers was conducted to collect 
baseline immunization and mobile phone ownership estimates for M-SIMU.  Predictors 
of mobile phone ownership were obtained through multivariable logistic regression. Risk 
factors for delayed immunizations and not receiving immunization were calculated using 
binomial regression with log link.  The M-SIMU trial randomized villages to four arms: 
Control, short message system (SMS) reminders only, SMS reminders + 75 Kenyan 
Schillings (KSH) incentive or, SMS reminders + 200 KSH incentive. Inverse Kaplan-
Meier curves and Cox regressions assessed the intervention’s effect on pentavalent3 and 
measles vaccination.   
Results:  Older maternal age, higher maternal literacy and education, smaller households, 
and higher socioeconomic status were associated with phone ownership.  Immunization 
coverage for the third dose of pentavalent vaccine (pentavalent3), measles, and fully 
immunized children (FIC) were 95%, 83%, and 80%, respectively.  Delayed pentavalent1 
was associated with not receiving pentavalent3 (RR: 5.61; 95%CI: 3.77-8.33), measles 
iii 
 
vaccine (RR: 1.51; 95%CI: 1.15-1.99), and FIC (RR: 1.87; 95%CI: 1.51-2.32).  The 
prevalence of delayed pentavalent1, pentavalent3, and measles were 11%, 24%, and 29%, 
respectively.  No common risk factors in the delay models were found.  For M-SIMU, 
Kaplan-Meier curves found significant differences across arms in time to pentavalent3 
(p<0.01) but not measles vaccination (p=0.10).  SMS + 200 KSH infants were associated 
with pentavalent3 vaccination (HR: 3.33; 95%CI: 1.71-6.47) and approached significance 
for measles (HR: 2.05; 95%CI: 0.95-4.41; p=0.07), as compared to controls.  The SMS 
only and SMS plus 75KSH were not significantly associated with either vaccine. 
Conclusions: In a population with moderate phone ownership, high immunization 
coverage, and moderate vaccine delays, SMS reminders plus 200KSH improved 
pentavalent3 vaccination. 
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Chapter 1. Introduction  
1.1 Executive summary 
Approximately one in 13 children in Kenya and one in five children in our study 
site, the Gem District in western Kenya, will die before their 5th birthday, with the 
majority of deaths attributed to infectious diseases.1,2  Many of these deaths are 
preventable by vaccination, yet many children in Kenya are not vaccinated or are 
vaccinated late.3  The third dose of pentavalent vaccine (pentavalent3; containing 
vaccines for diphtheria, tetanus toxoid, pertussis, hepatitis B, and Haemophilus influenzae 
type b antigens) is scheduled to be given at 14 weeks of age4 and is frequently used to 
assess the strength of a country’s immunization system.5,6 In our study site, 54% of 
infants received the third dose of pentavalent vaccine by 24 weeks of age in 2010.  When 
measured at 12-23 months, the pentavalent3 coverage increases to 83%, suggesting both 
the need for efforts at increasing vaccine coverage and vaccine timeliness.  
Measures of timely immunization are often omitted from immunization reporting 
systems, despite their importance.  First, most mortality from vaccine preventable 
diseases occur early in childhood in developing countries7-9; ensuring vaccinations are 
given as early as possible will save lives.  Second, timely vaccination ensures higher 
levels of herd immunity by reducing the pool of susceptible individuals, thereby 
protecting infants that are too young to be vaccinated from deadly vaccine-preventable 
diseases.10 
Two demand-side interventions, short message system (SMS) reminders and 
small monetary incentives, have been shown to motivate positive health behaviors 
elsewhere.11-16  However, the efficacy of SMS reminders to improve immunization 
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coverage in sub-Saharan Africa had neither been evaluated nor used in conjunction with 
monetary incentives until present.  This 152 village randomized controlled trial called the 
Mobile Solutions for Immunizations (M-SIMU) will test whether SMS immunization 
reminders, either with or without mobile-phone based incentives, can improve timeliness 
and coverage of routine pediatric vaccines. 
Critically, the success of our pilot study in a neighboring division, Karemo, 
showed that a mobile phone based system that delivers travel subsidies and SMS 
reminders is technically feasible and welcomed by the community.17 The pilot study 
identified several lessons that were incorporated into the design of the M-SIMU 
randomized controlled trial.  
Additionally, as part of M-SIMU’s implementation, 2632 households were 
interviewed as part of the baseline survey in April of 2013 to ascertain immunization 
coverage and mobile phone ownership estimates.  Furthermore, focus group discussions 
were conducted in June 2013, prior to M-SIMU enrollment, to receive both community 
feedback on mobile-health (mHealth) interventions and input on the study design.  These 
focus group discussions, baseline survey, and a pilot analysis of the M-SIMU randomized 
controlled trial serve as the backbone of this dissertation.   
Despite a lack of rigorous scientific evidence of effectiveness, mHealth and 
conditional cash transfer programs continue to spread throughout Africa.18-21 Lessons 
learned from these studies will help in the effective design of similar programs and will 
assist decision makers in the Kenyan Ministry of Health, as well as those in other African 
countries, before committing the investment, time, and effort that will be necessary to 
scale-up these programs.  Moreover, this project has the opportunity to assess the 
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potential of mobile phone technologies in achieving the Millennium Development Goal 






1.2 Study objectives  
 
Primary Aim #1: To identify and compare predictors of immunization coverage and 
timeliness for third dose pentavalent vaccine, measles vaccine, and fully immunized1 
children in a rural Kenyan pediatric population 
 
Primary Aim #2: To describe parents’ perceptions of mHealth interventions targeting 
immunization coverage and to identify predictors of mobile phone ownership and SMS 
utilization in rural western Kenyan mothers 
 
Primary Aim #3:  To determine the effect of SMS reminders, with or without monetary 
incentives, on timeliness of pentavalent vaccine series and measles vaccine as compared 














1 Fully immunized children have received BCG, three doses of polio, three doses of pentavalent, and 
measles vaccines  
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1.3 Organization of the dissertation  
This dissertation is presented in seven chapters.  The first chapter provides an 
executive summary and primary aims.  The second chapter is a substantive literature 
review of determinants of immunization coverage and timeliness, global and Kenyan-
specific mobile phone ownership levels and their determinants, randomized controlled 
trials employing SMS reminders conducted in sub Saharan Africa, and studies utilizing 
incentives to promote positive behavior change.  The third chapter details the study 
design and analyses conducted.  Chapters four through six describe three scientific 
studies.  Chapter four focuses on immunization coverage, timeliness, and their risk 
factors.  Chapter five assesses the mobile-health landscape of rural western Kenyan by 
detailing the results of focus group discussions on mobile-health interventions to improve 
immunization and an examination of predictors of mobile phone ownership and SMS 
utilization.  Chapter six describes the results of a pilot analysis of the Mobile Solutions 
for Immunization (M-SIMU) village randomized controlled trial.  Lastly, chapter seven 
provides a summary of key findings from chapters four through six, discusses potential 
policy implications, and suggests future research agendas.  Supplemental data, survey 
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Chapter 2. Relevant Literature 
 
2.1 Introduction 
Few interventions available to public health practitioners rival the cost-
effectiveness of vaccines when it comes to reducing childhood morbidity and mortality.1 
Recent 2013 estimates found that of approximately 6.3 million children died before their 
fifth birthday, with 51.8% (3.3 million) of these deaths attributed to infectious diseases. 
In regards to vaccine preventable diseases (VPDs), pneumonia (935,000 deaths) and 
diarrhea (578,000 deaths) were responsible for the most deaths.2  Measles, pertussis, 
tetanus, and meningitis, four other vaccine preventable diseases, were responsible for 
362,000 deaths in children under five years old. 
Across the globe, numerous studies have identified risk factors for being 
unimmunized 3-5 and not receiving vaccinations in a timely manner.6, 7   Identifying 
determinants of vaccination coverage and timeliness is important because it allows 
implementation of interventions aimed at those under- and un-immunized.8-11  The scale-
up of these interventions has the potential to save millions of lives across resource-
constrained countries.12 
Mobile-health (mHealth) is a burgeoning field due to exponential growth in mobile 
phone ownership, particularly in low-income countries.13, 14  Although this field of study 
is in its infancy15, mHealth technologies have been effective at promoting positive health 
behavior change.16 Moreover, there is increasing recognition that mHealth technologies 
may have a role in improving immunization rates of traditionally hard-to-reach infants 
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through use of Short Message System (SMS) reminders17, which target demand-side 
deficiencies in vaccine schedule knowledge and forgetfulness of immunization dates. 
Small monetary incentives, or other valuable goods, that are conditioned on vaccine 
receipt, are another example of demand-side interventions that can be employed to 
improve immunization coverage.  Although only a few rigorous studies on incentives 
exist, the results for improvements in timely vaccination rates are promising.18, 19 
In this chapter, global and Kenya-specific determinants of immunization coverage 
and timeliness will be described, followed by a discussion of mobile phone ownership 
coverage levels and their predictors.  A review of mHealth randomized controlled trials, 
particularly focusing on sub Saharan Africa and immunizations, ensues.  Chapter 2 
concludes with a summary of the evidence for small monetary incentives and their effect 
on health behavior change, including immunization. 
2.2 Estimates of immunization coverage and timeliness 
 Estimates of immunization coverage 2.2.1
Vaccination is one of the most cost-effective interventions for increasing 
childhood survival.1  Global estimates find that current immunization programs save over 
2.5 million lives a year.1  Despite the lifesaving potential of vaccines, in 2007 
approximately 20% of children, or about 24 million infants, did not receive all the 
scheduled vaccines1 and if they were immunized, they often received the vaccinations 
late.7   
DTP3 coverage (3 doses of diphtheria, tetanus toxoid, and pertussis antigen 
containing vaccine) of children 12-23 months old is a common indicator of the strength 
of a country’s immunization system to deliver vaccines.20, 21  The DTP vaccine is globally 
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being replaced by the pentavalent vaccine, which includes DTP antigens plus hepatitis B, 
and Haemophilus influenzae type b antigens.  DTP and pentavalent vaccines will be used 
interchangeably throughout the dissertation to broadly discuss immunization coverage.  
The DTP vaccine is recommended to be given when an infant is 6, 10, and 14 weeks old 
in accordance with the Expanded Programme on Immunization (EPI) schedule (Table 
2.1).22  In 2011, globally 83% of children ages 12-23 months received 3 doses of DTP23.  
These estimates are much lower for Africa and South East Asia, 71% and 75%, 
respectively.23   
 Estimates of immunization timeliness 2.2.2
An often overlooked aspect of DTP and other vaccine-specific estimates is the age 
group for which coverage is being assessed.  Although the DTP series is to be completed 
by 14 weeks of age in most lower-income countries, DTP vaccination coverage is 
routinely measured in infants aged 12-23 months.  The measurement at this time window 
does not capture any delays in vaccine administration.   
Timeliness of vaccine receipt is important for two reasons.  First, the diseases 
which pediatric vaccines protect against often have highest morbidities and mortalities at 
earlier stages of life.  Delays of infant immunization have been associated with increased 
cases of pertussis24, 25, hepatitis B26, and Haemophilus influenzae type b.27  Second, 
timely vaccination ensures maximal herd immunity28, thereby protecting those that are 
too young to be vaccinated, are medically contraindicated, or do not produce a sufficient 
immunological response to vaccination.  Herd immunity is dependent on the vaccine’s 
ability to produce an protective immunological response in a sufficient proportion of the 
population to reduce transmission of disease. Delays in vaccination lessen population 
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coverage and create a pool of susceptible individuals thereby increasing the pathogen’s 
ability to spread and potentially increasing the risk of exposure. 
Although timely vaccination in more affluent countries has been studied for some 
time29-33, this concept has only recently been applied to resource-constrained countries6, 7 
with many of these studies being published in 2012 and later.  When timely 
immunization has been examined, vaccination delays have been found to be prevalent 
across lower income countries.  Two systematic reviews identified a median delay of 6.2- 
6.3 weeks for DTP3 across 76 lower and middle-income countries (10 countries were 
replicated in both reviews).6, 7  In one review, the median delay of the 75% percentile 
across 45 countries was 13.5 weeks.7  National estimates of median delay for DTP3 in 
Kenya were lower, 3.2 weeks in 2003, but 25% of Kenyans had DTP3 delays greater than 
7.5 weeks.7  For our study site, Gem District Kenya, 2003 estimates found the median 
delay for DTP3 was greater than 10 weeks.34 
Still, as global immunization coverage levels have markedly improved over the 
past decade 21, 35, the paradigm must shift from concerns about children being vaccinated, 
to ensuring vaccinations are given on time.  
2.3 Predictors of immunization coverage and timeliness: global 
 Predictors of immunization coverage 2.3.1
The literature on predictors of vaccination coverage (i.e. receiving versus not 
receiving a vaccine) is abundant, especially when compared to that of vaccination 
timeliness (receiving a vaccine later than the recommended date).  Like vaccine 
timeliness, vaccination coverage is dependent on contextual factors that may be specific 
to its respective population.  In an analysis of Demographic and Health Survey (DHS) 
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immunization data from 26 sub Saharan African countries representing 27,094 children 
and 8,546 communities, the authors found that 32% and 21% of the variance in non-
vaccinated children was attributable to community and country-level variables, 
respectfully.  Maternal and paternal education, were strongly associated with non-
immunized children, (OR: 1.35, 95%CI 1.18 to 1.53) and (OR: 1.13, 95%CI 1.12 to 
1.40), respectively.  Maternal access to media (OR: 0.94, 95%CI 0.94 to 0.99) and 
maternal care-seeking behaviors (OR: 0.56, 95%CI 0.54 to 0.58) were found to be 
protective for non-immunization.3 
Because of the high dependence on community- and country-level factors, a broad 
discussion on potential determinants of immunization coverage is recommended and will 
later be followed with Kenya-specific findings.  Guiding this discussion of ‘global 
predictors’ will be a recent systematic review that classified these determinants into four 
broad categories: immunization systems, communication and information, family 
characteristics, and parental attitudes.4  Overall, this review encompasses 202 articles 
describing studies conducted in 51 unique countries.  The results from this systematic 
review will serve as a guideline for discussion of potential determinants of immunization 
and not be used to draw conclusions about the importance and strength of the socio-
demographic variable’s associations with immunization status. 
A. Immunization systems 
 The most commonly reported associations with immunization coverage were 
deficiencies in immunization systems.  Immunization systems included long distances 
from and poor access to vaccination clinic, costs associated with vaccination, rural 
residence, health worker knowledge, and missed opportunities to vaccinate.4   
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 Distance from the clinic has long been recognized as an important determinant of 
healthcare utilization, including vaccination.36-40  The so-called “distance decay effect” 
posits that the rate of utilization varies inversely with distance”.41  A recent systematic 
review and meta-analysis (manuscript in preparation by this dissertation’s author) found 
that this distant decay effect was observable in immunization, antenatal care, postnatal 
care, antenatal immunization with tetanus toxoid, delivery at a health facility or by a 
skilled birth attendant, and healthcare seeking for illness outcomes.42   
In this review, three main vaccination status outcomes were evaluated - 
completion of the full Expanded Programme on Immunization sequence (birth dose of 
BCG, three doses of DTP and polio, and one dose of measles vaccine)43-58, completion of 
DTP3/Pentavalent359-63, and BCG vaccination.45, 59, 61, 64, 65  Of the 21 studies examining 
full immunization status or DTP3/Penta3 completion as compared to incomplete and/or 
no immunization, 14 (66.7%) found a significant distance decay effect.  Similar findings 
were seen for analyses that adjusted for potential confounders; 12/17 studies (70.6%) 
found a distance-decay effect.  A significant dose-response effect of decreased 
immunization status with increasing distance was observed in three (42.9%) of seven 
studies that had multiple distance intervals.46, 50-52, 54, 56, 57  Additionally, significant 
distance decay effects were also found in three (60%) of five BCG immunization 
outcomes. 
In meta-analysis (Figure 2.1), the pooled summary estimates from six studies 
found that infants living greater one kilometer were significantly less likely to be 
completely immunized than infants living within one kilometer from a health facility 
[pooled OR (pOR): 0.61; 95% CI (0.45-0.82), I2=85%]46, 51, 53-55, 63, as were infants living 
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greater than two kilometers compared with those living within to two kilometers from a 
health facility in three studies [pOR: 0.64; 95% CI (0.43-0.94), I2=73%].44, 51, 56  No 
significant distance decay effect was found between those living greater than five 
kilometers from a health facility versus those within five kilometers in three studies 
[pOR: 0.55; 95% CI (0.27-1.12), I2=71%].48, 56, 59  The pooled estimate trended towards 
the suggestion of a distance decay effect and was likely underpowered. 
 B. Family Characteristics 
Family characteristics were the second most frequently cited reason for under-
immunization in resource-constrained countries.4  The most common subcategory was 
low maternal education.4  Gem District, Kenya 2003 cross-sectional survey results 
corroborate the systematic review’s finding of low maternal education (OR=0.32; 
95%CI: 0.12-0.86) and also found that higher numbers of children in the household 
(OR=0.24; 95%CI: 0.11-0.53) are associated with incomplete immunization.34  
The second most commonly cited reason within family characteristics was lower 
socio-economic status.4  Implicit with long distances from health facility are indirect and 
direct costs associated with transportation which for lower income families poses a 
significant burden or barrier. As a result, families either walk long distances to the health 
facility or do not seek care.66, 67    
C. Parental attitudes and knowledge 
The third category of reasons for under-immunization is parental attitudes and 
knowledge.  Parental attitudes and vaccination knowledge accounted for 22% of reasons 
for underimmunization in developing countries4.  The most common subgroupings were a 
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lack of knowledge that vaccinations prevent disease, belief that vaccinations cause harm 
or are not effective, and lack of motivation.4   
These determinants represent demand side deficiencies that are both infrequently 
acknowledged and targeted to increase immunization coverage68, but have found to be 
effective when interventions addressing these deficiencies were implemented. A 
randomized cluster controlled trial in Pakistan found that three community discussions 
over a span of seven months tripled the odds of DTP3 immunization in children ages 12-
23 months (OR= 3.36; 95%CI: 2.03-5.56).69  In Ghana, a cluster randomized controlled 
trial showed that study staff visiting homes and providing vaccination reminders 
statistically increased full immunization coverage by 20%.70 
 Predictors of immunization delay 2.3.2
Two reviews examined the determinants associated with DTP3 vaccination delays 
from Demographic and Health Surveys (DHS) in 45 countries and Multiple Indicator 
Cluster Surveys (MICS) from 31 low income countries.6, 7  Several predictors of DTP3 
delays from adjusted models were significant in both reviews, such as higher number of 
children in the household, rural residence, and younger mothers.  Findings were 
inconclusive for gender as a determinant of timely DTP3; male children were more likely 
to experience delays in the MICS review but gender was non-significant in the DHS 
review.6, 7  One review found that children being born at home and lower maternal 
education were significant predictors of delay.7  Lastly, of all determinants examined in 
both reviews, the poorest households had the highest odds of delayed vaccination 
(OR=2.08; 95%CI: 1.94-2.08).6  This finding hints at the potential of monetary incentives 
as a catalyst for increasing vaccine timeliness. 
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 In addition to these two reviews of national survey data, there is a growing body 
of literature for study site-specific predictors of vaccination delays in lower income 
countries71-84,with many of these studies being published in 2012 and later. These studies 
have been conducted in a range of countries including Ghana75, 77, Uganda71, 85, 
Tanzania78, Burkina Faso80, 82, Nigeria79, 81, South Africa74, India72, China76, and 
Bangladesh.84  
Three studies have examined determinants of delayed vaccination for the full EPI 
schedule (BCG, DTP, polio, and measles) in developing countries.71, 74, 85  Analyses that 
adjusted for potential confounders found that giving birth at home71, 74, increasing 
numbers of children in household71, 74, lowest wealth quintile71, unmarried mothers71, and 
low maternal education85 were significant predictors of a child’s timely full immunization 
status.   
In addition to studies examining risk factors for delays in FIC, there are two 
studies that have looked at delays in the administration of pentavalent3.78, 82  In both 
studies, lower socioeconomic status was associated with delayed pentavalent3.78, 82  
Lower maternal education and higher number of siblings were associated in one study.82 
Predictors of delay for full immunization status and DTP3 may differ due to the 
inclusion of measles vaccine in full EPI immunization analyses.  At younger ages infants 
visit health facilities for wellness checkups and immunizations, typically at 6, 10, and 14 
weeks of age.  Prior to measles vaccination at 9 months of age, there are no other 
scheduled visits.  Because of the long duration between the immunization visit at 14 
weeks of age and measles, it is likely there is a higher chance of mother’s forgetting 
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about the measles appointment. Still, as discussed above, there is some overlap in full 
immunization and DTP3 coverage delay determinants.   
2.4 Predictors of immunization coverage and timeliness: Kenya 
 Predictors of immunization coverage: 2.4.1
Over the past 25 years, numerous studies have reported Kenyan immunization 
coverage estimates and their associations with socio-demographic variables.34, 86-93  In 
these analyses, higher levels of maternal education34, 86, 87, 90, 92 and lower number of 
children in the household34, 87, 90, 91, 93 are consistently associated with higher 
immunization coverage levels. Yet, because these studies were conducted across a range 
of settings, including urban87, 88, 90, 92 and coastal areas89, 91, differences in primary 
immunization outcomes ranging from pentavalent3 coverage to fully immunized 
children, and a lack of uniformity in socio-demographic variables included in analyses 
across all studies, it should be expected that predictors of immunization coverage are not 
uniform.   
Moreover, it is possible that predictors of immunization coverage have changed 
over time as more Kenyan infants are being vaccinated.  Data from successive Kenyan 
Demographic and Health Surveys (DHS) found improvements in DTP3 coverage from 
2003, 72%, to 2009, 86%.94  Study site specific estimates for Gem District, Nyanza 
Province, Kenya found DTP3 and measles coverage estimates, respectively, to be 68%  
and 50% in 200334 and 95% and 84% in 2011.93  The gains in immunization coverage are 
likely tied to the heightened awareness and global efforts of improving immunization 
systems (95, 96) 
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To illustrate a temporal change in predictors of immunization coverage, a recent 
analysis from our study site found that the quality of interaction with community health 
workers (CHW) and the frequency of interaction were significant factors affecting FIC 
coverage.93 Recently, Kenya has integrated community health workers (CHW) into 
Kenyan national policy to improve the health of children and mothers.97  As part of their 
job duties, CHWs trace infants that have defaulted on their immunizations and refer them 
to the clinic.  The CHW successful referral of infants for vaccination may override some 
of the traditional risk factors for not bringing infants for vaccination.    
The most recent analysis of determinants of immunization status from this 
dissertation’s study area occurred in September 201193, though the geographic scope of 
this cross-sectional survey is much larger than the dissertation study area.  This analysis 
surveyed mothers from Siaya, Ugenya, Kisumu West, and Gem Districts.  The 
dissertation study area is confined to Gem District.  Results from multivariate logistic 
regression found that average (OR: 2.69; 95%CI: 2.02–3.60) and high knowledge of 
vaccination schedule (OR: 8.12; 95%CI: 5.51–11.98) were significantly associated with 
fully immunized child coverage. Long birth intervals (OR: 1.85; 95%CI: 1.10–3.09), first 
born children (OR: 2.15; 95%CI: 1.20–3.84), and lower numbers of children under five 
years old in the household (OR: 1.40; 95%CI: 1.04–1.88) were also significantly 
associated with full immunization. As discussed above, the investigators also measured 
the effect of CHW performance, a composite measure of quality and frequency of 
interactions.  Infants that had high levels of CHW performance had two-fold higher odds 
of being fully immunized than infants that had poor levels of CHW performance (OR: 
2.20; 95%CI: 1.40–3.47). 
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As global and Kenyan-specific immunization coverage levels have improved over 
the past decade, it is likely that predictors of immunization status may also change.  Risk 
factor analyses to determine socio-demographic variables associated with infants not 
being vaccinated are useful because they can identify particular subsets of the population 
to target public health interventions that improve immunization coverage.  When 
possible, analyses should include individual- and community-level variables in risk factor 
analyses to account for variation within individuals and their surroundings. 
 Predictors of immunization delay: Kenya 2.4.2
In regards to predictors of immunization delay in Kenya, three studies have 
examined distribution of immunization delays and determinants.  Two of these studies 
were conducted in a coastal city, Kilifi89, 91, and the other was an analysis of 2003 data 
from this dissertation’s study area.34  The two studies from Kilifi both used inverse 
Kaplan Meir curves and Cox Proportional Hazard Models to obtain estimates for 
predictors of pentavalent vaccination.  In one model, seasonality was the only predictor 
of timely immunization.  The authors found that infants with vaccination due during the 
rainy season were less likely to be timely immunized than those with vaccination due 
dates during the dry season (HR=0.86, 95% CI: 0.81–0.92).89  Bivariate analyses found 
that maternal education and migrant status were significantly associated with timely 
immunization, but that this effect disappeared in adjusted analyses.  Distance to the clinic 
and travel time was not significant in both bivariate and multivariate analyses. 
In the other Kilifi-based study, and similar to the previous results reported, rainy 
season was also predictive of timely pentavalent immunization, (HR=0.73, 95% CI: 
0.61–0.89).91  Unlike the previous study, the authors found that distance to the clinic was 
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predictive of timely immunization, although the effect size was modest (HR=0.95, 95% 
CI: 0.91–1.00).  Additionally, an increasing number of children in the family were found 
to be predictive of immunization delays. 
Overall, the research on immunization delays in Kenya is limited in both scope 
and depth, particularly from this dissertation’s study site.  The identification of risk 
factors and determinants of delayed immunization is important so that interventions and 
health programs can target particular subsets of the population to attempt to improve 
timely immunization coverage estimates.  Chapter four of the dissertation discusses the 
findings from a large cross-sectional survey that aims to assess risk factors of 
immunization coverage and timeliness. 
2.5 Mobile phone ownership 
Globally, the number of people owning mobile phones grew from 1 billion in 
2000 to 6 billion in 2012.14 The predominant driver of this growth was mobile phone 
adoption by lower income countries.  In 2010, 77% of mobile phones are located in 
developing countries, contrasted to only 22% in 2000.14   Particularly, the use of mobile 
phones has skyrocketed in Africa, with Kenya viewed as a pioneering country.  In 2005, 
12% of Africans were mobile phone subscribers.  This estimate tripled to 37% in 2009 
and population coverage, the percentage of inhabitants within a cellular signal, reached 
81%.13  In Kenya, September 2011 estimates reveal over 26 million cellular 
subscriptions, equating to a 20.4% increase from the previous year and resulting in 67% 
of the adult population as mobile phone subscribers.98  Approximately two-thirds of 
subscriptions are with the mobile provider Safaricom.  The other three mobile networks 
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operating within Kenya are Airtel, Essar Telecom (Yu), and Telkom Orange, with market 
shares, respectively, of 15.7%, 10.4%, and 6.2%.98 
Mobile phone usage and ownership levels have globally risen, yet a noticeable 
lack of data on sub-national levels of population coverage exists.  Nyanza Province, the 
site of the proposed study, observed that 69% of households possess a mobile phone in 
2009.99  Similarly, 70.9% of 72 households owned mobile phones in our 2011 pilot 
study.100  Our empirical ownership findings are consistent with national data where 85% 
of Kenyans reported using a mobile phone, but only 44% reported owning one one.101  In 
this national analysis, the authors found that high education levels, English literacy and 
gender were significant predictors of phone ownership.101   
Gender gaps in phone ownership pervade and their existence may impede the 
delivery of mHealth interventions targeting women and children.  In Kenya, sub-Saharan 
Africa, and South Asia, women are, respectively, 22%, 23% and 37% less likely 
(relative) than men to own a mobile phone.102  In Nyanza Province, Kenya, women are 
12% relatively less likely to own a mobile phone than men, with 65% of men and 57% of 
women owning a mobile phone.99  The presence of low mobile phone ownership levels, 
coupled with a documented gender gap, will require novel solutions to maximize the 
reach of mHealth interventions. 
Mobile phone ownership among women is not uniform.  Globally, wealthier, 
more educated, city-dwelling, and younger women are most likely to own mobile 
phones.102 Several studies have examined determinants of mobile phone ownership in 
Kenya.101, 103  However, data on determinants specific to phone ownership in women is 
lacking, but is likely similar to global determinants. 
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In a recent analysis of 1,167 caretakers presenting to a health facility, 82% of 
which were women, analyses found that higher levels of education, male gender, lower 
poverty index scores, and urban dwelling were significant of mobile phone ownership.103  
Critically, there was no stratification of results by gender, making it difficult to assess 
determinants for mobile phone ownership in women.  
It is imperative to study the distribution of mobile phone ownership in women 
across different socio-demographic strata.  The findings that older as compared to 
younger, more educated as compared to least educated, wealthier as compared to poorer 
women were more likely to own a mobile phone should give pause to program 
implementers that seek to address health disparities through mobile-health interventions.  
Historically, these predictors of mobile phone ownership are often similar to predictors of 
healthcare utilization.  Less educated, younger, impoverished women are individuals that 
would most likely benefit from mHealth interventions such as text message reminders, 
yet low levels of phone ownership complicates the delivery and receipt of intervention.  
In areas with low mobile phone ownership levels, mobile health interventions could be 
distributed to the phones of husband’s or other household members as the majority of 
women, despite not owning, have access to a mobile phone.101  
Lastly, in addition to low mobile phone ownership amongst females, a common 
critique of conducting mHealth interventions within Kenya is the country’s high 
penetration of mobile phones may prevent the study results from being generalizable or 
replicable to other parts of Africa.  The merits of this argument are discounted in two 
ways.  First, as described above, the low levels of mobile phone ownership among 
Kenyan women will require novel approaches to target this audience and are likely 
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similar to approaches that could be applied in other countries.  Second, although not all 
sub-Saharan countries have mobile phone ownership levels similar to Kenya, the rates of 
adoption over time are similar (Figure 2.2); characterized by low levels of adoption for 
several years and followed by exponential growth.  As countries progress through this 
‘mobile phone transition’, more and more countries will likely exhibit a similar mobile 
phone profile to Kenya.  
2.6 mHealth and SMS reminders 
Mobile phone applications have been used successfully for a variety of public 
health applications104-106, referred to broadly as “mHealth.”  These applications include 
raising HIV awareness and treatment107-109, remote data collection110, 111, monitoring and 
disease outbreak tracking112-114, health worker training115-117, and diagnostics118, to name 
a few.  As mobile phone ownership levels continue to rise in lower income countries, 
mHealth solutions become more realistic.15 
One of the most commonly employed applications of mHealth is the use of short 
message system (SMS; i.e. text messages) to promote a positive health behavior.  The 
mechanism by which reminder messages encourage behavior changes can be viewed in 
terms of the Health Belief Model (Figure 2.3).119, 120  First, reminder messages serve as a 
behavioral cue to prompt a health behavior.  Second, they lower perceived barriers to 
accessing services and reduce the threshold for completing health behaviors.  Reminders 
have been successful at increasing several forms of healthcare utilization121-124 and have 
been delivered through several mediums including household members or health 
workers70, 125, reminder cards delivered through postal mail126-128, telephone calls127, 129, 
e-mail messages130, 131, and more recently, SMS messages.107, 122, 132   
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The impact of reminder messages in higher income countries is well documented.  
A systematic review of 49 studies that used various forms of patient reminder and recall 
interventions for immunizations found that these interventions increased immunization 
rates by 5-20%9, although no studies were included from lower income countries.  With 
strong evidence demonstrating the efficacy of reminders, the Advisory Committee on 
Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the 
American Academy of Family Physicians (AAFP) recommended that reminder and/or 
recall systems be enacted to increase vaccination rates in the United States.133   
Although postal and email reminders may work in higher income countries, the 
limited access to such commodities in rural Kenya hinders their implementation.  
However, the rise in mobile phone penetration both within Kenya and across lower 
income countries provides an alternative delivery avenue through use of SMS.  
The scientific literature supporting the effectiveness of SMS reminders to enact 
positive changes across a variety of unique forms of healthcare utilization within higher 
income countries is abundant.121-123  Specifically, two systematic reviews and meta-
analyses concluded that SMS reminders improved rates of attendance at clinical 
appointments [(RR= 1.10; 95%CI: 1.02-1.19)121 and (OR=1.48; 95%CI: 1.23-1.72)].122 
 SMS reminders in Sub Saharan Africa 2.6.1
The scientific evidence for SMS reminder interventions in Africa is modest, but 
slowly growing.  As of August 2014, nine studies conducted in sub Saharan Africa (Table 
2.2) randomized SMS reminders, with the majority showing a positive effect, as 
compared to a control group, on the healthcare utilization outcome under study.107, 109, 116, 
134-139  These outcomes included HIV treatment adherence (n=3)107, 109, 137, HIV testing134, 
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treatment of pediatric malaria116, antenatal care attendance136, institutional delivery135, 
and post-circumcision clinic attendance.138, 139  A meta-analysis of two Kenyan studies 
found a lower risk of non-adherence to antiretroviral medications at 48-52 weeks in those 
randomized to weekly SMS reminders; (RR 0.78, 95% CI 0.68-0.89).124  Brief 
discussions for several of the studies will highlight lessons learned and points to consider 
with SMS reminder interventions. 
One study conducted in Nairobi, Kenya found that HIV+ patients who received 
weekly SMS messages were less likely to report being non-adherent, defined as < 95% of 
ART doses over 3 months, (RR=0.81, 95% CI: 0.69-0.94) and less likely to have 
virologic failure at 12 months follow-up (RR=0.84; 95% CI: 0.71-0.99) than those not 
receiving SMS messages.107  An additional study set in rural Nyanza Province, Kenya 
found similar improvements in adherence to those randomized to weekly SMS reminders 
(13% -16% difference mean difference), but no difference in those randomized to daily 
messages109; suggesting that a habituation effect may exist.    
While the previous study showed a habituation effect to daily reminders sent for 
48 weeks, a study set in South Africa found a frequency threshold may need to be 
reached in order to achieve an impact.  In this study, 2533 participants were randomized 
to either a control group or one of four intervention arms.  The interventions arms 
received either 3 or 10 SMS messages, of which their wording was either motivational or 
informational in aiming to increase HIV testing.  The authors found significant uptake of 
HIV testing to those randomized to 10 motivational SMS reminders as compared to 
controls (OR =1.70; 95% 1.19–2.44), while the other three interventions (short form + 
info, short form + motivational, and long form + informational) were not significant.134  
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Equally as important, this study emphasizes that, and despite its intuitiveness, frequency 
and content of SMS messages are important in producing behavior change and, when 
considering the studies described previously, there is a fine balance between sensitizing 
SMS recipients and sending too few messages. Moreover, successful outcomes may 
hinge on appropriate phrasing of messages.  This ‘habituation-minimum threshold’ 
balance may be dependent on the form of healthcare utilization (e.g. treatment versus 
prevention) the SMS messages aim to promote.   
In the three previous trials, SMSs were targeted to health care seekers.  In a recent 
Kenyan trial, community health workers were randomized to either control or 
intervention arms. Community health workers in the intervention arm received bi-daily 
text messages on case management for pediatric malaria.  The messages were sent 
Monday through Friday for six months.  The authors found that SMS reminders sent to 
health workers improved artemether-lumefantrine management of pediatric malaria by 
23.7% (95%CI 7.6-40.0; p=0·004) immediately after intervention and that this effect 
persisted for 6 months after cessation of text messages (24.5%; 95%CI: 8.1- 41.0; 
0.003)116.  Despite the seemingly high number of SMS messages sent, 18 of 24 health 
workers interviewed were happy with the frequency of messages while 6 health workers 
thought that high frequency of reminders received would eventually induce boredom.140    
 SMS reminders and immunizations 2.6.2
In regards to SMS reminders and immunizations, there are no randomized 
controlled trials using SMS reminders in Africa.  However, several randomized 
controlled trials conducted in lower-income, high-minority concentration neighborhoods 
of New York City found SMS reminders increase multiple types of vaccine coverage.141-
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144  The first trial found that SMS reminders sent weekly for 5 weeks led to a 3.7% 
difference (95%CI: 1.5 to 5.9) in seasonal flu vaccine coverage in children ages 6 months 
to 18 years old.  Subgroup analyses found that flu vaccine coverage increases were 
highest in children aged 6 to 23 months (6.2; 95%CI: 1.9%-10.5%).143  Another study 
sent weekly SMS reminders to mothers of girls 9-20 years old 3 weeks before their 
daughter’s next scheduled HPV vaccine dose.  Girls in the SMS reminder arm were 
nearly twice more likely to receive their next dose of HPV within one month of 
scheduled date than those not receiving SMS reminders, (AOR: 2.03, 95%CI 1.29–
3.22).141   
The theoretical underpinning of SMS reminders, as described above, is grounded 
in the Health Belief Model.  To improve immunization coverage, there are several points 
within health systems that could be intervened upon (Figure 2.4).8  The three main 
intervention points are at the provider level, enhancing access to immunizations, and 
increasing community and individual demand for vaccination.  Examples of provider 
level interventions include electronic immunization tracking systems145, 146 and pay-for 
performance schemes147, 148, where providers are paid small incentives for services 
delivered.  Interventions that enhance access to vaccination include increasing cold chain 
capacity and vaccine procurement.  Demand side interventions target healthcare seekers 
to increase the likelihood they are immunized.  These interventions could target 
misperceptions and fears of vaccination or forgetfulness of the infant’s immunization 
appointment.  If either forgetting a child’s immunization appointment or not knowing the 
vaccine schedule is the main reasons for infants not being vaccinated, or being vaccinated 
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late, SMS reminders that provide information on where and when the child is due for 
vaccination could improve timely immunization coverage. 
With evidence that reminder messages and small incentives increase various 
forms of healthcare utilization18, 19, 107, 109, 124, 149, we conducted a study in 2011 to test the 
feasibility of using a mobile phone based system to deliver SMS reminders and monetary 
incentives to increase vaccine coverage and timeliness in rural western Kenya.100  
Mothers were enrolled if they owned a mobile phone (26%) or had immediate access to 
one (74%).  All mothers approached were able to identify a mobile phone to receive SMS 
reminders and incentives. 
 In this study, 72 mothers were sent SMS messages reminding them of their 
infant’s pentavalent vaccination 3 days before, and on the date of, scheduled vaccination 
date.  Mothers were also randomized to receive either $2USD worth of airtime or mobile 
money if they brought their child for vaccination within 4 weeks of the first and second 
dose of pentavalent vaccine.   
Several lessons were learned from this feasibility study that benefitted the design 
of the M-SIMU cluster randomized control trial (Dissertation Chapter 6).  Coding 
glitches in the software that automatically sends SMS messages based on the child’s birth 
date were identified.  We also encountered some hesitation from parents, particularly 
husbands, in enrolling their child for the study.  For the RCT, the coding algorithms have 
been addressed and extensive community mobilization occurred to inform the population 
that these are not experimental vaccines.   
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  Despite minor technical problems in the execution of the feasibility study, the 
results were promising.  Approximately 57% of pentavalent doses were given on the 
scheduled date and 88% of pentavalent doses given within 3 days of scheduled date 
(Figure 2.5).  Although there was no control group built into this study, SMS reminders 
were not delivered correctly to all participants.  In as-treated analyses, pentavalent2 
coverage was 95% for the 42 participants who received SMS reminders and whose 
vaccination status could be ascertained compared to 60% coverage for the 20 individuals 
who did not receive SMS reminders and whose vaccine status was ascertained.  The 
small sample size and lack of a natural comparison group prevents drawing conclusions 
about the effectiveness of SMS reminders and CCTs to improve vaccine coverage and 
timeliness, but does suggest that SMS reminders, with incentives, may be effective at 
promoting timely immunizations in Kenya.100      
There is much promise for SMS reminders to increase vaccination coverage, yet 
several limitations may inhibit their successful implantation.  First, an implicit 
component of SMS interventions is the need for a literate population to guarantee that the 
intended reminders are being understood.  In Nyanza Province, our study location, 
literacy levels approach 90% in women ages 15-49 years old.94   However, a low literacy 
level is not an absolute contraindication for SMS usage; tools are being developed to 
assist illiterate populations.150  Voice messages and/or use of pictures combined with 
training could circumvent this issue in other illiterate populations.  Second, the 
effectiveness of SMS reminders is contingent on a population’s access to mobile phones. 
A 2009 national analysis of Kenyan mobile phone ownership found that despite 45% of 
the population owning a mobile phone, 85% of Kenyans had access to one.101  Sending 
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SMS reminders to populations with low mobile phone ownership levels will require 
novel solutions, such as sending text messages to friends and relatives of the intended 
recipient and relying on these individuals to relay the content of the SMS.  Lastly, even if 
individuals own a mobile phone, the delivery of SMS reminders may not be effective 
because the phone is not charged, there is no mobile phone network, or individuals have 
changed their phone number. 
In conclusion, SMS reminders have been modestly effective at enacting positive 
health behavior change across a range of health seeking behaviors in sub Saharan 
Africa.107, 109, 116, 134-139 Although no study has examined the efficacy of SMS reminders 
on vaccination coverage within resource constrained settings, several trials conducted 
within the United States yielded positive gains in immunization coverage.141-144  
Qualitative studies have found that care takers in Nigeria and Burkina Faso would 
welcome SMS reminders for vaccination appointments and that they believe these 
reminders would be effective.151, 152 Still, more scientific studies conducted in resource-
constrained settings are needed before making policy recommendations.      
 
2.7 Incentives for healthcare utilization 
 Conditional cash transfers 2.7.1
As described above, long distances to health facility and low socio-economic 
status are barriers to full immunization coverage.  Lower income families balance the 
direct and opportunity costs of seeking healthcare with the perceived benefits of curative 
and preventive services.  One potential solution is conditional cash transfers (CCTs) 
and/or incentives.  A CCT is the transfer of money or other remunerable good for 
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completion of a positive behavior and are classically associated with poverty alleviation 
schemes and social-welfare programs.149, 153  These positive behaviors can be non-health 
related (e.g. school attendance) or health-related, such as giving birth at a facility, 
returning for HIV test results, or immunization.  Demand-side incentives are similar to 
CCTs in that remuneration is provided for completing positive behaviors, but differ in 
that incentives are of smaller value amounts. 
 CCTs, employed most notably in Latin and South America, have increased 
utilization of healthcare, improved nutritional indicators, and enhanced uptake of 
immunizations.149, 154, 155  Importantly, CCT programs typically set the condition for 
transfer on broader behaviors (e.g. child wellness visits or school attendance) and then 
assess its effect both on the conditioned behavior and other indirect health indicators.149  
Moreover, and much like mHealth interventions, CCT programs are implemented before 
rigorous testing and assessed afterwards through program evaluations.156   
 The effect of CCTs on immunization coverage is mixed.  A Honduran study 
observed a 6.9% increase in first dose of infant DTP coverage but no effect on measles 
coverage in those randomized to receive monthly vouchers conditioned on school 
attendance or well visits.157 The effect may have been dampened as a result of the long 
lag between vaccination dates (DTP at 6 weeks, measles at 9 months) and age of 
assessment, 3 years old.  In Columbia, households received a monthly average of $50 
USD conditioned on school attendance and preventive healthcare visits.  The program 
evaluation found the CCT improved probability of DTP3 completion in infants less than 
24 months old.158  Although estimates for a Nicaraguan cash transfer study, $ 25 USD per 
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month, found no effect on full immunization coverage in infants 12-23 months, the point 
estimate trended towards effect.159   
 Demand-side incentives 2.7.2
There is substantial evidence that small incentives can produce positive behavior 
change across a range of health behaviors in developed countries160-162, which includes 
strong evidence for adult immunizations161, with insufficient evidence for pediatric163, 164 
and adolescent vaccines.165  Yet the literature on incentivizing immunizations in lower 
income countries is sparser than the evidence from both developed countries and 
conditional cash transfers.  Although the evidence on provision of demand-side 
incentives directly conditioned on vaccine receipt in resource constrained settings is 
limited, their effect is more definitive and robust.  Although incentives have not been 
tested in Kenya, Pakistani and Indian studies each found demand-side incentives improve 
immunization coverage.  A cluster-randomized controlled trial was conducted in poor 
communities with low baseline immunization coverage levels in rural India.  The authors 
randomized villages to one of three arms; control group, monthly immunization camps, 
and monthly immunization camps + an incentive of lentils for completion of each dose 
and metal plates for being fully immunized.  The researchers found that providing 
incentives with immunization camps had large positive effects on full immunization 
coverage (mean % difference, 34%; RR=6.66; 95%CI: 4.53-8.80) and the effect was 
greater than immunization camps alone (mean % difference, 21%; RR=2.16; 95%CI: 
1.54-2.78).18  In Pakistan, two cohorts were used to assess whether providing 
food/medicine vouchers worth 2 USD for completion of each dose of DTP vaccine 
increased DTP3 coverage. Families that received vouchers had 2 times higher probability 
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of DTP3 completion than the cohort that did not receive incentives. (RR=2.20 95% CI: 
1.95-2.48).19   
An important consideration in incentivizing healthcare utilization is the 
determination of the incentive amount.  The incentive needs to be sufficient to tip the 
mother’s cost-benefit analysis towards bringing their child to the clinic, but not be 
excessive.  High incentive amounts may inhibit the scalability and sustainability of a 
program and potentially distort the local economy.  Additionally, there may be marginal 
gains in healthcare utilization if an incentive threshold exists. 
Work in rural Malawi addressed this concern of incentive amounts and gains in 
healthcare utilization.  Individuals were randomized to vouchers ranging from $0 to 3 
USD that were redeemable if HIV test results were obtained.166  The authors found that 
very small incentives (e.g. <$1.00) induced high uptake of HIV test results (>90%) and 
that there is marginal gains in testing uptake with increasing incentives beyond $1.00.  
Moreover, the effectiveness of incentives was greater in those living farther than 1.5 
kilometers from the testing site.  This suggests that in rural Africa, incentives that only 
cover part or all of transport costs might be successful, at least for HIV testing, and there 
may be a threshold to gains from incentives.  
In addition to the Malawi study that randomized incentive amounts to determine if 
there was a dose response with the amount of the incentive and retrieving HIV test 
results, work from rural Kenya examined this phenomenon with voluntary male 
circumcision.167  In this study, uncircumcised males were randomized to receive one of 
four study arms.  The study arms were: (1) Control group where participants received 
standard of care and no incentive; (2) 200 KES incentive (85KES= 1USD); (3) 700 KES 
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incentive; and (4) 1200 KES.  The incentives amounts were chosen to reflect 
transportation costs (200 KES) plus either one day’s wage (500 KES) or two day’s wage 
(1000 KES).  Participants received the incentive if they were circumcised within two 
months.  Adjusted analyses found that participants randomized to the 700 KES (OR: 4.3; 
95%CI 1.7-10.1) and 1200 KES arm (OR: 6.2; 95%CI 2.6-15.0) were significantly more 
likely to go for circumcision.  The transport cost incentive, 200 KES, was not significant 
and there was no statistical difference between the 700 and 1200 KES arms.167 
Although the point estimates were extremely robust for the two higher incentive 
arms, the effect on the prevalence of male circumcision was quite low.  Proportions of 
participants circumcised in the control, 200 KES, 700 KES, and 1200 KES arms were, 
respectively, 1.6%, 1.9%, 6.6%, and 9.0%.  Unlike the Malawi HIV testing incentive 
study, the provision of small incentives did not elicit behavioral change and action in the 
Kenya circumcision study.  This discrepancy is most likely explained by the type of 
health service each study examined.  In the Kenyan study, adult participants were asked 
to go a medical procedure, circumcision, where the HIV testing study only asked 
participants to go back to the clinic to pick up test results.  Additionally, behavioral 
economics reveals that individuals place greater value and emphasis on cost-benefits that 
are immediate versus delayed.168  In health terms, immediate benefits would be 
considered treatment, where delayed benefits are preventive measures.  HIV testing 
allows one to know their HIV status, and if positive, initiate treatment. Adult male 
circumcision does not have immediate benefits.  The procedure is a preventive procedure 
to reduce one’s risk of obtaining HIV and other sexually transmitted infections.169-171   
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In conclusion the effect of incentives, in both monetary form166, 167 and as 
consumable goods18, 19, while limited, is robust in enacting positive behavior change, 
including immunization.18, 19  Yet, additional studies are still needed before making 
policy recommendations.  In particular, randomized controlled trials should include 
incentive amounts to identify the incentive that is small enough to elicit behavior change. 
In regards to the sustainability or scalability of incentives, to the knowledge of 
this dissertation’s author, no scaled programs exist within Kenya that provide small 
monetary incentives for health care seeking behaviors.  Although not an incentive 
program, the Government of Kenya’s Cash Transfer for Orphans and Vulnerable 
Children (Kenya CT-OVC) has provided $20 USD monthly to the poorest households 
with orphans or chronically ill parents since 2007.172  This suggests, that if incentives 
drastically improved immunization coverage levels, the Kenyan Government may 
support and finance their adoption. 
 Mobile money (M-MONEY) 2.7.3
While 89% of people living in high-income countries have a formal banking 
account, only 41% of those living in developing countries do; translating to 2.5 billion 
people in lower income countries without any means of saving or sending money.173  In 
sub-Saharan Africa, account ownership at formal institutions is 24%, and much lower for 
the poorest quintile, 12%.173  The major advantages of owning a bank account is the 
ability to save money to manage risks responsibly, build credit, and make transactions 
easier.14, 174, 175  However, several barriers inhibit higher formal account ownership in 
lower income countries.  In sub-Saharan Africa, 81% of individuals without an account 
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said they did not have enough money, it was too expensive to own an account (36%), or 
the branch was too far away (31%).173 
 Over 1 billion people in developing countries own a mobile phone but do not 
have a bank account.176  With increasing mobile phone use, financial services are rapidly 
being integrated into mobile phones in what is termed mobile-money (M-Money).  M-
Money services include savings, insurance, credit, banking and payments, from either 
person-to-person, consumer-to-business, or business-to-business.174  As of October 2012, 
there are 129 mobile-money networks operating in 65 lower and lower middle income 
countries; in 2009, there were 17 providers.177  Many organizations have attempted to 
establish the current number of M-Money users.178  Estimates include, 45 million users in 
2009 with a projected 360 million by 2012179, 100 million active users in 2011 with 
greater than 200 million users by 2013180, and 133 million users in 2010 with upwards of 
709 million users by 2015.181  Irrespective of the exact estimate, mobile-money platforms 
are rapidly expanding.  
Kenyans may prefer mobile banking to traditional banking because of the lower 
fees and ease of transactions.  As of September 2011, over 18 million Kenyans used 
mobile banking services, representing 69% of all mobile subscribers and deposits totaling 
nearly 700 million USD in the last financial quarter.98  M-PESA, the first and most 
widespread mobile money network operated by Safaricom, is a uniquely successful 
mobile financial services program that is widely accepted.  Launched in March of 2007, 
there are presently 14 million registered M-PESA users, representing a 44% increase 
from 2010.  Additionally, there are almost 28,000 M-PESA retail stores throughout 
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Kenya, half of them in rural locations.182 There is ample evidence that M-PESA is 
penetrating to the traditionally hard to reach population.183  
Kenya’s second largest mobile phone company, Airtel, offers Airtel Money with 
approximately 6000 agents throughout Kenya.  Essar Telecom and Telkom Orange have 
also launched mobile banking platforms called, respectively, yuCash and Orange Money.  
With the emergence of competitors, tariffs on transaction costs are likely to decrease, 
thereby further promoting mobile-money expansion. 
The ubiquity of M-PESA in rural Kenya affords opportunity to conduct 
interventions and programs.  One potential application of mobile-money is the use of 
incentives to promote positive behavior change.  Where other studies have provided 
consumable goods or food coupons18, 19, instead, mobile-money incentives could be 
provided.  This alternative provides several advantages.  First, the provision of mobile-
money based incentives allows freedom of the recipient to spend the money as he or she 
sees fit, as contrasted to providing consumable goods.  Second, mobile-money incentives 
may lessen the likelihood of theft and corruption by eliminating the need to have physical 
money, food coupons, or consumable goods at the health facility.  Lastly, mobile-money 
simplifies tracking of payments through the use of a centralized account used to make 
transactions. 
2.8 Contribution to public health  
 
This dissertation will address gaps in the literature surrounding mobile phone 
ownership and texting behavior in lower income countries, identify recent estimates and 
predictors of immunization coverage and, often overlooked, immunization delays.  
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Lastly, the preliminary analysis of the M-SIMU trial, while too small and underpowered 
to provide solid evidence for or against the use of SMS reminders and small monetary 
incentives to improve immunization coverage and timeliness, will expedite the process 
with which results from the full M-SIMU trial can be disseminated to the scientific 
community and policy makers. 
Although the field of mHealth is in its early infancy15, evidence suggests that 
mHealth technologies are effective at promoting positive health behavior change.16 As 
mHealth interventions continue to go to scale, it is imperative to study the distribution of 
mobile phone ownership and SMS behavior in women across different socio-
demographic strata, particularly for mHealth interventions that are aimed at care-seekers.  
If mobile phone ownership is concentrated in older, more educated, wealthier women, 
mHealth interventions may not target recipients that would truly benefit from the 
intervention and novel routes of delivering health messages may be needed. 
Few interventions available to public health practitioners and policy makers rival 
the cost-effectiveness of vaccines at reducing childhood morbidity and mortality.1  
Globally, the literature is plentiful concerning risk factors for being immunized3-5 while 
estimates and predictors of timely immunization is just recently gaining traction in 
resource constrained settings.6, 7  The identification of vaccination coverage and delay 
determinants is important because it allows for public health policies that implement 
interventions aimed at those under- and non-immunized.8-11  Critically, the scale-up of 




Despite the improvement in global immunization coverage levels, there are still 
countries and sub-populations that require interventions and policies that promote 
vaccination uptake.21, 35  In areas where immunization coverage levels are high, the 
paradigm can shift from concerns about getting children vaccinated, to ensuring 
vaccinations are given in a timely manner. The preliminary results of the M-SIMU trial 
will provide some evidence as to whether demand side interventions, SMS reminders and 
monetary incentives, can improve immunization coverage and timeliness in a population 
that has relatively high immunization coverage levels, moderate vaccination delays, and 
adequate mobile phone ownership levels.  This study is the first randomized controlled 
trial that employs SMS reminders for routine pediatric immunizations in lower income 
countries and the first to study the use of monetary incentives for immunization in sub 
Saharan Africa. 
The evidence generated by this dissertation will assist decision makers in the 
Kenyan Ministry of Health, as well as those in other African countries and the greater 
scientific community, before committing the investment, time, and effort that will be 
necessary to scale-up these programs.  Moreover, this project has the opportunity to 
demonstrate the potential of mobile phone technologies in achieving the Millennium 
Development Goal of reducing childhood mortality in Africa. 
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2.9 Tables for Chapter 2 
Table 2.1 The Kenyan Division of Vaccinations and Immunizations pediatric immunizaiton schedule  
 Age at which vaccine is due 
Vaccine Birth 6 weeks 10 weeks 14 weeks 9 months 
BCG X     
Pentavalent  X X X  
Polio  X X X  
Measles     X 
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Table 2.2 Randomized Controlled Trials employing short message system (SMS) reminders to improve healthcare utilization in sub 
Saharan Africa  
Author (year) Population SMS reminder Phone ownership Result 
Lund (2014) 2550 with 1 ANC-Zanzibar Bi-monthly + voucher 37% own 
Share? 
13% difference in >4 
ANC visits 
Pop-Eleches (2011) 431 adults on ART-Kenya Weekly for 48 weeks 100%- given phones 13% difference in 
ARV adherence 
Zurovac (2011) 119 HW  
Kenya 
2 per day for 6 months ≈100% of HW 23.7% difference in 
correct treatment 
Odeny (2012) 1200 adults circumcised- 
Kenya 
Daily for 1 week 100% own 5.7% difference in 
post-op visit 
Lund (2012) 2550 with 1 ANC-Zanzibar Bi-monthly + voucher 37% own 
Share? 
13% difference in 
skilled delivery 
Mbuagbaw (2012) 200 adults on ART-Cameroon Weekly for 6 months 100% -3.4% difference in 
ART adherence. NS 
Lester (2010) 538 adults on ART-Kenya Weekly for 1 year 86% own 
14% share 
12% diff. in ART 
adherence 
De Tolly (2011) 2553 adults S. Africa 3 or 10 SMS 
Motivational or 
Informational 
100%? OR=1.7 Moti-10 in 
HIV testing 
Abbreviations: ANC, antenatal care; ART, anti-retroviral therapy; HW, health worker; post-op, post-operation; NS, not significant; 
OR, odds ratio; SMS, short message system
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2.10 Figures for Chapter 2 
 
Figure 2.1 Pooled odds ratios and forest plot for full immunization status or 3 doses of 
DTP as compared to incomplete status.  
 
 
CAPTION: Reference group for each forest plot is distance closer to the health facility 
(i.e. <1km, <2km, <3km).  This figure comes from a manuscript that is in preparation by 
this dissertation’s author 
 
References for studies included in forest plots: 
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Figure 2.2 Mobile phone subscriptions per 100 adults in eight representative sub Saharan 
Countries (2000-2010) 
 
Data for this figure come from ‘ITC Data and Statistics at www.itu.int  
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Figure 2.3 The Health Belief Model components and linkages 
 
 





Figure 2.4 Intervention points for increasing immunizaiton coverage 
 
Briss, P et al. Reviews of Evidence Regarding Interventions to Improve Vaccination 







Figure 2.5 Distribution of vaccination timelines for pentavalent1 and pentavalent2 
vaccines from the M-SIMU feasibility study conducted in Siaya, County Kenya (2011)  
 
Image adapted from Wakadha, H., Chandir, S., Were, E., Rubin, A., Obor, D., Levine, O., Gibson, DG., 
Odhiambo, F., Laserson, K., Feikin D. The feasibility of using mobile-phone based SMS reminders and 
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Chapter 3. Methods 
 
3.1 Introduction 
The dissertation’s primary aims all arise from various components of the Mobile 
Solutions for Immunization (M-SIMU) village randomized controlled trial.  An overview 
of major project milestones is found in Figure 3.1.  Prior to M-SIMU enrollment, an 
immunization and mobile phone ownership survey was conducted to inform sample size 
and randomization requirements of the randomized trial.  Moreover, focus group 
discussions were conducted to assist with the construction of SMS reminders, incentive 
amounts, and to help foresee any potential problems with mobile-health (mHealth) 
interventions.  The baseline survey provides data for primary aims #1 and #2.  The focus 
group discussion findings are included in primary aim# 2.  Primary aim #3 utilizes pilot 
data from the M-SIMU trial.  A priori, the first 107 infants who were enrolled and had 12 
month follow-up completed were excluded from the larger trial’s formal analyses.  This 
cohort was created to assess the readiness of the automated SMS system to correctly 
deliver SMS reminders This preliminary cohort received all study procedures as those in 
the formal randomized controlled trial and serve as the data source for primary aim#3. 
A brief overview of the study setting will start this chapter followed by a detailed 
description of the M-SIMU study design, randomization procedures, study objectives, 
and sample size requirements; all conducted by this dissertation’s author.  Next, data 
collection, independent and dependent variables, and statistical analyses will be described 
for each primary aim and followed up a discussion of ethical issues.  
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3.2 Study setting 
This dissertation’s studies were conducted in villages within the Kenyan Medical 
Research Institute and Centers for Disease and Control (KEMRI/CDC) Health and 
Demographic Surveillance System (HDSS).   The HDSS is located within Siaya County, 
Nyanza Province in western Kenya and includes Asembo and Gem Districts (Figure 3.2).  
Since 2001, the HDSS has systematically collected vital events; including births, deaths, 
and pregnancies for a population of over 220,000 individuals.1  In addition, every fourth 
months HDSS staff conduct household visits to collect disease morbidity estimates and 
socio-demographic indicators. The HDSS has served as a platform for numerous 
scientific studies, including randomized controlled trials for bed-net efficacy, and 
rotavirus vaccine efficacy.2, 3  
Nyanza Province is one of Kenya’s poorest provinces.4  The major health 
indicators, such as infant mortality rate and third dose coverage of DTP are worse than 
national averages (Table 3.1).  The predominant occupation of Gem and Asembo 
habitants is subsistence farming and the majority of people belong to the Luo ethnic 
group.  Compounds, consisting of 2 to 6 households, are widely dispersed across a bushy 
landscape that is pockmarked with small farming fields.  The north and south are bound 
by paved roads, with only dirt roads cutting through central Gem District. 
Malaria transmission continues to be holoendemic and occurs year-round.5, 6  The 
HIV prevalence among women aged > 13 years old was 15% in 2010, as determined by a 
home-based counseling and testing program (K. Laserson, KEMRI/CDC personal 
communication).   The area has a high under-5 mortality rate (U5MR), 212 deaths per 
1,000 live births, with pneumonia and diarrhea as common causes of childhood 
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mortality.6  In Gem, unpublished DSS data found that coverage with the third dose of 
pentavalent vaccine was 38% at 18 weeks of age and 54% by 24 weeks of age in 2010.  
By ages 12-23 months, the pentavalent3 coverage had increased to 83%, suggesting both 
the need for efforts at increasing vaccine coverage and vaccine timeliness.  
From 2003-2010, Gem was part of a Health and Demographic Surveillance 
System (HDSS) run by KEMRI/CDC.5  In August 2010, the full HDSS stopped in Gem 
due to lack of continued funding.  KEMRI/CDC has maintained good relationships with 
the community throughout this period and has gained the trust and collaboration of the 
leaders and citizens of central Gem.  Pregnancy, births, and deaths were still collected 
from Gem District while the HDSS was postponed.  
 The study area has approximately 24 health facilities where immunizations are 
given.  The majority of these health facilities are government operated and staffed by the 
Kenyan Ministry of Health.  The supply of vaccines to areas clinics is maintained by a 
push system with tri-monthly delivery of vaccines from the District Ministry of Health 
(DMOH).  If clinics run out of vaccines between these tri-monthly deliveries, they can 
request more vaccine from the DMOH.  Periodic vaccine stock-outs, most often measles 
and/or BCG, do occur in Gem clinics and are often due to lack of transportation to get the 
vaccines to the clinic or poor planning to predict impending deficits.  There are little 
problems with pentavalent supply at each clinic, unless there is a national stock-out 
which will affect clinics country wide. 
3.3 The Mobile Solutions for Immunization trial (M-SIMU) 
As discussed previously, the sample for the third manuscript (Chapter 6) comes 
from the first 107 infants that completed 12 month follow up visits.  All study procedures 
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in this preliminary cohort were conducted in the same manner as those infants in the 
parent trial.  A more detailed description of M-SIMU study procedures, as compared to 
methods from Chapter 6, follows. 
 Study design  3.3.1
The M-SIMU study was a four-arm cluster randomized controlled trial.  Villages, 
as defined by the KEMRI/CDC Health and Demographic Surveillance System (HDSS), 
were the units of randomization. Villages were randomized to one of four study arms in a 
1:1:1:1 allocation ratio in September, 2013 (Figure 3.3).  The study arms included: (1) 
Control; (2) SMS reminders; (3) SMS reminders plus 75 Kenyan Schillings (KSH; 85 
KSH=1USD); and (4) SMS reminders plus 200KSH.  SMS reminders were sent both 
three days and one day before immunization doses scheduled at 6 weeks, 10 weeks, 14, 
weeks, and 9 months.  Incentives were delivered to the participant’s mobile phone if the 
participant’s child is brought for immunization within two weeks of the scheduled date.  
All eligible mothers/caretakers residing within a study village were assigned to the study 
arm that the village was allocated.  
 Randomization 3.3.2
The GAUSS™ Mathematical and Statistical System (Aptech Inc., Chandler, AZ) 
was used to conduct a constrained randomization. The GAUSS program iterated until 
5000 acceptable randomizations were found that met the following criteria: 
+/- relative 10% over all 152 villages for the means of the variables:  full 
immunization coverage, phone ownership, distance to the nearest clinic, and 
village population of children 12-23 months old . 
72 
 
+/- relative 25% within each region (Asembo, Gem) for the means of the 
variables:  full immunization coverage and phone ownership. 
The randomization was also stratified on region such that each study arm 
contained 30 villages from Gem and 8 villages from Asembo region.  Data for the 
randomization came from a baseline survey conducted within the study area in March-
April 2013. 
 Setting and participants 3.3.3
Villages were included in the study if they resided within either Gem or Asembo 
HDSS boundaries. Villages were excluded from the M-SIMU study if there were active 
immunization intervention/programs (e.g. NGO outreach immunization clinics) that 
would interfere with the study objectives. Sample size calculations were conducted to 
determine the number of villages needed to be able to detect a 15% absolute difference in 
full immunization coverage at 12 months of age between control and intervention arm.   
To ensure accurate population numbers, KEMRI/CDC HDSS casually employs 
‘village reporters’ to identify births, deaths, and pregnancies within their community. For 
the M-SIMU trial, village reporters identified new births and sent a birth notification 
SMS to the RapidSMS server, a free and open-source platform (Figure 3.4). The 
notification SMS included the study village and compound number.  The RapidSMS 
server automatically relayed the notification to a Community Interviewer (CI).  The CI 
visited newborn’s compound to explain the trial and screen the mother/caretaker for the 




1) Mother of infant aged 0-4 weeks during the study period 
2) Current resident of one of the study villages  
3) Willing to sign informed consent for the study 
Exclusion Criteria: 
1) Plans to move out of the study area in the next 6 months 
2) Has already received immunizations other than birth dose of BCG or polio  
Mothers were eligible independent of mobile phone ownership.  Mothers only 
needed to have access to a mobile phone, whereby access was defined by the mother and 
could include someone that lives in household, compound or a neighbor.  If no phone was 
identified, community interviewers were tasked to deliver incentives.  According to our 
baseline survey, 94% of mothers owned or had access to a mobile phone within the 
compound (See Chapter 5). 
Eligible mothers were required to provide both oral and written informed consent 
to the Community Interviewer.  Upon providing consent, the Community Interviewer 
sent an enrollment SMS to the RapidSMS server that contained the mother’s village and 
compound number, the phone number that can be used to receive an SMS, the child’s 
date of birth, the preferred language to receive SMS’s (English, Kiswahili, or Dholuo), 
and the baby’s first and last name.  Upon completion of a successful enrollment SMS, the 
RapidSMS server sent a personalized SMS to the mother (Table 3.2).   
 Control and intervention arm descriptions 3.3.4
The interventions, SMS reminders and incentives, were designed to motivate mothers and 




SMS reminders were a component of all three intervention arms.  SMS reminders 
were sent using RapidSMS on both 3 days and 1 day before the scheduled immunization 
visits at 6,10, and 14 weeks for the three doses of pentavalent vaccine and at 9 months for 
measles as per  Kenyan Expanded Programme on Immunization (KEPI) guidelines.  SMS 
reminders were sent as text messages in English, Kiswahili or Dholuo language, 
according to the mother’s preference as indicated at enrollment.  If a pentavalent 
vaccination was given later than the scheduled date, then the SMS reminders for the 
subsequent pentavalent dose were reprogrammed to occur at four weeks from the date of 
vaccine receipt, as per KEPI guidelines.7  As an example, if a child received pentavalent1 
at 8 weeks of age (scheduled to be given at 6 weeks), the immunization reminders for 
pentavalent2 were sent when the child was 12 weeks old (instead of the KEPI schedule of 
10 weeks).   
SMS reminders were composed of a core text and a motivational saying (Table 
3.2).  The core message stated which vaccine is due this week.  If the participant was in 
an incentive arm, the SMS also contained the amount of money the mother would be 
remunerated for timely vaccinating her infant. The motivational sayings attached at the 
end of the SMS were chosen from the results of a Focus Group Discussion on using 
mobile phones to improve immunizations (See Chapter 5).  The four sayings included in 
M-SIMU SMSs were: “Vaccines save Kenyan babies lives”, “Baby < INSERT BABY 
FIRST NAME> is happy when healthy “Most <INSERT DISTRICT: ASEMBO or 
GEM> babies get vaccinated, be one of them”, and “Vaccines are available now”.  For 
each vaccine dose, one of the four motivational sayings was randomly selected, with 
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replacement, by the RapidSMS software.  The same motivational saying was used for the 
3 day and 1 day reminder for that particular vaccine dose. 
Incentives 
Mobile phone based monetary incentives were a component of study arms #3 and 
#4.  The delivery of the incentive in arms #3 and #4 was identical; only the incentive 
amount differed.  In addition to SMS reminders, mothers were sent either 75KSH or 
200KSH (arm #4) to the mobile phone number they identified at enrollment for each 
timely dose of pentavalent and measles vaccine, defined as within 2 weeks of the 
scheduled date (i.e., pentavalent1 at 6 weeks, pentavalent2 and pentavalent3 four weeks 
after the previous dose and measles at 9 months.)  If a mother brought her child for 
vaccination after 2 weeks of scheduled date, no incentive was transferred.  Cash transfers 
were done using the preferred mobile money network of the participant and were to be 
delivered within 24 hours of vaccine receipt.   
The incentive amounts in arms #3 and #4 were guided by opinions of mothers, 
village reporters, and local transport costs.  The intent of the incentive was to help offset 
the costs associated with transportation to the clinic.  The transaction costs associated 
with mobile-money transactions were borne by the study such that mothers will receive 
the full amount indicated.  
Control 
Mothers that resided in control arm villages received a congratulatory SMS at 
enrollment which included a general-health related saying, “The greatest wealth is 
health”.  No additional SMS’s or incentives were sent to mothers.  At the 12 month 
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follow-up visit, community interviewers referred mothers of under-vaccinated children to 
the nearest clinic. 
 Study objectives 3.3.5
The following primary and secondary objectives are for the formal M-SIMU trial 
and do not necessarily represent objectives of this dissertation. 
Primary objective 
The study was powered to determine if SMS reminders, with or without 
incentives, could increase the percentage of fully immunized children (FIC) by 15% as 
compared to control group at 12 months of age in rural western Kenya.  A fully 
immunized child was defined as children that received one dose of BCG, 3 doses of 
pentavalent and polio, and 1 dose of measles vaccine. 
Secondary objective 
The study assessed several secondary objectives that primarily focused on timely 
receipt of individual vaccines and effect modifiers on the primary outcome.  These 
secondary objectives included: 
1. To determine if interventions increased timely vaccine coverage by 15% as compared 
to control group at 10 months of age 
2. To determine if interventions increased the percentage of children vaccinated within 2 
weeks of each scheduled vaccine date compared with control group;  
3. To determine if interventions decreased drop-out in vaccination between first and third 
pentavalent dose compared with control group;  
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4. To determine if the 200KES arm increased timely vaccine coverage, increased the 
percentage of infants vaccinated within 2 weeks of scheduled date, and decreased drop-
out between 1st and 3rd dose of pentavalent vaccines as compared to the 75KES arm;  
5. To determine if either the 75 or 200 KES arm increased timely vaccine coverage, 
increased the percentage of infants vaccinated within 2 weeks of scheduled date, and 
decreased drop-out between 1st and 3rd dose of pentavalent vaccines as compared to the 
SMS alone arm;  
6. To determine if measles vaccine coverage varied by study arm; 
7. To determine if pentavalent3 vaccine coverage varied by study arm; 
8.  To determine if there was a differential effect on vaccine coverage  based on owning 
one’s own phone versus using someone else’s phone; 
9. To determine if there was a differential effect on vaccine coverage based on residential 
distance from a health facility; 
10. To determine if the interventions impacted other indicators of health status, including 
anthropometric measurements (e.g. weight-for-height, weight-for-age), bed-net usage, 
vitamin A coverage, retention of the “maternal child health” card, and all-cause mortality;  
11. To evaluate the direct costs for each intervention arm per additional child vaccinated 
beyond the status quo (i.e. control group); 
3.4 Data collection 
 Primary Aim #1 3.4.1
The first primary aim was to determine immunization coverage and timeliness 
using data from a baseline survey of the M-SIMU trial conducted in March and April of 
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2013.  This survey is also the source of data for primary aim #2 (excluding the focus 
group discussion portion).  The questions for this survey were selected from a cache of 
HDSS surveys that are routinely used for immunization coverage.  Specifically, questions 
for our baseline survey came from the KEMRI/CDC HDSS Bed-net form, Religion, 
Ethnicity, and Marriage form, Education Status Form, Immunization Form, and 
Household Socio-Economic Form.  A written version of the pooled questions was 
provided to a KEMRI/CDC programmer to digitize the survey (Appendix 1).  The 
surveys were constructed using ODK collect and placed on Huawei Y200 simple smart 
phones.  Skip patterns and quality checks were programmed into ODK to help minimize 
potential errors in data entry and analysis.  The survey was piloted by KEMRI/CDC staff 
members and revisions to survey were made as needed.   
Prior to commencement of baseline survey, twenty-two KEMRI/CDC 
Community Interviewers underwent five days of training.  Each survey question was 
discussed in Swahili, Luo, and English language. One day was spent doing role-play 
interviews in front of the trainees.  The last day, community interviewers piloted the 
baseline survey in the field.  Additionally, community interviewers were taught research 
ethics, interview techniques and handling methods of the mobile phone.  Of note, the 
majority of the community interviewers were previously employees of KEMRI/CDC or 
had experience administering surveys with other local organizations  
  With a census of HDSS consented households, community interviewers 
approached eligible households and asked the compound head if they could interview the 
caregiver of the child between the ages of one and two years.  Staff members then asked 
the caregiver if the maternal and child health (MCH) booklet was available, and if so, 
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immunization dates were entered into the mobile-phone based survey.  If no MCH 
booklet was present, staff collected immunization history through verbal report.  Verbal 
report of BCG vaccination was validated by examination of infant’s arm for a scar.  No 
efforts were made to validate other vaccinations.  Data was cleaned continuously after 
data entry and missing or questionable data points were relayed back to field staff for 
follow-up visits. 
   
 Primary Aim#2 3.4.2
The second primary aim is to assess the mHealth preparedness of the community 
through focus group discussions and a baseline survey of mobile phone ownership and 
text messaging behavior.  As the data source for mobile phone ownership and SMS 
behavior was the same survey used in primary aim #1, this section will focus on focus 
group discussion.  
  A semi-structured questionnaire guide was used to elicit mother’s responses on 
barriers to immunization, SMS reminders for pediatric immunization dates, and monetary 
incentives to motivate mothers to bring children for immunization (Appendices 2 and 3).  
This guide was created by members of the Johns Hopkins study team and edited by 
KEMRI/CDC staff to ensure cultural appropriateness.  The focus group discussion was 
piloted twice with community interviewers playing the role of participants.  
A total of thirty women participated in one of three focus group discussions over 
the span of two days in June 2013.  Prior to the group discussions, participants were 
individually surveyed by KEMRI/CDC study staff to assess mobile phone literacy. Focus 
group discussions, lasting approximately 2-2.5 hours were audio recorded, transcribed 
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into Dholuo, and then translated into English.  Audio recordings were destroyed after 
transcription and translation.  Mothers were given participant IDs, which were used to 
identify women during the focus group discussions.  No names were recorded during 
discussions or written on questionnaires. 
During the focus group discussion, we required individual responses of 
participants. For these questions, participants either wrote the answer on a small piece of 
paper or placed a pre-printed response in bins labeled #1 (i.e. favorite, preferred, best), #2 
(i.e. second favorite, preferred, best), etc.  De-identified responses from individual 
surveys and group discussions were entered into Microsoft Excel and stored on the secure 
KEMRI/CDC network. 
 Primary Aim#3 3.4.3
Primary aim #3 is to determine the effect of SMS reminders with or without 
monetary incentives on timely immunization of pentavalent3 and measles vaccines.  A 
priori, the first 107 M-SIMU participants that completed a 12 month follow-up visit were 
designated as a pilot cohort to assess the performance of SMS delivery system and survey 
instruments. These participants underwent all study procedures as those in the formal 
(non-pilot) trial and serve as the population for this dissertations third primary aim. 
The M-SIMU study is designed to minimally interfere with routine care-seeking 
behaviors of mothers and routine delivery of care by health practitioners.  Participants 
were interviewed, at most, six times.  All participants were interviewed at enrollment 
when infant was between 0 and 4 weeks old and at follow up when the infant was 12 
months old.  If a mother brought her infant for vaccination at an M-SIMU clinic, there 
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was a short interview for each of the four immunization visits (pentavalent1, 
pentavalent2, pentavalent3, and measles vaccines). 
Eight community interviewers from the baseline survey in primary aims #1 and 
#2 were rehired for the randomized controlled trial to conduct screening, informed 
consent, enrollment surveys, and follow-up surveys.  Community interviewers underwent 
five days of training in August 2013 where refresher courses on interview techniques and 
research ethics were provided.  The screening, consent form, and enrollment survey were 
also presented to the Community Interviewers and each section was discussed in Swahili, 
Luo, and English languages.  Informed consent and enrollment role plays occurred during 
the training session and community interviewers piloted the instruments in the field.  The 
screening form and enrollment survey were conducted using ODK Collect software 
installed on a simple smart mobile phone (Huawei Ascend Y200 model).  Information 
collected at enrollment includes mobile phone literacy, demographics, vaccine 
perceptions, transportation, and socioeconomic status.  After the enrollment survey was 
completed, community interviewers sent an enrollment SMS to the KEMRI/CDC based 
RapidSMS server (Figure 3.4).8  This SMS included the infant’s village number, 
compound number, first and last names, preferred language to receive SMS, and the 
caregiver’s mobile phone number. 
To prospectively document immunization status, KEMRI/CDC health facility 
recorders were stationed in twenty-four health facilities that resided within the study 
setting.  Health facility recorders were rehired from the M-SIMU baseline survey or from 




 All infants that presented to M-SIMU health facilities were queried by Health 
Facility recorders for their M-SIMU enrollment status.  Enrollment status was confirmed 
using enrollment lists located on password protected netbooks.  For enrolled children, the 
health facility recorder sent an SMS message to the RapidSMS server after an enrolled 
infant was vaccinated (Figure 3.4).  This SMS contained the child’s study id, the date of 
vaccination, which vaccine was received, and the new phone number if the mother has 
changed phone lines.  After the vaccine receipt SMS was sent, health facility recorders 
interviewed participants using a net-book based questionnaire.  
For clinics where few immunizations are given per day, there was no permanent 
health facility recorder stationed due to financial constraints.  Rather, health facility 
recorders from neighboring clinics visited these smaller clinics at the end of the day, 
collected immunization information for enrolled mother-infant pairs, and sent the vaccine 
receipt SMS to RapidSMS system.   
When enrolled infants reached 12 months of age, community interviewers 
conducted in-home follow up visits to ascertain immunization status and collect 
information on mothers’ perceptions of intervention.  Surveys were conducted using the 
ODK application loaded on a simple smart phone as described during the enrollment 
procedures.  Community Interviewers also hand-wrote immunization dates on a paper 
form as a measure of double-data entry. 
3.5 Definition of dependent variables 
 Primary Aim #1 3.5.1
Data for primary aim#1, to estimate prevalence and risk factors for delayed 
vaccination and not receiving immunization were collected from a baseline survey of the 
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M-SIMU trial. The two primary outcomes were infants that did not receive vaccination 
and infants with delayed vaccination.  Analyses for infants that did not receive vaccine 
were restricted to pentavalent3, measles vaccine, and fully immunized coverage (FIC), 
defined as infants that received BCG, three doses of pentavalent vaccine, three doses of 
polio vaccine, and measles vaccine.  Analyses for infants that received delayed 
vaccination were restricted to pentavalent1, pentavalent3, measles vaccine, and FIC.  The 
proportion of infants not receiving a vaccine was generated for each vaccine and defined 
as: 
% 𝑛𝑛𝑛 𝑣𝑣𝑣𝑣𝑣𝑛𝑣𝑛𝑣𝑣 =
𝑛 𝑣𝑛𝑖𝑣𝑛𝑛𝑖 𝑛𝑛𝑛 𝑣𝑣𝑣𝑣𝑣𝑛𝑣𝑛𝑣𝑣
𝑁
 
  where, N= the full sample of infants 
 For each regression model, non-vaccination was defined as dichotomous variable with 
infants that did not receive vaccination coded as a 1 and infants that received vaccination 
as 0.   
 An infant was labeled delayed if vaccination occurred greater than four weeks 
from the Kenyan Division of Vaccination and Immunization (DVI) scheduled date.9  For 
pentavalent1, pentavalent3, and measles, infants were labeled delayed if vaccinated after 
10 weeks, 18 weeks, and 302 days, respectively.  Delayed FIC was defined as infants that 
received at least one vaccine after 12 months of age, given that all eight vaccines were 
received. The proportion of infants with delay for a vaccine was generated for each 
vaccine and defined as: 
% 𝑣𝑣𝑑𝑣𝑑 =
𝑛 𝑣𝑛𝑖𝑣𝑛𝑛𝑖 𝑣𝑣𝑑𝑣𝑑𝑣𝑣 𝑣𝑣𝑣𝑣𝑣𝑛𝑣





For each regression model, delayed immunization was defined as a dichotomous 
variable with infants that were vaccinated with delay coded as 1 and infants that were 
timely vaccinated coded as 0.  
Underimmunization was defined as an infant that neither received the vaccine nor 
received the vaccine within four weeks of the scheduled date.   Severely underimmunized 
infants were defined as the proportion of infants that were underimmunized for greater 
than 90 days in the first 12 months of life and were delayed for three of five vaccines 
(BCG, pentavalent1, pentavalent2, pentavalent3, and measles). Infants were not severely 
underimmunized if the total number of days underimmunized was less than 90 days or if 
less than three vaccines were received with delay. 
% 𝑖𝑣𝑣𝑣𝑟𝑣𝑑𝑑 𝑢𝑛𝑣𝑣𝑟𝑣𝑢𝑢𝑢𝑛𝑣𝑢𝑣𝑣 =
𝑛 𝑣𝑛𝑖𝑣𝑛𝑛𝑖 𝑖𝑣𝑣𝑣𝑟𝑣𝑑𝑑 𝑢𝑛𝑣𝑣𝑟𝑣𝑢𝑢𝑢𝑛𝑣𝑢𝑣𝑣
𝑁 
 
where, N= the full sample of infants 
  For each regression model, severely underimmunized was defined as dichotomous 
variable with infants that were severely underimmunized coded as a 1 and infants that 
were not severely underimmunized coded as 0.   
 Primary Aim #2 3.5.2
Data for primary aim#2, to estimate mobile phone ownership levels, SMS 
utilization, and their respective predictor variables were collected from a baseline survey 
of the M-SIMU trial. All three primary outcomes were self-reported by caregivers with 
infants aged 12-23 months and analyzed using logistic regression.  Mobile phone 
ownership was coded as ‘1’ if the mother owned a mobile phone and coded as ‘0’ if the 
mother either shared or did not own a mobile phone. For receiving and sending SMS 
primary outcomes, participants were asked if they received or sent an SMS in the past 
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week.  Participants that replied yes were coded as ‘1’ and participants that replied no 
were coded as ‘0’.   
 Primary Aim #3 3.5.3
Data for primary aim#3, to determine the effect of SMS reminders, with or 
without monetary incentives, on pentavalent3 and measles vaccination, arose from the 
first 107 participants with completed M-SIMU 12 month follow-up visits.  The two 
primary outcomes were pentavalent3 vaccination and measles vaccination. To determine 
a final immunization status for pentavalent and measles, decision trees were generated 
and employed based on whether the mother provided a maternal and child health card 
(MCH) (Figure 3.5) or oral report (Figure 3.6).  A child was defined as vaccinated for 
measles or pentavalent3 if there was written confirmation independent of the M-SIMU 
study staff’s records (i.e. the immunization SMS sent by the health facility recorder).   
Infants with maternal and child health booklet at follow-up was sufficient for determining 
primary outcomes, unless there was discrepancy with dates from immunization SMS 
records, in which case, the clinic immunization log book was used to resolve date 
differences.  For those that orally reported at follow-up, clinic records were searched and 
immunization date recorded. 
The infant’s age at vaccination was calculated by subtracting the infant’s date of 
birth from the date of vaccination.  Infants were considered vaccinated with pentavalent3 
by 24 weeks of age if the infant received the three dose pentavalent sequence before the 
infant aged to 168 days (24 weeks).  Infants were considered vaccinated with measles 
vaccine by 10 months of age if the infant received measles vaccine by 302 days of age 
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(10 months).  The measles primary outcome was independent of child’s pentavalent3 
status.  
3.6 Statistical analyses 
 Primary Aim #1 3.6.1
Data were explored for incomplete or nonsensical immunization data (i.e. 
pentavalent vaccine given before child was born).  Crude risk ratios with 95% confidence 
intervals were obtained by binomial regressions with log link function were conducted to 
obtain crude risk ratios and their 95% confidence intervals for each of the independent 
variables.   
Log((P(Y=1)/(Pr(Y=0)) = β0 + β1X1 + β2X2 +….βnXn 
where Y = immunization outcome, Y=1 for participants that were delayed, did not 
receive immunization, or were severely underimmunized and Y=0 for participants that 
were timely immunized, received immunization, or were not severely underimmunized. 
Three separate models were used for the three primary outcomes.  The first model 
compared infants who did not receive vaccination to infants who received vaccination.  
The second model compared infants that received vaccinations with delay to infants that 
received vaccinations on time. The third model compared infants that were severely 
underimmunized to infants that were not severely underimmunized.  Variables that were 
included in final adjusted models were selected using forward-stepwise selection with an 
alpha of 0.05. Analyses were performed using STATA/IC, version 11.2 (Stata Corp, 
College Station, Texas). An alpha of 0.05 was used for all hypothesis testing.   
87 
 
 Primary Aim #2 3.6.2
Prior to construction of regression models, data were checked for completeness 
and accuracy.  Three separate models were used to obtain odds of mobile phone 
ownership as compared to odds of not owning a mobile phone; odds of sending an SMS 
in the past week as compared to odds of not sending an SMS in the past week; and odds 
of receiving an SMS in the past week as compared to odds of not receiving an SMS in the 
past week. Unadjusted odds ratios with 95% confidence intervals were obtained using 
bivariate logistic regressions for each of the independent variables.   
Log((P(Y=1)/(1-Pr(Y=0)) = β0 + β1X1 + β2X2 +….βnXn 
where Y = dichotomous mobile phone ownership with 1= a mother that owned a mobile 
phone and 0= a mother that did not own a mobile phone; Xn = covariates 
 
Variables for final multivariate models were selected using forward step wise 
Akaike Information Criteria.10 Potential interactions were explored and included in model 
if statistically significant.  Additional models for odds of receiving and sending SMS with 
the mobile phone ownership variable were also created. An alpha of 0.05 was used for all 
hypothesis testing. 
 Primary Aim #3 3.6.3
 
Cluster level and individual level estimates of baseline variables were generated for 
each study arm and visually inspected to see if there were any differences in study arms.  
The large number of clusters per study arm allowed us to conduct individual level 
analyses as compared to cluster level analyses.  Individual analyses were favored because 
of their efficiency and their ease to adjust for covariates in a single.11 
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Analyses were first conducted using intention-to-treat (ITT) for delivery of SMS 
reminders.  Per protocol analyses were conducted to support ITT analyses.12  Inverse 
Kaplan-Meier curves were created for the pentavalent3 and measles primary outcomes.13-
15  Infants were censored at 24 weeks for pentavalent3 and 302 days for measles if the 
vaccine was not received by the respective time points.  As applicable, infants were 
censored at age of death or out-migration if vaccine was not received. Log rank tests with 
trend option were used to assess the global equality of inverse survival curves and 
differences in trends across the four study arms.16  To assess the proportional hazards 
assumption for Kaplan-Meier survival analysis, log-log plots were created and visually 
assessed for parallel curves.17   Additionally, the proportional hazard assumption for Cox 
regression models was tested based on examination of Schoenfeld residuals.18   
Cox regressions that included adjustment for the cluster design of the trial by use 
of robust variance estimates of immunization status at village level19 were employed to 
obtain unadjusted hazard ratios and 95% confidence intervals by study arms for 
pentavalent3 and measles vaccination.20  
Log((H(t)/(H0(t)) =  i.β1StudyArm  
Where H(t) is equal to hazard at time t for measles or pentavalent3 vaccination and H0(t) 
is equal to baseline hazard at time t for those with all predictor variables equal to 0 
 
 For all models, study arm was entered into the model as a dummy variable where 
the control arm served as the reference group. A priori, we included mobile phone 




Log((H(t)/(H0(t)) =  i.β1StudyArm β1MobilePhone + β2Region + β3Time 
Additional variables were included in adjusted Cox regressions if there were 
differences in their distribution by study arm and if their unadjusted Cox regression 
estimates were statistically significant. Added variables to multivariate models were 
included with the ‘strata’ option to allow for different baseline hazards of covariates.  
Effect modifications of mobile phone ownership and time to clinic on pentavalent3 and 
measles vaccinations by study arm were explored.  An alpha of 0.05 was used for all 
hypothesis testing.  Analyses were performed using STATA/IC, version 11.2 (Stata Corp, 
College Station, Texas).   
 Power calculations for M-SIMU 3.6.4
The sample size for the M-SIMU preliminary cohort was predetermined.  With a 
fixed sample size, control arm survival probabilities (that is the proportion of those not 
vaccinated) surrounding the observed survival probabilities of pentavalent3 and measles 
vaccination were varied to assess the power of different effect estimates (Figure 3.7).  
 Power calculations were calculated for comparisons of 200KSH arm (n=27 
infants) to control arm participants (n=22 infants).  Survival probabilities of control arm 
participants at 16 weeks for pentavalent3 (60%) and 286 days for measles vaccination 
(50%) were used to generate survival probabilities for hazards ratios ranging from 1.5 to 
3.0.  The control arm survival probabilities were varied +/- 10 absolute percentage points.  
For pentavalent3 and measles vaccination, we had approximately 50% power to detect a 
hazard ratio of at least 2.0 for the primary vaccination outcomes 




The study protocol received ethical clearance from the Scientific Steering 
Committee (SSC), the KEMRI-Nairobi Ethical Review Committee (ERC; SSC#2409), 
Johns Hopkins University Bloomberg School of Public Health (deferred ethical clearance 
to KEMRI); Centers for Disease Control and Prevention (deferred ethical clearance to 
KEMRI) (Appendices 4 and 5).  Letters of support were obtained from the Provincial 
Ministry of Health and District Ministries of Health.  Extensive community mobilization 
activities occurred prior to the start of the trial.  These activities entailed meetings with 
village elders, chiefs, and Community Advisory Board members. A large focus of these 
activities was explaining to the community that different villages will be receiving 
different interventions (i.e. you may not receive an incentive) and that no experimental 
vaccines will be given. The trial is registered with ClinicalTrials.gov as NCT01878435. 
Data storage and study participant confidentiality: 
Interviews and surveys were conducted privately and participants were told that 
their participation was voluntary. Data and study forms were kept confidential.  Data 
were stored in a secure database, either in a locked file cabinet or password -protected 
computer, at the study headquarters in KEMRI/CDC-Kisian.  This field site has 24 hour 
security and requires identification badges and key-codes for entrance.  A limited number 
of authorized staff was allowed access to the data.  Staff that had access to data were 
required to sign a document stating they agree to maintain confidentiality of participants’ 
personal records. 
For focus group discussions, mothers were given ID numbers which were used to 
identify women throughout the focus groups.  No names were recorded during 
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discussions or written on questionnaires. Audio recordings of focus group discussions 
were destroyed after transcription and translation to English language. 
Consent process  
For focus group discussions and the M-SIMU trial, community interviewers 
approached eligible mothers and explained study procedures, risks involved, any 
potential benefits, participation was completely voluntary, and participants could 
withdraw from study at any time.  Community interviewers allowed ample time for any 
questions from potential participants.  The informed consents were provided in English, 
Dholuo, and Kiswahili languages (Appendices 6 and 7).  In rare instances where a mother 
or caretaker was illiterate, verbal consent was sought in the presence of someone who 
was neither study staff nor a family member.  For the M-SIMU trial, if participants were 
interested in participation, a short screening form was administered 
Risks 
For the M-SIMU randomized controlled trial and focus group discussions, the risks 
assumed by study participation were minimal.  M-SIMU specific risks included: 
1. Potential inconvenience from survey questions.  Some people might find the 
questions asked of them take too much time out of their day. 
2. Potential anxiety or discomfort from not being randomized to an incentive arm. 
3. Potential invasion or loss of privacy 
There was no physical risk to the mother or infant as a result of their participation.  
All vaccines given in the study were routine immunizations recommended by the Kenyan 
MOH EPI program.  Although there were risks of adverse events associated with 
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vaccines, the trial does not require infant vaccination for participation.  No experimental 
or unapproved vaccines were given.  Furthermore, no biological samples were taken. 
Minimizing risks 
The risks associated with inconvenience of time were minimized by ensuring that 
the field staff was well trained in survey administration and reminding mothers that their 
participation was completely voluntary.  There were several short surveys conducted at 
several time points.  These included enrollment and screening surveys conducted at 
participant’s house, a twelve month follow-up survey conducted at participant’s house 
when infant aged 12 months, and up to four surveys conducted at clinic, if infant was 
vaccinated. No sensitive questions, such as HIV status were asked throughout the trial. 
Risks of anxiety or discomfort felt by participants that were randomized to a non-
incentive arm were minimized by the study’s decision to conduct a public randomization 
ceremony.  Village chiefs and community members were involved with randomization 
and allocation of study arms.  Intensive community mobilization efforts were made prior 
to study initiation.  
Risks of invasion or loss of privacy were minimized by conducting surveys in 
private areas at the both the household and immunization clinic.  Additionally, study 
records were de-identified, kept in locked cabinets and/or password protected computers, 
and their access was restricted to principal investigators and those involved with data 
collection and analysis. 
Potential benefits to participants 
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Possible benefits to the child included improved timeliness of immunizations.  
Some mothers received incentives up to 800 Ksh ($10 USD) if their infant was brought 
on time for pentavalent1, pentavalent2, pentavalent3, and measles vaccine, an amount she 
would typically not have received if not for this trial.  The results of this study will be 
shared with the Kenyan Ministry of Health and may help future Kenyan infants in 




3.8 Tables for Chapter 3 
 
Table 3.1 Socio-demographic indicators for Gem District, Nyanza Province, and Kenya  
 












% population < 5 years old 17.2% NA 15.7% 
Crude Birth Rate 39.8 NA 34.8 
Total Fertility Rate 5.7 5.4 4.6 
Neonatal Mortality Ratio 
(deaths per 1000 live births) 34.6 39 31 
Infant Mortality Ratio  
(deaths per 1000 live births) 119.9 95 52 
Under-5 Mortality Ratio  
(deaths per 1000 live births) 212 149 74 
% literate females age 15-49 
years old NA 89.8% 84.9% 
DTP3 Coverage 12-23 
months  86% 77% 86.4% 
Data for this table come from the KEMRI/CDC database (Gem District Column) and Kenya National 
Bureau of Statistics (KNBS), ICF Macro. Kenya demographic and health survey 2008-2009. 
2010;Calverton, Maryland:KNBS and ICF Macro (KDHS, 2009)
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Table 3.2 Content of short message system (SMS) for enrollment and reminders in the Mobile Solutions for Immunization (M-SIMU) 
trial 
Message Type Message Timing  Control SMS Reminders Only 75 KSH 200 KSH 
Enrollment 
message  
Enrollment  Thank you for 
enrolling Baby 
<FName> to the 
KEMRI/CDC M-
SIMU study.  The 
greatest wealth is 
health. 
 
Thank you for enrolling your 
child in the KEMRI/CDC M-
SIMU study. You will get 
periodic reminders for Baby 
<Baby FName>’s 
vaccinations. The greatest 
wealth is health. 
Thank you for enrolling your 
child in the KEMRI/CDC M-
SIMU study. You will get 
periodic reminders for Baby 
< Baby FName >’s 
vaccinations. The greatest 
wealth is health. 
Thank you for enrolling your 
child in the KEMRI/CDC M-
SIMU study. You will get 
periodic reminders for Baby 
< Baby FName >’s 
vaccinations. The greatest 
wealth is health. 
3 day reminder 
message  
 
Pentavalent 1  
DOB  + 6 weeks – 
3 days   
 
No message   
 
Tell Mama<Baby FName> 
that Penta-1 vaccine is due 
this week. <Motivational 
Message>  
 
Tell Mama <Baby FName> 
that Penta-1 vaccine is due 
this week. You get 75ksh if 
Baby vaccinated in next 2 
weeks. <Motivational 
Message>  
Tell Mama<Baby FName> 
that Penta-1 vaccine is due 
this week. You get 200ksh if 
Baby vaccinated in next 2 
weeks. <Motivational 
Message> 
1 day reminder 
message 
 
Pentavalent 1  
DOB  + 6 weeks – 
1 day   
No message   
 
Tell Mama <Baby FName> 
that Penta-1 vaccine is due 
this week. Go to the clinic if 
you haven’t already. 
<Motivational Message> 
Tell Mama < Baby FName > 
that Penta-1 vaccine is due 
this week. Go to the clinic if 
you haven’t already. 
<Motivational Message> 
Tell Mama<Baby FName> 
that Penta-1 vaccine is due 
this week. Go to the clinic if 
you haven’t already. 
<Motivational Message> 




DOB  + 10 weeks 
– 3 days 
No message   Tell Mama<Baby FName> 
that Penta-2 vaccine is due 
this week. <Motivational 
Message>  
Tell Mama<Baby FName> 
that Penta-2 vaccine is due 
this week. You get 75ksh if 
Baby vaccinated in next 2 
weeks. <Motivational 
Message>  
Tell Mama<Baby FName> 
that Penta-2 vaccine is due 
this week. You get 200ksh if 
Baby vaccinated in next 2 
weeks. <Motivational 
Message> 




DOB  + 10 weeks 
– 1 day 
No message Tell Mama<Baby FName> 
that Penta-2 vaccine is due 
this week. Go to the clinic if 
you haven’t already. 
<Motivational Message>  
Tell Mama<Baby FName> 
that Penta-2 vaccine is due 
this week. Go to the clinic if 
you haven’t already. 
<Motivational Message> 
Tell Mama<Baby FName> 
that Penta-2 vaccine is due 
this week. Go to the clinic if 
you haven’t already. 
<Motivational Message> 
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Message Type Message Timing  Control SMS Reminders Only 75 KSH 200 KSH 




DOB  + 14 weeks 
– 3 days   
No message   
 
Tell Mama<Baby FName> 
that Penta-3 vaccine is due 
this week. <Motivational 
Message>  
 
Tell Mama<Baby FName> 
that Penta-3 vaccine is due 
this week. You get 75ksh if 
Baby vaccinated in next 2 
weeks. <Motivational 
Message>  
Tell Mama<Baby FName> 
that Penta-3 vaccine is due 
this week. You get 200ksh if 
Baby vaccinated in next 2 
weeks. <Motivational 
Message> 




DOB  + 14 weeks 
–1 day   
 
 
No message   
 
Tell Mama<Baby FName> 
that Penta-3 vaccine is due 
this week. Go to the clinic if 
you haven’t already. 
<Motivational Message>  
Tell Mam <Baby FName> 
that Penta-3 vaccine is due 
this week. Go to the clinic if 
you haven’t already. 
<Motivational Message> 
Tell Mama<Baby FName> 
that Penta-3 vaccine is due 
this week. Go to the clinic if 
you haven’t already. 
<Motivational Message> 




DOB  + 9 months – 
3 days   
No message   
 
Tell Mama <Baby FName> 
that Measles vaccine is due 
this week. <Motivational 
Message>  
Tell Mama <Baby FName> 
that Measles vaccine is due 
this week. You get 75ksh if 
Baby vaccinated in next 2 
weeks. <Motivational 
Message>  
Tell Mama <Baby FName> 
that Measles vaccine is due 
this week. You get 200ksh if 
Baby vaccinated in next 2 
weeks. <Motivational 
Message> 




DOB  + 9 months – 
1 day   
No message   
 
Tell Mama <Baby FName> 
that Measles vaccine is due 
this week. Go to the clinic if 
you haven’t already. 
<Motivational Message>  
Tell Mama <Baby FName> 
that Measles vaccine is due 
this week. Go to the clinic if 
you haven’t already. 
<Motivational Message> 
Tell Mama <Baby FName> 
that Measles vaccine is due 
this week. Go to the clinic if 




Appended on to 3 




No message   
 
1. Vaccines save Kenyan babies lives 
2. Most <District: Asembo or Gem> babies get vaccinated, be one of them 
3. Baby < Baby FName > is happy when healthy. 
4. Vaccines are available now. 
 
Motivational message is the same for the 1st and 3rd day reminder of the specific vaccine dose 
Abbreviations: DOB, date of birth; Fname, first name; KSH, Kenyan Schilling;   
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3.9 Figures for Chapter 3 
Figure 3.1 The Mobile Solutions for Immunization (M-SIMU) timeline 
 





Figure 3.2 Maps of study site and health facilities 
 
 




Figure 3.3 Villages randomized to study arms and health facilities 
 
Abbreviations: KES, Kenyan Schilling; SMS, short message system 
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 Figure 3.4 Short message system (SMS) and incentive flow diagram 
 
Image from Wakadha, H, et al. The feasibility of using mobile-phone based SMS reminders and conditional cash transfers to improve timely immunization in 
rural Kenya. Vaccine. 2013 Jan 30;31(6):987-93.
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Abbreviations: MCH, maternal and child health booklet; SMS, short message system
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Abbreviations: SMS, short message system
103 
 
Figure 3.7 Power calculations for hazard ratios for pentavalent3 and measles vaccination 
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Chapter 4. Predictors of non-immunization, delayed immunization, and severely 
underimmunized infants in rural western Kenya 
4.1 Abstract 
Objectives: To determine vaccination coverage, timeliness, and underimmunized 
estimates.  To identify risk factors for not being vaccinated, receiving vaccinations with 
delay, and being severely underimmunized in rural western Kenya. 
Methods:  In preparation for the Mobile Solutions for Immunizations (M-SIMU) 
randomized controlled trial, KEMRI/CDC HDSS identified 2632 households with infants 
aged 12-23 months who were surveyed in March 2013 to ascertain immunization history.  
Risk factors for delayed, not receiving immunization, and severely underimmunized were 
calculated using binomial regression with log link and controlling for potential 
confounders in a sample of 1748 infants who had complete immunization records from 
the maternal and child health booklet.  Infants were considered delayed if immunization 
was received greater than four weeks from the scheduled date.  Severely underimmunized 
infants were infants that had greater than 90 days of not being immunized cumulatively 
across five vaccines (BCG, pentavalent1, pentavalent2, pentavalent3, and measles) in the 
first 12 months of life and also had at least three of the five vaccines delayed.   
Results: Immunization coverage for pentavalent1, pentavalent3, measles, and FIC were 
99%, 95%, 83%, and 80%, respectively.  Older mothers and delayed pentavalent1 
vaccine were the only significant predictors common in models of not receiving  
pentavalent3 or measles vaccine, and not being fully immunized. Infants that received 
pentavalent1 late (> 4 weeks from scheduled date) were associated with not receiving 
pentavalent3 (aRR: 5.61; 95%CI: 3.77-8.33), measles vaccine (aRR: 1.51; 95%CI: 1.15-
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1.99), and FIC (aRR: 1.87; 95%CI: 1.51-2.32).  The proportion of infants with delayed 
vaccination for pentavalent1, pentavalent3, and measles were 11%, 24%, and 29%, 
respectively.  There were no common risk factors in models of delayed pentavalent1, 
pentavalent3, and measles vaccines.  Approximately 14% of infants were severely 
underimmunized in the first year of life.  Older mothers, mothers with lowest levels of 
education, inability to read English, and not owning a mobile phone were associated with 
severely underimmunized infants. 
Conclusions: Immunization coverage for pentavalent1, pentavalent3, and measles 
vaccines was high, with lower proportions of timely vaccination and underimmunization.  
Delayed pentavalent1 receipt was strongly predictive of pentavalent series drop-out and 
not receiving measles vaccine.  Interventions targeted to this subset of population may 









Vaccines are one of the most cost-effective interventions for increasing childhood 
survival.1 The health impact of vaccination, however, is diminished when children do not 
receive all their vaccines, receive them late, or do not complete the full series of one or 
more vaccines– all of which are still problems in Africa.  Despite the lifesaving potential 
of vaccines, in 2012 approximately 17% of children, or about 23 million infants, did not 
complete the three dose sequence of pentavalent vaccine.2  
In Kenya, the Division of Vaccine and Immunization (DVI) recommends infants 
receive bacillus Calmette–Guerin (BCG) vaccine at birth, three doses of polio and 
pentavalent (diphtheria, tetanus toxoid, pertussis, hepatitis B, and Haemophilus 
influenzae Type B antigens) vaccines at 6, 10, and 14 weeks of age, and measles vaccine 
at 9 months of age.3  Kenya included the pneumococcal conjugate vaccine (PCV) and 
rotavirus vaccine in their national immunization plan in 2011 and 2014, respectively. 
Coverage estimates for three doses of pentavalent (pentavalent3), or in countries 
where pentavalent is not available, DTP3 (3 doses of diphtheria, tetanus toxoid, and 
pertussis antigen containing vaccine) in children 12-23 months old is a common indicator 
of the strength of a country’s immunization system to deliver vaccines.4, 5  Data from 
successive Kenyan Demographic and Health Surveys (DHS) found improvements in 
DTP3 coverage from 72% in 2003, to 86% in 2009.6  Study site specific estimates for 
Gem District, Nyanza Province, Kenya found DTP3 coverage estimates to be 55% in 
20037 and 88% in 2011.8  
As global DTP3 coverage estimates have improved over time5, 9, focus is shifting 
from antigen-specific coverage estimates towards the concept of a fully immunized child 
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(FIC).10  Traditionally, a fully immunized child is an infant receiving BCG, 3 doses of 
DTP/hepatitis B/polio and 1 dose of measles vaccines.  As more vaccines have been 
made available to lower income countries, pneumococcal, rotavirus, HPV, and rubella 
vaccines merit inclusion in FIC definitions.  
However, an often overlooked aspect of DTP and FIC estimates is the age group 
for which coverage is being assessed.  Although the DTP series is to be completed by 14 
weeks of age in most developing countries, DTP vaccination coverage is routinely 
measured at 12-23 months with no restrictions on age of vaccine receipt.  The 
measurement at this time window does not fully capture delays in vaccine administration.   
Timeliness of vaccine receipt is important.  First, the diseases which pediatric 
vaccines protect against often have highest morbidities and mortalities at earlier stages of 
life.  Delays of infant immunization have been associated with increased cases of 
pertussis11, 12, hepatitis B13, and Haemophilus influenzae type b.14  Second, timely 
vaccination ensures maximal herd immunity15, thereby protecting those that are too 
young to be vaccinated, medically contraindicated, or do not produce an immunological 
response (vaccine failure).  Delays in vaccination lessen population coverage and create a 
pool of susceptible individuals thereby increasing the pathogen’s ability to spread and 
theoretically increasing the risk of exposure. 
Vaccination delays are prevalent across lower income countries.  Two systematic 
reviews identified a median delay of 6.2- 6.3 weeks for DTP3 across 76 lower and 
middle-income countries (10 countries were replicated in both reviews).16, 17  National 
estimates of median delay for DTP3 in Kenya were lower, 3.2 weeks in 2003, but 25% of 
Kenyans had DTP3 delays greater than 7.5 weeks.17   
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The objectives of this study were to: (1) Determine the proportion and predictors 
of infants not receiving vaccination by antigen; (2) Determine the proportion and 
predictors of infants receiving vaccinations with delay; and (3) Determine the proportion 
and predictors of infants severely underimmunized.  
4.3 Methods 
 Context within the M-SIMU trial 4.3.1
 
During March and April of 2013, a cross-sectional survey was conducted in Gem 
District, Siaya County, Nyanza Province, Kenya to ascertain immunization coverage in 
infants 12-23 months old.  The primary purpose of this survey was to collect 
immunization coverage and other variables, such as socioeconomic status and mobile 
phone ownership, to inform sample size requirements and randomization for the Mobile 
Solutions for Immunization (M-SIMU) cluster randomized trial. 
The study site was nested within the boundaries of KEMRI/CDC Health and 
Demographic Surveillance System (HDSS).  Since 2001, the HDSS has systematically 
collected information on vital events, migration, disease morbidity and demographics 
every four months for a population of over 220,000 people.18  The HDSS has served as a 
platform for numerous studies and intervention trials, notably including randomized 
controlled trials to test efficacies of insecticide-treated bed-nets and the rotavirus 
vaccine.19, 20 
Gem District was under HDSS surveillance from 2003 to 2010 when financial 
support for HDSS activities stopped. In January 2013, additional funding was obtained 
and HDSS activities resumed.  During the period when Gem was not under surveillance, 
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village reporters (VRs) continuously recorded vital events and households were 
enumerated. 
In March and April of 2013, the HDSS provided a census of enumerated DSS 
consented households with infants aged 12-23 months for 120 villages located in Gem 
District. Using this list of eligible households, M-SIMU community interviewers 
approached mothers and caretakers of eligible infants and administered a survey at the 
participant’s household.   
The study protocol received ethical clearance from the Scientific Steering 
Committee (SSC), the KEMRI-Nairobi Ethical Review Committee (ERC; SSC#2409), 
Johns Hopkins University Bloomberg School of Public Health (deferred); Centers for 
Disease Control and Prevention (deferred). 
 Definitions of independent variables 4.3.2
Participants self-reported demographic variables were included in regression 
analyses.  These variables included number of children under 5 years old that slept in the 
house last night, the number of people regularly in the household, marital status, 
socioeconomic status, maternal age, number of maternal education years attempted, 
mother’s ability to read English, infant’s age, infant’s sex, and maternal mobile phone 
ownership.  Data collected as continuous variables were categorized based on 
interpretability and relevancy to previous studies.  Maternal age was categorized into 
mothers aged 15-24 years, 25-29 years, and greater than 30 years.  Maternal education 
was grouped into 0-8 years of education attempted, 9-12 years, and greater than 12 years.  
Child’s age was categorized into infants aged 12-18 months and infants aged greater than 
18 months.  Socioeconomic status was calculated by KEMRI/CDC staff using principal 
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components analysis from data collected using the KEMRI/CDC DSS Household Socio-
economic Form.   These variables included occupation, drinking water treatment, type of 
cooking fuel, and household possessions including livestock.  Socio-economic status was 
provided in quintiles and collapsed to lower 40% and upper 60% for present analysis.  
Straight-line distances from a child’s household to the nearest health facility were 
calculated using ArcView Geographic Information Systems (GIS; Esri, Redlands, CA).  
Distance to clinic was categorized into infants living less than or equal to 2 kilometers 
from the health facility and infants living greater than 2 kilometers from the health 
facility. 
 Definitions of dependent variables 4.3.3
The three primary outcomes for regression analyses were: (1) not receiving 
vaccination; (2) delayed vaccination; and (3) severely underimmunized.  Non- 
vaccination and delayed vaccination estimates were restricted to pentavalent1 (delayed 
only), pentavalent3, measles vaccine, and fully immunized child (FIC), defined as 
receiving BCG, three doses of polio vaccine, three doses of pentavalent vaccine, and one 
dose of measles vaccine.  Non-vaccination was the proportion of infants from the full 
sample that had not received a particular vaccination when surveyed at ages 12-23 
months of age.  Non vaccination estimates were independent of timeliness.  The 
converse, vaccination coverage, was defined as the proportion of infants from the full 
sample that received the vaccination. Not achieving FIC was defined as the proportion of 
infants from the full sample that had not received one or more of the eight vaccines by 




  Delayed vaccination was defined as the proportion of infants that were 
immunized greater than four weeks from the DVI recommended schedule.  For 
pentavalent1 and pentavalent3, a vaccine was delayed if received after 10 and 18 weeks, 
respectively.  Delayed measles was defined as receiving measles after 302 days of age.  
FIC was considered delayed if the infant received all eight vaccines but at least one 
vaccination was received after 12 months of age, while timely FIC was defined as infants 
that receive all eight EPI vaccines by 12 months of age.  Timely vaccination was defined 
as the proportion of infants that were immunized within four weeks of the recommended 
schedule.  The denominator for delayed and timely proportions was the number of infants 
that were immunized, irrespective of timeliness, for the particular vaccine of the estimate.  
Severely underimmunized infants were defined as the proportion of infants that 
were underimmunized for greater than 90 days in the first 12 months of life and were 
delayed for three of five vaccines (BCG, pentavalent1, pentavalent2, pentavalent3, and 
measles). Underimmunized infants were defined as infants that neither received the 
vaccine nor received the vaccine within four weeks of the scheduled date. Infants were 
not severely underimmunized if the total number of days underimmunized was less than 
90 days or if less than three vaccines were received with delay. 
 Data Collection and Analysis 4.3.4
Community interviewers were provided simple, smart-phones (Huawei Y200) 
employing the ODK application to conduct and collect survey data (Appendix 1).  Skip 
patterns and quality checks were programmed into ODK to help minimize potential errors 
in data entry and analysis.  Staff visited HDSS identified households and asked the 
compound head if they could interview the caregiver of the child between the ages of 1 
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and 2 years.  Staff members then asked the caregiver if the maternal and child health 
(MCH) booklet was available, and if so, immunization dates were entered into the 
mobile-phone based survey.  If no MCH booklet was present, staff collected 
immunization history through verbal report (data excluded from present analysis).  Data 
were cleaned continuously after data entry and missing or questionable data points were 
relayed back to field staff for follow-up visits. 
For the delayed primary outcome, the age at which the vaccine was received was 
calculated by subtracting the child’s date of birth from the date of vaccination.  Ages of 
vaccination were then dichotomized into delayed and timely as described above.  Inverse 
Kaplan-Meir curves were created to graphically depict timeliness of vaccination as 
performed elsewhere.21-23  Infants were censored at age immunized or at the age of 
survey if vaccination was not received. 
For the severely underimmunized outcome, infants were censored at 12 months of 
age. The definition of delayed immunizations used in the delayed outcome was applied to 
count the number of days delayed.  If infants did not receive vaccination, the age at which 
delays started to accumulate was subtracted from 365 days.  The maximum number of 
days underimmunized for BCG, pentavalent1, pentavalent2, pentavalent3, and measles 
were, respectively, 337 days, 295 days, 267 days, 239 days, and 62 days.  Infants could 
be cumulatively underimmunized at most for 337 days. If infants received vaccination 
within 4 weeks of scheduled date, they were given 0 days underimmunized for that 
vaccine  
 For BCG, pentavalent1-3, and measles vaccines, the number of days delayed and 
the number of days the infant was not vaccinated were summed to produce the total 
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number of days underimmunized. Days underimmunized were not double counted if 
underimmunized vaccines overlapped.  For example, if an infant did not receive BCG 
and measles vaccine, but received all other vaccines on time, the infant would be 
underimmunized 337 days for BCG (365-28 days) and 62 days for measles (365-302; 
where 302=10 months).  In total, this infant would be considered underimmunized for 
337 days as measles overlapped with BCG.  The number of vaccines infants either 
received with delay or were not given was summed.  Infants with 3 or more vaccines that 
were delayed or not given were considered severely underimmunized if the total number 
of days underimmunized was greater than 90 days. 
Crude risk ratios with 95% confidence intervals for each independent variable 
were obtained by binomial regression with log link function.   For primary objective 1, 
infants that were not vaccinated were compared to infants that were vaccinated.  Primary 
outcome 2 compared infants that received delayed vaccinations with infants that were 
timely vaccinated. Primary outcome 3 compared infants with severe underimmunization 
to all other infants.  Final adjusted models were created using forward-stepwise selection 
of variables with an alpha of 0.05. Analyses were performed using STATA/IC, version 
11.2 (Stata Corp, College Station, Texas) and used an alpha of 0.05 for all hypothesis 
testing.   
4.4 Results  
A total of 2632 households with infants aged 12-23 months were visited.  Excluded 
from present analysis are 9 (0.3%) infants with unknown birthdate, 66 (2.5%) infants not 
within 12-23 months, 747 (28.4%) infants with no immunization booklet, and 64 (2.4%) 
infants with illegible or incomplete immunization records.  In total, the final sample 
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contained 1746 infants aged 12-23 months with complete vaccination history from the 
immunization booklet.  Approximately half of sampled mothers were younger than 25 
years old, forty percent completed primary education, ninety percent could read English 
with difficulty or easily, and over fifty percent of mothers owned a mobile phone (Table 
4.1).  The average household size was 4 individuals, with the majority of mothers having 
1 or 2 infants aged less than five years old in the house.  The median straight line distance 
to the nearest clinic was about 2 kilometers. 
 Vaccination Coverage 4.4.1
Antigen-specific vaccination coverages measured at 12-23 months were high for 
all individual vaccines (Table 4.2).  Approximately 95% of infants received pentavalent3 
vaccine, independent of timeliness.  Socio-demographic variables significant for 
predicting infants not receiving pentavalent3 in crude analyses included mothers aged 
greater than 30 years as compared to mothers aged 15-24 years old  (RR: 2.26; 95%CI: 
1.43-3.59); households with two children younger than five years old as compared to 
households with one children under five years old (RR: 1.54; 95%CI: 1.00-2.36), 
households with more residents (RR: 1.65; 95%CI: 1.11-2.46), and receiving 
pentavalent1 four weeks late from the scheduled date (RR: 6.32; 95%CI: 4.28-9.35; 
Table 4.3).  Variables associated with receiving pentavalent3 included mothers with 9-12 
years of education as compared to those with less than 9 years (RR: 0.56; 95%CI: 0.37-
0.87), ability to easily read English as compared to those who cannot (RR: 0.38; 95%CI: 
0.22-0.66) and maternal mobile phone ownership (RR: 0.50; 95%CI: 0.34-0.75).  There 
was no association between child’s gender, distance to the clinic, and socioeconomic 
status with pentavalent3 receipt. 
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In multivariable analyses, mothers aged 25-29 years (aRR: 1.73; 95%CI: 1.04-
2.89) and greater than 30 years (aRR: 1.99; 95%CI: 1.23-3.22) and delayed pentavalent1 
vaccination (aRR: 5.61; 95%CI: 3.77-8.33) were significantly associated with not 
receiving pentavalent3 vaccine (Table 4.3).   Maternal mobile phone ownership (aRR: 
0.52; 95%CI: 0.34-0.78) was associated with infants receiving pentavalent3 vaccine. 
Eighty-three percent of infants received measles vaccine (Table 4.2). 
Determinants of measles vaccination in crude analyses were similar to pentavalent3 
except for the addition of mothers in polygamous marriages as compared to single or 
divorced mothers (RR: 1.60; 95%CI: 1.05-2.42) and older infants (RR: 0.72; 95%CI: 
0.58-0.89; Table 4.3).  Mothers greater than 30 years old as compared to mothers aged 
15-24 years (RR: 1.53; 95%CI: 1.21-1.95), households with 2 infants younger than five 
years old as compared to those with 1 infant (RR: 1.39; 95%CI: 1.10-1.75), households 
with more residents (RR: 1.29; 95%CI: 1.05-1.59), and receiving pentavalent1 four 
weeks late from the scheduled date (RR: 1.63; 95%CI: 1.23-2.15) were predictive of not 
receiving measles vaccine.  Variables associated with measles vaccine receipt include 
mothers with 9-12 years of education as compared to those with less than 9 years (RR: 
0.64; 95%CI: 0.51-0.80); ability to easily read English as compared to not being able to 
read (RR: 0.58; 95%CI: 0.42-0.81); and maternal mobile phone ownership (RR: 0.76; 
95%CI 0.62-0.94).  Child’s gender, distance to the clinic, and socioeconomic status were 
not associated with measles vaccination in crude analyses 
In multivariable analyses, mothers aged greater than 30 years (aRR: 1.38; 95%CI: 
1.08-1.76), households with 2 children under five years old (aRR: 1.34; 95%CI: 1.06-
1.70), and infants with delayed pentavalent1 vaccination (aRR: 1.51; 95%CI: 1.15-1.99) 
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were significantly associated with not receiving measles vaccine (Table 4.3).  A mother’s 
ability to easily read English (aRR: 0.67; 95%CI: 0.48-0.94) and older infants (aRR: 
0.71; 95%CI: 0.58-0.88) were associated with receiving measles vaccine. 
The proportion of infants that were fully immunized with BCG, three doses of 
polio, three doses of pentavalent, and measles vaccine was 80% (Table 4.2).  Crude 
analyses found a pattern of variables associated with not being fully immunized similar to 
those associated with not receiving measles or pentavalent3. Socio-demographic 
variables significantly associated with not being fully immunized include mothers aged 
greater than 30 years as compared to those 15-24 years old (RR: 1.46; 95%CI: 1.18-1.81), 
households with 2 infants less than five years old as compared to those with 1 infant (RR: 
1.34; 95%CI: 1.10-1.66), households with more residents (RR: 1.30; 95%CI: 1.08-1.57), 
and delayed pentavalent1 vaccination (RR: 2.06; 95%CI: 1.65-2.56). Variables associated 
with fully immunized infants in crude analyses included mothers with 9-12 years of 
education and greater than 12 years as compared to those with less than 8 years, 
respectively, (RR: 0.67; 95%CI 0.55-0.83) and (RR: 0.59; 95%CI: 0.35-0.99); ability to 
easily read English as compared to not being able to read (RR: 0.55; 95%CI: 0.41-0.73), 
maternal mobile phone ownership (RR: 0.74; 95%CI: 0.61-0.89), and older infants (RR: 
0.78; 95%CI: 0.65-0.94).  Similar to pentavalent3 and measles, child’s gender, distance to 
the clinic, and socioeconomic status were not associated with failure to be fully 
immunized. 
In multivariable analyses, statistically significant variables associated with not 
being fully immunized included mothers aged greater than 30 years as compared to those 
15-24 years old (aRR: 1.28; 95%CI: 1.02-1.59), household with 2 children under 5 years 
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old (aRR: 1.27; 95%CI: 1.03-1.57), and delayed pentavalent1 vaccination (aRR: 1.87; 
95%CI: 1.51-2.32).  Factors associated with fully immunized infants include mother’s 
ability to easily read English as compared to not being able to read (aRR: 0.75; 95%CI: 
0.53-0.99), maternal mobile phone ownership (aRR: 0.83; 95%CI: 0.68-0.99), and older 
infants (RR: 0.79; 95%CI 0.66-0.95).  
 Vaccination Timeliness 4.4.2
When considering timely receipt of immunization, antigen-specific estimates are 
notably lower than their coverage estimates at 12-23 months with BCG, pentavalent3, 
and measles the most likely to have delays (Table 4.2).  The median age of BCG 
vaccination was two weeks (IQR: 1-5weeks) and for the 31% of infants that received 
BCG late (>4 weeks of age), the median length of delay was three weeks (IQR: 1-7 
weeks; Figures 4.1 and 4.2).  For pentavalent1, the median age of vaccination was six 
weeks (IQR: 6-7 weeks) with a median delay of three weeks (IQR: 1-7 weeks) in the 11% 
of infants who were delayed.  For pentavalent3 and measles, the median ages of receipt 
were, respectively, 16 weeks (IQR: 15-18weeks) and 41weeks (IQR: 39-44weeks).  Of 
the 24% that had delayed pentavalent3, the median length of delay was three weeks 
(IQR: 1-9weeks) and for the 29% of measles vaccines administered late, the median 
delay was four weeks (IQR: 1-9weeks).   
The results of regression analyses for factors associated with delayed vaccination 
are presented in Table 4.4.  Socio-demographic variables significantly associated with 
pentavalent1 delay in crude analyses include mothers aged greater than 30 years as 
compared to those younger than 25 years (RR: 1.66; 95%CI: 1.20-2.32), polygamous 
marriage as compared to singled or widowed mothers (RR: 1.81; 95%CI: 1.07-3.08), 
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households with three or more children under five years old as compared to households 
with 1 infant under five years of age (RR: 1.59; 95%CI: 1.06-2.40), and households with 
more residents (RR: 1.34; 95%CI: 1.01-1.77). Ability to easily read English (RR: 0.58; 
95%CI: 0.38-0.90) was associated with timely pentavalent1 vaccination.  In multivariable 
analyses, only mothers aged greater than 30 years as compared to those aged 15-24 years 
were associated with pentavalent1 delay (aRR: 1.66; 95%CI: 1.20-2.32).  
Variables significantly associated with delayed pentavalent3 vaccination in crude 
analyses included oldest mothers (RR: 1.46; 95%CI: 1.19-1.80); households with 2 or 3 
infants younger than five years old, respectively, (RR: 1.50; 95%CI: 1.23-1.83) and (RR: 
1.44; 95%CI: 1.10-1.89), larger households (RR: 1.25 95%CI: 1.05-1.49), and older 
children (RR: 1.31; 95%CI: 1.10-1.57). Mothers with 9-12 years and greater than 12 
years of education, respectively, (RR: 0.73; 95%CI 0.61-0.89) and (RR: 0.61; 95%CI: 
0.38-0.98) and maternal mobile phone ownership (RR: 0.82; 95%CI: 0.69-0.97) were 
associated with timely measles vaccination. Multivariable analyses found oldest mothers 
(aRR: 1.40; 95%CI: 1.15-1.72), households with 2 (aRR: 1.48; 95%CI: 1.21-1.79) or 3 
children under 5 years old 2 (aRR: 1.40; 95%CI: 1.07-1.84), and older infants (aRR: 
1.36; 95%CI: 1.14-1.62) were associated with delayed pentavalent3.  Mothers with 9-12 
years of education (aRR: 0.74; 95%CI: 0.62-0.90) was associated with timely 
pentavalent3 with mothers with greater than 12 years trending towards statistical 
significance (aRR: 0.62; 95%CI: 0.39-1.01; p value= 0.051). 
 Delayed measles vaccination was associated with numerous socio-demographic 
variables in crude analyses (Table 4.4). Oldest mothers (RR: 1.31; 95%CI: 1.08-1.58), 
households with 3 children younger than five years old (RR: 1.29; 95%CI: 1.02-1.63), 
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larger households (RR: 1.21 95%CI: 1.03-1.42), farther distances to the clinic (RR: 1.26; 
95%CI: 1.06-1.49), and older children (RR: 1.37; 95%CI: 1.16-1.62) were significantly 
associated with delayed measles vaccination. Mothers with the highest level of maternal 
education (RR: 0.50; 95%CI: 0.30-0.84); ability to read English easily or with difficulty, 
respectively, (RR: 0.76; 95%CI: 0.59-0.98) and (RR: 0.65; 95%CI: 0.50-0.83), and 
maternal mobile phone ownership (RR: 0.85; 95%CI: 0.73-0.99) were associated with 
timely measles vaccination.  Multivariable analyses found that maternal ability to easily 
read English (aRR: 0.68; 95%CI: 0.53-0.87) was associated with infants receiving timely 
immunization, with mothers who read English with difficulty trending towards 
significance (aRR: 0.81; 95%CI: 0.62-1.04).  Households with more residents (aRR: 
1.20; 95%CI: 1.03-1.41) and older children (aRR: 1.37; 95%CI: 1.16-1.61) were 
significantly associated with delayed measles vaccination. 
 Crude analyses of factors associated with delayed FIC found significant risk ratios 
for mothers with 9-12 years of education as compared to those with less than 9 years 
(RR: 0.62; 95%CI: 0.42-0.93), maternal mobile phone ownership (RR: 0.68; 95%CI: 
0.47-0.99) and older infants (RR: 2.49; 95%CI: 1.63-3.82).  In multivariable analyses, 
only mothers owning a mobile phone (aRR: 0.68; 95%CI: 0.47-0.98) and older infants 
(aRR: 2.50; 95%CI: 1.63-3.83) were significantly associated with delayed FIC. 
 Overall, the median number of vaccines delayed per child was 1 (IQR: 0-2), 
(Table 4.5). Restricting analyses to only those who received at least 1 delayed vaccine, 
the median number of vaccines delayed per infant was 2 (IQR: 1-4).  As infants received 
fewer vaccines, the proportion of the timely received vaccinations decreased. For 
example, in infants that received a total of five vaccinations, only 15% of the infants 
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received all five vaccinations on time.  Of the 85% that had at least one of these five 
vaccines delayed, the median number of vaccines delayed was 3 (IQR: 2-4).  In contrast, 
for the infants that received eight vaccinations, 46% received all eight vaccinations in a 
timely manner.  Of the 54% that had at least one vaccination delayed, infants had a 
median of two vaccines delayed (IQR 1-4). 
 Underimmunized 4.4.3
Infants were underimmunized on average for 55.7 days, or 16.5% of the time they 
were age-eligible for vaccination, during their first twelve months of life (Table 4.6).  Of 
the 1086 infants (62.1%) that were underimmunized for at least one vaccine, the average 
number of days underimmunized was 89.6 days, with 29.8% of infants underimmunized 
for greater than 90 days.  Vaccine-specific estimates for all infants found low average 
days of underimmunized for BCG (16.5 days), pentavalent1 (5.6days), pentavalent2 
(13.1days), pentavalent3 (23.4 days), and measles (18.0 days).  When estimates were 
restricted to those underimmunized for at least one vaccine, vaccine-specific average 
days underimmunized increased for all vaccines; BCG (51.3 days), pentavalent1 
(53.3days), pentavalent2 (73.8 days), pentavalent3 (84.1 days), and measles (44.2 days). 
Approximately 14% of infants were severely underimmunized in the first year of 
life.  In crude analyses (Table 4.7), infants severely underimmunized were more likely to 
have mothers aged 25 to 29 years old (RR: 1.39; 95%CI: 1.01-1.93) or greater than 30 
years old (RR: 2.51; 95%CI: 1.90-3.32), as compared to mothers 15-24 years old and to 
live in households with more residents (RR: 1.62 95%CI: 1.27-2.07).  Mothers with 9-12 
years of education (RR: 0.54; 95%CI: 0.41-0.70) and greater than 12 years of education 
(RR: 0.25; 95%CI: 0.09-0.66) were less likely to have severely underimmunized infants 
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than those with less than 9 years of education. Mother’s ability to read English easily or 
with difficulty, respectively, (RR: 0.35; 95%CI: 0.25-0.49) and (RR: 0.60; 95%CI: 0.44-
0.82), and maternal mobile phone ownership (RR: 0.58; 95%CI: 0.46-0.74) were 
associated with infants not being severely underimmunized. 
Multivariable analyses found several factors associated with severely 
underimmunized infants.  Mothers 25-29 years old (aRR: 1.46; 95%CI: 1.06-2.02), and 
greater than 30 years old (aRR: 2.27; 95%CI: 1.71-3.02), as compared to mothers less 
than 25 years old, were more likely to have infants severely underimmunized.  Mothers 
with 9-12 years of education (aRR: 0.70; 95%CI: 0.53-0.94) and greater than 12 years of 
education (aRR: 0.37; 95%CI: 0.14-0.99) were less likely to have severely 
underimmunized infants than those with less than 9 years of education; with a trend 
towards significance in mothers educated for more than 12 years.  A mother’s ability to 
read English easily (aRR: 0.61; 95%CI: 0.42-0.86) and mobile phone ownership (aRR: 
0.63; 95%CI: 0.49-0.81) were also significantly associated with infants not severely 
underimmunized. Additional analyses of risk factors for severely underimmunized infants 
are located in Appendix 8.  In these analyses, where the comparator group was infants 
that received all vaccinations in a timely manner, risk factors identified were similar to 
those where comparator group was infants not severely underimmunized.  
4.5 Discussion 
Immunization coverage levels in our study site have vastly improved since 2003, 
likely a result of the renewed global commitment to improving immunization delivery 
systems.  Pentavalent3, measles, and FIC 2003 coverage estimates were 68%, 50%, and 
41%, respectively.7  Our 2013 survey found these vaccination coverage estimates 
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increased to, and correspondingly, 94%, 83%, and 80%. Our vaccination coverage 
estimates for BCG, pentavalent1, pentavalent3, measles and FIC were very similar to the 
estimates obtained by others during a survey of the present study site in September 20118 
which suggests that immunization coverage levels may be plateauing in rural western 
Kenya.  Importantly, pentavalent1 coverage levels were nearly 100%.  We chose not to 
analyze its predictors because of the high coverage.  The near uniform population 
coverage of pentavalent1 may make identification of predictors difficult and, more 
importantly, a moot point as neither intervention nor programs are needed to target a 
particular subset of the population that is not receiving pentavalent1. 
In regards to predictor variables associated with receipt of pentavalent3, measles, 
and FIC, each model produced a signature panel of significant predictor variables specific 
to that vaccine.  Older infants were 21 to 29% less likely to achieve FIC or be vaccinated 
for measles.  This finding was expected as there was no age cutoff for coverage, therefore 
giving older children at the time of the survey a longer time window to be vaccinated.  
Maternal mobile phone ownership was significantly associated with pentavalent3 and 
FIC receipt in adjusted models and was significant for measles vaccination in bivariate 
analysis.  This finding is supported by informal discussions with staff from several health 
facilities staff where nurses have described their efforts to call the mothers of infants that 
are defaulting on their pentavalent3 sequence.  Higher levels of maternal education was 
only associated with pentavalent3, measles vaccine and fully immunized infants in 
bivariate analyses.  The literature evaluating maternal education and vaccination 
coverage is inconsistent in lower-income countries; some studies have shown a link of 
higher education to vaccination24-26, while others have found that higher education is 
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associated with lower coverage, where it has been theorized that educated mothers are 
more likely to have jobs and may be too busy to bring their infant to the clinic.27  These 
contrasting findings may be dependent on the population surveyed and how education is 
categorized.  In our analyses, we categorized years of education by completion of 
primary school (0-8 years), secondary school (9-12 years), and post-secondary education 
(greater than 12 years). 
For pentavalent3, measles, and FIC, delayed pentavalent1 vaccination was the only 
variable that was statistically significant across all three models and its point estimates 
were by far the largest.  Infants that received pentavalent1 four weeks late were 5.61 
(95%CI: 3.77- 8.33) times more likely to not receive pentavalent3 vaccine, 1.51 (95%CI: 
1.15-1.99) times more likely to not receive measles vaccine, and 1.87 (95%CI 1.51-2.32) 
times more likely to not be fully immunized when compared to infants that received 
pentavalent1 on time.  Kaplan-Meier curves of delayed pentavalent1 on pentavalent3 and 
measles time to vaccination are presented in figure 4.3.  In sensitivity analyses where the 
time window for delays was decreased from four to two weeks, the point estimates 
slightly decreased while maintaining statistical significance.  Briefly, infants that received 
pentavalent1 two weeks from the scheduled date were 4.90 (95%CI: 3.27-7.34), 1.42 
(95%CI: 1.12-1.80), and 1.61 (95%CI: 1.32-1.97) times more likely to not receive 
pentavalent3, measles, and be fully immunized, respectively. Numerous studies have 
found that United States infants with delayed first vaccination are at higher risk of not 
receiving future vaccinations.28-31  To our knowledge, this is the first demonstration that 




In the study area, immunization coverage estimates were robust, yet there were 
significant delays associated with measles and pentavalent3 vaccinations.  Although 
timely vaccination in industrialized countries has been studied for some time32-36, it is 
only recently being applied to resource-constrained settings.7, 17, 22-24, 27, 37-47  In the 
current study site, the proportion of infants that received timely pentavalent3 and measles 
vaccination improved from, respectively, 27% and 18% in 2003 to 72% and 59% in 
2013. In our sample, adjusted analyses found that infants aged 18-24 months were 36%, 
37%, and 150% more likely to have delayed vaccinations for pentavalent3, measles, and 
fully immunized as compared to infants aged 12 to 17 months.  This suggests that even 
within a one year sampling window, timely immunization is improving.  Still, as global 
immunization coverage levels have markedly improved over the past decade5, 9, the 
paradigm must shift from concerns about children being vaccinated, to ensuring 
vaccinations are now given on time.  
The finding that older, less educated mothers, with more children in the household 
were more likely to have their infant’s vaccination delayed has been found in other low-
income countries.24, 27, 37, 40, 45  Although only significant in the delayed FIC model, 
mothers owning a mobile phone were more likely to have timely vaccinations than those 
without a mobile phone.  As discussed above, this finding may partially be explained by 
anecdotal accounts of health facility staff calling mothers to remind them of vaccination.  
Marital status, infant’s gender, distance to the clinic, and socioeconomic status were not 
significant in any of the adjusted models for coverage, delay, or severely 
underimmunized.  Far distances to the clinic have frequently been associated with poor 
immunization coverage levels.48-59  Our study site had an average distance of about 2 
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kilometers to the clinic which may suggest that access is less a barrier to immunization; 
however, in multiple linear regression analyses of days delayed, distance was 
significantly associated for pentavalent3 and measles delay (Appendix 9).  The lack of 
association between socioeconomic status and vaccination delay or coverage may be 
potentially explained due to the overall poverty in this rural site, with little practical 
differences between the quintiles.   
We found that, on average, infants were underimmunized for about two of their 
first eleven months of life (infants could not be considered underimmunized until age 28 
days).  In the 62% of infants that were underimmunized for at least one vaccine, the 
average duration of underimmunization increased to 3 months.  For pentavalent3, there 
was a substantial proportion underimmunized (28%), with a corresponding average of 84 
days underimmunized--the longest duration for any of the vaccine-specific estimates.  
The cumulative number of days underimmunized marries immunization coverage and 
timeliness estimates, making it a useful estimate to comprehensively examine the 
magnitude of deficiencies in immunization systems. For measles vaccination, only 53% 
of infants were immunized by 10 months of age.  Although this estimate increased to 
72% at 11 months of age, these percentages are concerning, particularly if the delayed 
and non-immunized are clustered.  Measles is a highly contagious virus60, evidenced by 
the ability for measles outbreaks to occur in populations comprised of as little as 10% 
susceptible (i.e. no immune protection).61  In Kenya, the most recent measles outbreak 
was in 2011 where 2,461 cases were identified, thus prompting costly, and time-
consuming, outreach immunization campaigns.62 
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The risk factors for severely underimmunized were more robust than the separate 
models for immunization delays and coverage, with the exception of delayed 
pentavalent1 vaccination in coverage models.  Caregivers aged 25-29 years old and 
caregivers older than 30 years old were, respectively, 46% and 127% more likely to have 
severely underimmunized infants as compared to caregivers less than 25 years old. Our 
finding that more educated mothers were less likely to have severely underimmunized 
infants is consistent with a United States study that examined risk factors for severely 
delayed infants.36 Additional studies that examine the magnitude and risk factors of the 
severely underimmunized are needed from resource constrained countries. 
 This study has a number of strengths as well as limitations. The first strength is in 
regards to our sample and its representativeness.  By surveying all known caregiver’s 
with eligible infants, selection bias was minimized.  Secondly, the high proportion of 
infants with immunization cards present allowed for a detailed analysis of immunization 
timeliness.  Lastly, risk factors were concurrently identified for immunization coverage, 
immunization timeliness, and severely underimmunized from a single sample.  The 
majority of previous studies have separately examined either immunization coverage, or, 
less frequently, immunization timeliness.  
A potential limitation is that mothers who provided verbal report of immunization 
history were not included in analyses because the maternal and child health booklet was 
missing.  This limitation is particularly important if those providing verbal report were 
less likely to be immunized than those with a maternal and child health booklet. Adjusted 
analyses for predictors of having immunization booklet present at time of survey as 
compared to verbal report found that women living closer to the health facility (RR: 0.93; 
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95%CI 0.88-0.97), younger infants at time of survey (RR: 0.91; 95%CI 0.87-0.96), and 
male infants (RR: 1.05; 95%CI 1.01-1.10) were more likely to have an immunization 
card present (Table 4.8).  Previous research has found that younger infants, less people in 
a household, delivery at a health facility, and male infants as factors associated with 
retention of immunization booklet.63-65  Because of these differences in socio-
demographic characteristics between those with an MCH booklet and those without, it is 
likely that the vaccination coverage and delay estimates in this study are higher (i.e. more 
children are vaccinated and more receive timely vaccination) than the true population 
estimate.  
Furthermore, we identified caregivers with infants aged 12-23 months of age 
through the KEMRI/CDC database.  With surveillance activities being just recently 
resumed in the study site, it is likely that not all of the households had been mapped and 
interviewed.  If these missing households are in more remote regions, it is possible that 
these infants have lower immunization coverage and increased delays.  Therefore, our 
immunization coverage and timely estimates may be overestimated. 
 Additional limitations of the present study include a non-comprehensive list of 
demographic variables that have been found to be associated with immunization coverage 
and timeliness in other studies.  In the study area, community health workers (CHW) are 
part of a Kenyan national policy to improve the health of child and mother.66  A previous 
study found that the quality of interaction with the CHW and the frequency of interaction 
were significant factors for FIC coverage.8  Moreover, we had no information on 
mother’s antenatal care seeking behavior and tetanus toxoid immunization42, 47, paternal 
characteristics including age and education37, and place of delivery23, all of which have 
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been significant risk factors in other published models.  The omission of these variables 
in our analyses may result in different point estimates and significant factors (i.e. 
unmeasured confounding bias). 
 Additionally, our measure of severely underimmunized may not adequately 
capture the magnitude of underimmunization in the population.  To ensure that all infants 
contributed equal person-time to analyses, it was decided to censor infants at 12 months, 
which limits the contribution of measles vaccine for underimmunization estimates to 62 
days.  Future studies would benefit from surveying caregivers of infants greater than 2 
years of age to determine if underimmunization persists equally into the second year of 
life, and to allow measles vaccine opportunity to equally contribute to estimates of 
cumulative days underimmunized. 
 Furthermore, only BCG, the pentavalent series, and measles vaccine were 
included calculations of days underimmunized with the polio vaccine series being 
omitted.  Polio vaccine was omitted from our analysis because it is given at the same time 
as pentavalent series, with any differences in immunization history of pentavalent and 
polio doses likely due to vaccine stock-outs or errors in the maternal child and health 
booklet.  In our sample, there was 99% congruency in receiving polio1-3 and 
pentavalent1-3 vaccines.  
 Lastly, a potential limitation of the present analyses rests with our definition of 
timely and delayed vaccination.  We defined timely and delayed vaccination as the 
receipt of vaccine within or after four weeks of the scheduled date as performed in other 
analyses.22, 24, 44, 45   However, this arbitrary boundary limit could also then be considered 
a coverage estimate, albeit at a time point nearer the recommending dosing schedule.  An 
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alternative analysis may have examined days delayed as a continuous variable where 
days delayed begin to accrue at scheduled date and stop once vaccine is received.  One 
could then tabulate a cumulative measure of ‘days delayed’, as published elsewhere36, 
and which would be more sensitive for detecting timeliness.  We opted against this as a 
main analysis for two reasons.  First, very few studies or national immunization surveys 
have used this measure in their reporting of delay.  This would make comparison and 
generalization of our results to other populations difficult.  Our definition of delays as 4 
weeks (or 1 month) from the scheduled date is an easily calculated and interpretable 
statistic that would make it amenable to inclusion in routine immunization reporting 
systems.  Second, there is some ambiguity in the interpretation and clinical ramifications 
of the results.  Is a child with a pentavalent1 delay of 5 days more likely to contract a 
vaccine preventable illness than an infant with pentavalent1 delay of 10 days?  Although 
this cumulative measure of days delayed may be more sensitive to measuring delay, the 
clinical implications and correlates are not yet well understood.   
 Still, as a supplementary analysis (Appendix 9), the results of linear regressions of 
days delayed for pentavalent1, pentavalent3, and measles vaccines were overall similar, 
with some minor differences in risk factors significant for delay.  For pentavalent1, only 
mother’s English literacy was associated with delay in linear models, while only oldest 
mothers were significant in the main dichotomous analyses of delayed or timely.  
Maternal age, number of children under five years old in the house, and infants’ age were 
significant in both linear and dichotomous models of delay.  Maternal English literacy, 
socioeconomic status, and distance to the clinic were significant in only the linear model, 
with maternal education no longer being significant as found in the dichotomous model.  
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For measles vaccine, maternal English literacy and age of infant were significant in both 
models.  Distance to the clinic was also significant in the linear model, but not the 
dichotomous model.  
 Traditionally, immunization coverage and timeliness have been conceptualized as 
separate measures.  In this study, we created a severely underimmunized variable that 
combines vaccination delays and not receiving vaccines.  Moreover, the distinction 
between timeliness and coverage is blurred by the finding that timely vaccination 
(pentavalent1) predicts drop-out of the pentavalent sequence, not receiving measles 
vaccination, and children not being fully immunized with the eight standard EPI vaccines 
in resource-limited countries.  Although this finding needs to be replicated in other 
settings, delayed pentavalent1 vaccine could be used as an early warning system to alert 
practitioners that this infant is at higher risk for drop-out of the EPI schedule.  This 
finding affords several potential interventions that could target early immunization delays 
to ensure future vaccination. 
 One solution could be to send short message system (SMS) reminders for future 
vaccination dates to mothers of infants with delayed pentavalent1.  SMS reminders, or 
text messages, have been found to modestly improve vaccination uptake in the United 
States.67-70  Although their efficacy at improving vaccination coverage and timeliness has 
not been evaluated in resource-constrained countries, aside from a small pilot study71, the 
majority of randomized controlled trials in sub Saharan Africa have found SMS 
reminders improve various forms of healthcare utilization.72-80  The biggest advantage of 
employing SMS reminders is that they are relatively inexpensive to send and the process 
can be easily automated.  However, sending SMS reminders is contingent on a literate 
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population that has high levels of mobile phone ownership.  In our study area, literacy 
levels are high, but only 55% of mothers own a mobile phone with approximately 95% 
having access to one (Dissertation Chapter 5).  The low levels of individual mobile phone 
ownership would require novel solutions to reach mothers without a mobile phone. 
 An alternative solution to SMS reminders is the utilization of small incentives 
paired to timely immunization.  Studies conducted in Pakistan and India found that 
providing food vouchers or provisions conditioned on vaccine receipt markedly improved 
vaccination coverage.81, 82  In practice, health facility staff would identify a pentavalent1 
delayed infant and inform the mother that for pentavalent2, pentavalent3, and measles 
doses, she will receive a small incentive (either monetary or food provision) if she brings 
her infant for future vaccinations.  Some may argue against this due to the associated cost 
of providing payments to mothers. However, the provision of incentives could be cost-
neutral, or at best cost-saving, if the incentives dramatically improve vaccination 
coverage.  In Kenya, health facilities hold out-reach campaigns once a month where 
clinic staff goes into the community to vaccinate for pentavalent series and measles 
vaccines.  If incentives are prompting mothers to go to the clinic for vaccination, the 
frequency and length of the outreach campaigns would decrease, therefore saving both 
human and financial resources.  Moreover, providing incentives to only those with delay 
could create a perverse incentive to intentionally delay vaccination in order to receive 
money. 
 Lastly, a potential solution to decrease vaccination drop-out in those with delayed 
pentavalent1 is to provide education on the benefits of vaccination and the potential 
adverse health outcomes for infants that are not vaccinated.  A study in Pakistan found 
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that health center-based education, lasting approximately two to three minutes, 
significantly improved completion of the DTP sequence when compared to infants that 
did not receive such education.83  This type of approach is advantageous, as compared to 
the other offered solutions, because it neither requires any technology (i.e. SMS) nor have 
any financial costs.  
 In conclusion, vaccination coverage for routinely recommended vaccines in our 
study area is high.  Yet there is a substantial proportion of infants that are being 
vaccinated after the recommended ages, with a small proportion that are severely 
underimmunized.  Although not often included in reporting of immunization programs, 
vaccination timeliness is an important measure as those with delays are at higher risk for 
infection, are more likely to not receive future vaccinations, and lower the population 
herd immunity.  Delayed pentavalent1 receipt was most strongly associated with failure 
to be immunized in our risk factor analysis. Interventions that target this subset of the 




4.6 Tables for Chapter 4 
Table 4.1 Socio-demographic characteristics of children aged 12-23 months old with 
immunization card in Gem District, Kenya 
 
Characteristic N=1748 
Mother’s age (years)  
15-24 806 (46.2%) 
25-29 474 (27.2%) 
>30 463 (26.6%) 
Mother’s education (years)  
 0-8 934 (54.0%) 
9-12 702 (40.6%) 
13+ 92 (5.3%) 
Mother’s English reading ability  
Not at all 147 (8.4%) 
With Difficulty 631 (36.1%) 
Easily 969 (55.5%) 
Marital status  




Polygamous Married/ Cohabitating 192 (11.0%) 
Children < 5 years old in house  
< 1 708 (40.6%) 
2 802 (45.9%) 
>3 236 (13.5%) 
Household size (no. of people)  
<4 920 (52.7%) 
>4 827 (47.3%) 
Socioeconomic status1   
Bottom 40% 713 (41.0%) 
Upper 60% 1026 (59.0%) 
Mother’s mobile phone 
ownership 
 
Owns Phone 946 (54.1%) 
Has Access/None 802 (45.9%) 
Distance to clinic (km)  
< 2 729 (42.9%) 
>2 970 (57.1%) 
Child’s age (months)  
12-18 860 (49.2%) 
>18 - 24 888 (50.8%) 
Child’s gender  
Female 827 (47.3%) 
Male 921 (52.7%) 
1Socioeconomic status derived from Principal Components Analysis of household possessions
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Table 4.2 Vaccination coverage and timeliness in infants ages 12-23 months old with 










 % (n) 
BCG 31.3% (540) 68.7% (1187) 98.8% (1727) 
Polio1 10.5% (182) 89.5% (1556) 99.4% (1738) 
Polio2 16.4% (280) 83.6% (1425) 97.5% (1705) 
Polio3 24.0% (390) 76.0% (1237) 93.1% (1627) 
Pentavalent1 10.2% (176) 89.8% (1564) 99.6% (1740) 
Pentavalent2 16.0% (273) 84.0% (1438) 97.9% (1711) 
Pentavalent3 23.6% (389) 76.4% (1262) 94.5% (1651) 
Measles 29.3% (425) 70.7% (1025) 83.0% (1450) 
FIC-12months3 7.2% (101) 92.8% (1293) 79.8% (1394) 
Abbreviations: BCG, Bacillus Calmette–Guérin vaccine; FIC, full immunization coverage; Polio1, first 
dose of polio vaccine; Polio2, second dose of polio vaccine; Polio3, third dose of polio vaccine; 
Pentavalent1, first dose of pentavalent vaccine; Pentavalent2, second dose of pentavalent vaccine; 
Pentavalent3, third dose of pentavalent vaccine 
 
1 For individual vaccines, delayed is receiving vaccine greater than 4 weeks from the scheduled date. For 
fully immunized child (FIC), delayed is receiving all vaccines but at least one of the vaccines was received 
after 12 months of age 
2 For individual vaccines, timely is receiving vaccine within 4 weeks from the scheduled date. For FIC, 
timely is receiving all vaccines by 12 months of age 
3 FIC= Fully immunized child and includes BCG, Polio1-3, Pentavalent1-3, Measles
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Table 4.3 Bivariate and multivariate analyses for predictors of non-immunized vs those receiving immunization by antigen and for 
fully immunized children (FIC).   
 Pentavalent3 Not Received Measles Not Received FIC Not Achieved1 
Mother’s age Crude RR(CI) Adj RR (CI) Crude RR (CI) Adj RR (CI) Crude RR (CI) Adj RR (CI) 
15-24years Ref. Ref. Ref. Ref. Ref. Ref. 
25-29years 1.53 (0.92-2.54) 1.73 (1.04-2.89) 1.08 (0.83-1.41) 1.06 (0.81-1.39) 1.07 (0.84-1.36) 1.07 (0.84-1.36) 
>30years 2.26 (1.43-3.59) 1.99 (1.23-3.22) 1.53 (1.21-1.95) 1.38 (1.08-1.76) 1.46 (1.18-1.81) 1.28 (1.02-1.59) 
Mother’s education       
 0-8years Ref.  Ref.  Ref. Ref. 
9-12years 0.56 (0.37-0.87)  0.64 (0.51-0.80)  0.67 (0.55-0.83) 0.82 (0.66-1.02) 
13+years 0.15 (0.02-1.10)  0.58 (0.33-1.03)  0.59 (0.35-0.99) 0.75 (0.43-1.31) 
Mother’s English 
reading ability 
      
Not at all Ref.  Ref. Ref. Ref. Ref. 
With Difficulty 0.60 (0.34-1.03)  0.86 (0.62-1.19) 0.96 (0.68-1.33) 0.79 (0.60-1.06) 0.90 (0.68-1.20) 
Easily 0.38 (0.22-0.66)  0.58 (0.42-0.81) 0.67 (0.48-0.94) 0.55 (0.41-0.73) 0.75 (0.53-0.99) 
Marital status       
Single/Divorced/Widowed Ref.  Ref.  Ref.  
 Monogamous Married 1.59 (0.83-3.04)  1.36 (0.98-1.90)  1.19 (0.90-1.58)  
Polygamous Married 1.86 (0.83-4.16)  1.60 (1.05-2.42)  1.37 (0.95-1.98)  
Children < 5 years old in 
house 
      
< 1 Ref.  Ref. Ref. Ref. Ref. 
2 1.54 (1.00-2.36)  1.39 (1.10-1.75) 1.34 (1.06-1.70) 1.34 (1.10-1.66) 1.27 (1.03-1.57) 
>3 1.16 (0.66-2.22)  1.30 (0.94-1.81) 1.23 (0.89-1.70) 1.27 (0.95-1.71) 1.19 (0.89-1.60) 
Household size       
<4 people Ref.  Ref.  Ref.  
>4 people 1.65 (1.11-2.46)  1.29 (1.05-1.59)  1.30 (1.08-1.57)  
Socioeconomic status2        
Bottom 40% Ref.  Ref.  Ref.  
Upper 60% 0.74 (0.50-1.09)  0.97 (0.79-1.21)  0.95 (0.78-1.14)  
Mother’s mobile phone        
Has Access/None Ref. Ref. Ref.  Ref. Ref. 
Owns Phone  0.50 (0.34-0.75) 0.52 (0.34-0.78) 0.76 (0.62-0.94)  0.74 (0.61-0.89) 0.83 (0.69-1.00) 
Distance to clinic       
< 2km Ref.  Ref.  Ref.  
>2km 0.99 (0.67-1.47)  1.10 (0.89-1.36)  1.03 (0.85-1.25)  
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Child’s age        
12-18months Ref.  Ref. Ref. Ref. Ref. 
>18 – 24months 0.84 (0.57-1.24)  0.72 (0.58-0.89) 0.71 (0.58-0.88) 0.78 (0.65-0.94) 0.79 (0.66-0.95) 
Child’s gender        
Female Ref.  Ref.  Ref.  
Male 1.46 (0.98-2.17)  1.08 (0.88-1.33)  1.06 (0.88-1.28)  
Pentavalent1 receipt3       
On time Ref. Ref. Ref. Ref. Ref. Ref. 
Delayed  6.32 (4.28-9.35) 5.61 (3.77-8.33) 1.63 (1.23-2.15) 1.51 (1.15-1.99) 2.06 (1.65-2.56) 1.87 (1.51-2.32) 
Abbreviations: Pentavalent3, third dose of pentavalent vaccine; RR, risk ratio; FIC, full immunization coverage; pentavalent1, first dose of pentavalent vaccine 
 
1Child that received BCG, Polio1-3, Penta1-3, and Measles.   
2 Socioeconomic status derived from Principal Components Analysis of household possessions 
3 Delay defined as receiving pentavalent1 four weeks greater than the scheduled date.  






Table 4.4 Bivariate and multivariate analyses for predictors of delayed immunization.   
 Pentavalent1 delayed1 Pentavalent3 delayed1 Measles delayed1 FIC delayed2 
Mother’s age  Crude RR (CI) Adj RR (CI) Crude RR (CI) Adj RR (CI) Crude RR (CI) Adj RR (CI) Crude RR (CI) Adj RR (CI) 
15-24 years Ref. Ref. Ref. Ref. Ref. Ref. Ref.  
25-29 years 1.35 (0.95-1.91) 1.35 (0.95-1.91) 1.22 (0.98-1.51) 1.18 (0.95-1.46) 1.13 (0.93-1.37)  1.23 (0.79-1.94)  
>30 years 1.66 (1.20-2.32) 1.66 (1.20-2.32) 1.46 (1.19-1.80) 1.40 (1.15-1.72) 1.31 (1.08-1.58)  1.33 (0.85-2.10)  
Mother’s education          
 0-8 years Ref.  Ref. Ref. Ref.  Ref.  
9-12 years 0.89 (0.66-1.19)  0.73 (0.61-0.89) 0.74 (0.62-0.90) 0.88 (0.75-1.04)  0.62 (0.42-0.93)  
13+years 0.82 (0.41-1.62)  0.61 (0.38-0.98) 0.62 (0.39-1.01) 0.50 (0.30-0.84)  0.00 (0 - ∞)  
Mother’s English 
reading  
        
Not at all Ref.  Ref.  Ref. Ref. Ref.  
With Difficulty 0.72 (0.46-1.13)  0.99 (0.73-1.34)  0.76 (0.59-0.98) 0.81 (0.62-1.04) 0.80 (0.42-1.50)  
Easily 0.58 (0.38-0.90)  0.76 (0.56-1.03)  0.65 (0.50-0.83) 0.68 (0.53-0.87) 0.57 (0.30-1.06)  
Marital status         
Single/Divorce/Widow Ref.  Ref.  Ref.  Ref.  
 Monogamous Married 1.23 (0.80-1.90)  1.13 (0.87-1.56)  1.16 (0.92-1.47)  0.81 (0.50-1.32)  
Polygamous Married 1.81 (1.07-3.08)  1.35 (0.96-1.88)  1.34 (0.98-1.82)  1.06 (0.55-2.08)  
Children < 5 years old 
in house 
        
< 1 Ref.  Ref. Ref. Ref.  Ref.  
2 1.32 (0.96-1.82)  1.50 (1.23-1.83) 1.48 (1.21-1.79) 1.14 (0.96-1.36)  1.27 (0.83-1.92)  
>3 1.59 (1.06-2.40)  1.44 (1.10-1.89) 1.40 (1.07-1.84) 1.29 (1.02-1.63)  1.50 (0.86-2.61)  
Household size         
<4 people Ref.  Ref.  Ref. Ref. Ref.  
>4people 1.34 (1.01-1.77)  1.25 (1.05-1.49)  1.21 (1.03-1.42) 1.20 (1.03-1.41) 1.42 (0.98-2.08)  
Socioeconomic status3          
Bottom 40% Ref.  Ref.  Ref.  Ref.  
Top 60% 0.90 (0.68-1.20)  0.94 (0.79-1.12)  1.04 (0.89-1.23)  0.79 (0.54-1.14)  
Mother’s mobile 
phone  
        
Has Access/None Ref.  Ref.  Ref.  Ref. Ref. 
Owns Phone  0.81 (0.61-1.07)  0.82 (0.69-0.97)  0.85 (0.73-0.99)  0.68 (0.47-0.99) 0.68 (0.47-0.98) 
Distance to clinic         
< 2 km Ref.  Ref.  Ref.  Ref.  
>2 km 1.04 (0.78-1.39)  1.15 (0.97-1.39)  1.26 (1.06-1.49)  1.34 (0.90-2.00)  
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Child’s age          
12-18 months Ref.  Ref. Ref. Ref. Ref. Ref. Ref. 
>18 – 24 months 1.06 (0.80-1.41)  1.31 (1.10-1.57) 1.36 (1.14-1.62) 1.37 (1.16-1.62) 1.37 (1.16-1.61) 2.49 (1.63-3.82) 2.50 (1.63-3.83) 
Child’s gender         
Female Ref.  Ref.  Ref.  Ref.  
Male 1.08 (0.82-1.43)  0.90 (0.76-1.07)  0.92 (0.78-1.08)  1.05 (0.72-1.53)  
Abbreviations: Pentavalent1, first dose of pentavalent vaccine; Pentavalent3, third dose of pentavalent vaccine; RR, risk ratio; FIC, full immunization coverage;  
 
1 Delayed is vaccination received after four weeks of scheduled date. Reference group is infants that received vaccine within four week of scheduled date 
2 Child that received BCG, Polio1-3, Penta1-3, and Measles.  Delay is receiving at least 1 vaccine at age greater than 12 months.  Reference group is receiving all 
8 vaccines by 12 months of age 
3 Socioeconomic status derived from Principal Components Analysis of household possessions 
 




Table 4.5 Proportions of vaccines given on time and delayed stratified by the number of 






















0  1 -------- -------- ------- ------- 
1 4 4 (100%) 0 (0.0%) ------- ------- 
2 2 2 (100%) 0 (0.0%) ------- ------- 
3 27 4 (14.8%) 23 (85.2%) 2 (1-3) 2 (1-3) 
4 11 3 (27.3%) 8 (72.7%) 2 (1-3.5) 1 (0-3) 
5 39 6 (15.4%) 33 (84.6%) 3 (2-4) 2 (1-4) 
6 21 1 (4.8%) 20 (95.2%) 4 (2-5) 4 (2-5) 
7 249 107 (43.0%) 142 (57.0%) 2 (1-5) 1 (0-3) 
8 1394 635 (45.6%) 759 (54.4%) 2 (1-4) 1 (0-2) 
Total 1748 762 (43.6%) 986 (56.4%) 2 (1-4) 1 (0-2) 
Abbreviation: IQR, Inter-quartile range 
 




Table 4.6 Days underimmunized in first 12 months of life1 
































































Infants underimmunized, n (%) 
0 days NA  525 (48.3) 902 (83.1) 776 (71.5) 600 (55.3) 373 (34.4) 
1-7 126 (11.6) 102 (9.4) 64 (5.9) 68 (6.3) 85 (7.8) 93 (8.6) 
8-30 227 (20.9) 215 (19.8) 49 (4.5) 94 (8.7) 136 (12.5) 133 (12.3) 
31-60 128 (11.8) 113 (10.4) 30 (2.8) 49 (4.5) 64 (5.9) 76 (7.0) 
61-90 282 (26.0) 51 (4.7) 10 (0.9) 21 (1.9) 39 (3.6) 411 (37.9) 
91-180 141 (13.0) 47 (4.3) 12 (1.1) 20 (1.8) 49 (4.5) NA  
181-270 89 (8.2) 6 (0.6) 6 (0.6) 58 (5.3) 113 (10.4) NA  
271-337 93 (8.6) 27 (2.5) 13 (1.2) NA  NA  NA  
Total possible 
delay (days) 337  337  295  267  239  62  
Abbreviations: SE; standard error; NA, not applicable 
1 Underimmunized is the number of days the infant was either unvaccinated or delayed in receiving the vaccine.  Underimmunized days started to accumulate 
four weeks from the scheduled date 
2 All vaccines include BCG, pentavalent1, pentavalent2, pentavalent3, and measles vaccines
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Table 4.7 Bivariate and multivariate analyses for predictors of severe underimmunization  
Characteristic Crude RR (CI) p  Adj RR (CI) p  
Mother’s age (yrs)     
15-24 Ref.  Ref.  
25-29 1.39 (1.01-1.93) 0.04 1.46 (1.06-2.02) 0.02 
>30 2.51 (1.90-3.32) <0.01 2.27 (1.71-3.02) <0.01 
Mother’s education (yrs)     
 0-8 Ref.  Ref.  
9-12 0.54 (0.41-0.70) <0.01 0.70 (0.53-0.94) 0.02 
13+ 0.25 (0.09-0.66) <0.01 0.37 (0.14-0.99) 0.049 
English reading ability     
Not at all Ref.  Ref.  
With Difficulty 0.60 (0.44-0.82) <0.01 0.78 (0.57-1.08) 0.14 
Easily 0.35 (0.25-0.49) <0.01 0.61 (0.42-0.86) <0.01 
Marital status     
Single/Divorced/Widowed Ref.    
 Monogamous Married 1.26 (0.88-1.82) 0.21   
Polygamous Married 1.38 (0.86-2.23) 0.18   
Children < 5 years old in 
house 
    
< 1 Ref.    
2 1.40 (1.08-1.83) 0.01   
>3 1.31 (0.90-1.90) 0.16   
Household size (no. of 
people) 
    
<4 Ref.    
>4 1.62 (1.27-2.07) <0.01   
Socioeconomic status1     
Bottom 40% Ref.    
Upper 60% 0.77 (0.61-0.98) 0.03   
Mobile phone ownership     
Has Access/None Ref.  Ref.  
Owns Phone  0.58 (0.46-0.74) <0.01 0.63 (0.49-0.81) <0.01 
Distance to clinic (km)     
< 2 Ref.    
>2 1.12 (0.88-1.43) 0.35   
Child’s age (months)     
12-18 Ref.    
>18 - 24 1.05 (0.83-1.34) 0.66   
Child’s gender     
Female Ref.    
Male 1.05 (0.82-1.33) 0.71   
Abbreviation: RR, risk ratio; yrs, years 
1 Socioeconomic status derived from Principal Components Analysis of household possessions 
CAPTION: Severely underimmunized infants had greater than 90 days underimmunized and were delayed 
for three of five vaccines (BCG, pentavalent1, pentavalent2, pentavalent3, measles).  Comparison group 
was all other infants. 
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Table 4.8 Comparison of socio-demographic characteristics of children aged 12-23 






Crude RR (CI) 
Card Present 
Adj RR (CI) 
Mother’s age (years)     
15-24  806 (46.2%) 340 (50.2%) Ref.  
25-29 474 (27.2%) 171 (25.2%) 1.04 (0.98-1.11)  
>30 463 (26.6%) 167 (24.7%) 1.04 (0.98-1.11)  
Mother’s education (years)     
 0-8 934 (54.0%) 371 (55.5%) Ref.  
9-12 702 (40.6%) 253 (37.9%) 1.03 (0.75-1.08)  
13+ 92 (5.3%) 44 (6.6%) 0.94 (0.84-1.07)  
Mother’s English reading      
Not at all 147 (8.4%) 49 (7.1%) Ref.  
With Difficulty 631 (36.1%) 267 (38.8%) 0.94 (0.86-1.03)  
Easily 969 (55.5%) 372 (54.1%) 0.96 (0.88-1.05)  
Marital status     
Single/Divorced/Widowed 275 (15.8%) 135 (19.7%) Ref. Ref. 
 Monogamous married 1279 
(73.3%) 
470 (68.6%) 1.09 (1.01-1.17) 1.06 (0.99-1.14) 
Polygamous married 192 (11.0%) 80 (11.6%) 1.05 (0.95-1.16) 1.02 (0.92-1.12) 
Children < 5 years old in 
house 
    
< 1 708 (40.6%) 341 (49.6%) Ref. Ref. 
2 802 (45.9%) 248 (36.1%) 1.13 (1.07-1.19) 1.13 (1.04-1.16) 
>3 236 (13.5%) 98 (14.3%) 1.05 (0.97-1.14) 0.99 (0.91-1.08) 
Household size (no. of 
people) 
    
<4 920 (52.7%) 396 (57.6%) Ref. Ref. 
>4 827 (47.3%) 291 (42.3%) 1.06 (1.01-1.11) 1.04 (0.99-1.10) 
Socioeconomic status1     
Bottom 40% 713 (41.0%) 260 (41.0%) Ref.  
Upper 60% 1026 
(59.0%) 
422 (61.9%) 0.97 (0.92-1.02)  
Mobile phone ownership     
Owns Phone 946 (54.1%) 398 (57.8%) Ref.  
Has Access/None 802 (45.9%) 291 (42.2%) 0.96 (0.91-1.01)  
Distance to clinic (km)     
< 2 729 (42.9%) 244 (36.7%) Ref. Ref. 
>2 970 (57.1%) 421 (63.3%) 0.93 (0.89-0.98) 0.93 (0.88-0.97) 
Child’s age (months)     
12-18 860 (49.2%) 282 (40.9%) Ref. Ref. 
>18 - 24 888 (50.8%) 407 (59.1%) 0.91 (0.87-0.96) 0.91 (0.87-0.96) 
Child’s gender      
Female 827 (47.3%) 364 (52.8%) Ref. Ref. 
Male 921 (52.7%) 325 (47.2%) 1.06 (1.01-1.12) 1.05 (1.01-1.10) 
Abbreviation: RR, risk ratio 
 
1 Socioeconomic status derived from Principal Components Analysis of household possessions 
 
Bold estimates and confidence intervals represent significant finding at an alpha of 0.05
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4.7 Figures for Chapter 4 
Figure 4.1 Inverse Kaplan-Meir curves for immunization timeliness by antigen in infants 
aged 12-23 months in Gem District, Kenya.   
 
Abbreviations: BCG, Bacillus Calmette–Guérin vaccine; Pentavalent1, first dose of pentavalent vaccine; 
Pentavalent3, third dose of pentavalent vaccine 
 
CAPTION: Shaded bars indicate timely window of vaccination. Infants censored at 12 months of age
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Figure 4.2 Box plots for weeks delayed by antigen in infants aged 12-23 months in Gem 
District, Kenya 
 
Abbreviations: BCG, Bacillus Calmette–Guérin vaccine; Pentavalent1, first dose of pentavalent vaccine; 
















Figure 4.3 Inverse Kaplan-Meir curves for time to pentavalent3 and measles vaccination 
by pentavalent1 status 
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Chapter 5.  Mobile-health interventions to improve immunization: Formative 
research findings and epidemiology of mobile phone ownership and short 
message system (SMS) behavior in rural western Kenyan women 
5.1 Abstract 
Objectives:  To assess the feasibility, challenges, and willingness to receive mHealth 
interventions targeting pediatric immunization in rural western Kenya 
Methods:  Focus group discussions were conducted with 30 rural Kenyan mothers to 
inform an intervention trial using short message system (SMS) reminders and mobile 
money based incentives.  A cross-sectional survey of 2393 mothers with infants aged 12-
23 months was conducted to assess mobile phone ownership and SMS utilization. 
Predictors of phone ownership and SMS behavior were determined using multivariate 
logistic regression analyses.  
Results:  Overall, focus group participants thought mobile-health interventions could 
improve immunization coverage.  Mothers mentioned several challenges to such 
interventions, including low mobile phone ownership, language barriers, and appropriate 
content.  The wording of incentives to potential recipients was important as incentives 
were viewed as travel subsidies.  From the cross-sectional survey, 55% of mothers owned 
a mobile phone, 76% received SMS, and 54% sent SMS in the past week. Significant 
predictors of mobile phone ownership included older maternal age, higher maternal 
literacy, increased maternal education, smaller households, and higher socioeconomic 
status.  Maternal literacy, education, and phone ownership predicted receiving SMS.  
Marital status, socioeconomic status, and phone ownership predicted sending SMS. 
Conclusions: Most mothers in rural Kenya had access to mobile phones and had received 
SMS previously, indicating the potential for mobile Health-based interventions to 
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improve immunization.  Challenges to such interventions include unequal access to 
mobile phones and proper framing of the SMS reminders. mHealth interventions and 
programs are often implemented prior to soliciting community input.  Despite the global 
increase in mobile phone ownership, additional efforts and consideration are needed to 
ensure the successful delivery and receipt of mHealth interventions to populations with 





For public health practitioners, vaccines remain one of the greatest tools at reducing 
childhood mortality and morbidity.1  Current immunization programs are estimated to 
save over 2.5 million lives per year.1  Despite their lifesaving potential, approximately 
20% of children, or about 24 million infants, did not receive all the scheduled vaccines1 
and if they were vaccinated, they often received the vaccinations late.2   
Traditionally, supply side strategies, such as improving cold chain capacity and 
increasing procurement, have been employed to address immunization coverage 
deficiences3, 4, yet immunization gaps persist.  Complimentary approaches to supply side 
strategies are demand-side interventions that target high transport costs, misperceptions 
and fear of vaccines, and forgetfulness of child’s immunization. Two of these potential 
demand side interventions are reminder messages and small monetary incentives 
conditioned on vaccine receipt.  
Incentives are a remunerable good or cash that is provided and conditioned on a 
participant’s behavior.  In the context of immunization, incentives could be given if a 
caretaker brings her child for timely immunization.  Quantitative and qualitative research 
on pairing incentives and immunization is limited, yet the findings afford much promise.  
Studies conducted in Pakistan and India found that providing food vouchers or food 
provisions conditioned on vaccine receipt markedly improved vaccination coverage.5, 6  
In addition to incentives, a reminder aimed at targeting parent’s forgetfulness of 
their child’s immunization appointments is another potential demand-based intervention.  
In high income countries, medical practitioners are recommended to send reminders for 
pediatric vaccines based on the strong evidence supporting reminders to improve 
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vaccination.7, 8  Postal, electronic-mail, and voice mails may work well in higher income 
countries, but access to such commodities in lower income countries may hinder their 
implementation.  With global increases in mobile phone ownership and access, 
particularly within lower-income countries9, reminder messages delivered through SMS 
may also prove effective at improving vaccination rates. 
Short message system (SMS) reminders, or text messages, modestly improved 
vaccination uptake in trials conducted in the United States.10-13  Although the efficacy of 
SMS reminders on vaccination uptake has not been studied in resource-constrained 
settings, aside from a small pilot study14, the majority of randomized controlled trials in 
sub Saharan Africa have found SMS reminders improve various forms of healthcare 
utilization.15-23 
In the pilot study referenced above, 72 Kenyan mothers were randomized to 
receive SMS reminders and either $2 USD in mobile money or airtime.  Although no 
control group was employed, 57% of the 72 infants received Pentavalent1 and 
Pentavalent2 on the scheduled dates while 88% of infants were vaccinated within three 
days of the scheduled date.14  Of the 54 mothers who completed a follow-up visit, all 
participants reported that incentives and reminders would influence other mothers to get 
their child vaccinated on time. 
The use of SMS reminders to improve a particular form of healthcare utilization is 
contingent on the targeted population’s access or ownership of a mobile phone.  In a 2009 
national analysis of Kenyan mobile phone ownership, the authors found that despite 45% 
of the population owning a mobile phone, 85% of Kenyans had access to one and that the 
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strongest predictor of mobile phone ownership was higher education24.   However, this 
analysis examined determinants of ownership in both sexes, and research shows a high 
gender gap in mobile phone ownership levels.25 
A more recent analysis of adult patients and caregivers of sick children at Kenyan 
health facilities found that 60.5% of caregivers owned a mobile phone26.  Similar 
analyses of mobile phone ownership determinants were conducted as above, with male 
gender, higher education, lower poverty, higher literacy, and urbanization being 
predictive of phone ownership. In a separate analysis of SMS use, education, age, and 
literacy were found to be statistically significant.26  Importantly, in both analyses24, 26, 
interaction terms with gender were not included. 
In preparation for the Mobile Solutions for Immunization (M-SIMU) village 
randomized controlled trial that uses SMS reminders with or without small monetary 
incentives to improve vaccine coverage and timeliness in western Kenya, we conducted 
focus group discussions to receive local and contextual-specific feedback on the content 
and timing of the SMS reminders, incentive amounts, willingness to receive reminders 
and incentives, and address any problems or complications associated with delivering 
SMS reminders and incentives.  Additionally, a baseline survey of the study area sought 
to examine the distribution of mobile phone ownership and SMS behaviors. 
5.3 Methods 
 Focus Group Sample 5.3.1
The primary purpose of the focus group discussions was to inform the M-SIMU 
trial on SMS content and incentives. The Kenya Medical Research Institute (KEMRI) 
Demographic Surveillance System (DSS) database was searched to identify mothers with 
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children ages 12-23 months and residing in one of ten villages surrounding Siaya Town.  
From this list of eligible participants, a random sample of 48 mothers was taken (nine 
villages contributed five eligible participants and one village three participants).  
KEMRI/CDC staff approached eligible participants for informed consent to one of three 
focus group discussions (FGD). While taking informed consent, mothers were informed 
that a SMS password, written in the local language Dholuo, would be sent 1 day before 
the Focus Group to the phone number that they indicate having access to.  The SMS 
passwords were unique for each individual and were grouped into colors, animals, and 
means of transportation.  Mothers were reimbursed approximately $3.50 USD for round-
trip transportation to the venue.  The focus groups were led by a moderator and three 
assistants and conducted on June 3rd and 4th, 2013.  Each focus group lasted 
approximately 2-2.5 hours and was conducted in the local language, Dholuo.   
 Focus Group Data Collection 5.3.2
 Individual questionnaires 5.3.2.1
Prior to the start of the group discussion, individual questionnaires were 
conducted with each mother to collect demographic information, mobile phone 
ownership and characteristics, evaluate the ability to open and read an SMS message, 
assess whether the SMS password was received, and to rank-order the top 3 of 12 phrases 
that could be included on an SMS to encourage a mother to vaccinate her child.  For 
ability to open and read an SMS message, KEMRI interviewers sent an SMS to the 
participant containing the question, “Hi, how are you today?”  The interviewer observed 
the participant as she opened the message, read it, and answered the question.  The 
response was coded as ‘Yes, easily’, if there was no delay in locating the SMS inbox and 
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opening the message.  If the mother could not immediately locate the SMS inbox and 
open the message, the response was coded as ‘Yes, with difficulty”.  If the mother could 
not open the message, or could not read, the response was coded as “No, cannot open or 
read”. 
 Focus group discussion 5.3.2.2
A semi-structured questionnaire guide was used to elicit mother’s responses on 
barriers to immunization, SMS reminders for pediatric immunization dates, and monetary 
incentives to motivate mothers to bring children for immunization (Appendix 3).  The 
moderator was encouraged to probe further for interesting responses.  For questions 
requiring individual responses within the group session, participants ranked the responses 
by either writing the answer on a small piece of paper or placing a pre-printed response in 
bins labeled #1 (i.e. favorite, preferred, best), #2 (i.e. second favorite, preferred, best), 
etc.  These responses were made before any group discussion and were considered as 
independent, rather than group, responses.   The six highest ranking phrases identified 
from the individual questionnaire were re-ranked privately during the focus group 
discussion.  
In discussion about incentive amounts for immunization, participants were 
presented a scenario where a mother was too busy to bring her child for immunization 
and asked if providing small monetary incentive might cause this mother to bring her 
infant to the immunization clinic. The amounts ranged from 10-200ksh and were 
presented randomly one at a time.  Participants placed a check mark next to the incentive 




Focus group discussions were audio recorded, transcribed in Dholuo, and then 
translated into English.  Audio recordings were destroyed after transcription and 
translation.  Mothers were given participant IDs, which were used to identify women 
during the focus group discussions.  No names were recorded during discussions or 
written on questionnaires. 
Responses in individual surveys and group settings were entered into Microsoft 
Excel and tabulated for frequencies, but no hypothesis tests were made.  Results of focus 
group were resented thematically.    
The protocol and informed consent for the Focus Group were approved by the 
Ethical Review Committee of KEMRI. 
 Mobile phone ownership and SMS behavior Survey 5.3.3
In March and April of 2013, KEMRI/CDC staff surveyed all known mothers with 
infants aged 12-23 months old from DSS-consented compounds in 120 villages of Gem 
District, Nyanza Province.  The primary purpose of this survey was to collect 
demographic variables and immunization coverage to inform sample size and 
randomization for the M-SIMU village randomized controlled trial.   
 Data Management and Analysis 5.3.3.1
Trained KEMRI/CDC staff conducted surveys on Huawei Y200 smart mobile 
phones equipped with the ODK Collect application and preprogrammed with range limits 
and double data entry.  Incoming data were cleaned as collected and community 
interviewers made follow-up visits for participants with ambiguous data.  Analyses were 
performed using STATA/IC, version 11.2 (Stata Corp, College Station, Texas).  
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The primary outcomes were proportions of self-reported mobile phone ownership, 
receiving SMS, and sending SMS.   Mobile phone ownership was coded as ‘1’ if the 
mother is the primary owner of a mobile phone and ‘0’ if the mother either shared or did 
not own a mobile phone. In addition, participants who did not own a mobile phone were 
asked if they had access at the household or compound.  For receiving and sending SMS, 
participants were asked if they regularly received or sent SMS reminders, coded as ‘1’.  
For those that indicated receiving reminders, participants were asked how soon SMS 
were received if a mother owns the mobile phone or how quickly SMS were relayed if 
mobile phone is shared.  In addition, mothers were queried on the frequency of sending 
and receiving SMS in the last week. 
In addition to primary outcome variables, participant’s self-reported demographic 
variables, which were included in regression analyses.  These variables included number 
of children under 5 years old that slept in the house last night, the number of people 
regularly in the household, marital status, socioeconomic status, and maternal age, 
highest level of education attempted, and ability to read English.  Data collected as 
continuous variables were categorized based on reporting relevance and interpretability.  
Maternal age was categorized into mothers aged 15-24 years, 25-34 years, and greater 
than 34 years.  Maternal education was grouped into categories 0 to 8, 9 to 12, and 
greater than 12 years of education attempted. Number of children under five years in the 
household was categorized as 1, 2 or 3 number of children.  The socioeconomic variable 
was calculated by KEMRI/CDC staff using principal components analysis from variables 
on the KEMRI/CDC DSS Household Socio-economic Form.   These variables included 
occupation, drinking water treatment, type of cooking fuel, and possessions.  The socio-
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economic status was provided in quintiles and collapsed to lower 40% and upper 60% for 
present analysis.   
Prior to construction of regression models, data were checked for completeness and 
accuracy.  Frequency distributions were performed to explore data.  Unadjusted logistic 
analyses were conducted with the three primary outcomes: mobile phone ownership, 
receiving SMS, and sending SMS for each demographic variable.  For each primary 
outcome’s adjusted model, variables were selected using forward step wise Akaike 
Information Criteria to obtain adjusted odds ratios and 95% confidence intervals.  An 
alpha of 0.05 was used for all hypothesis testing. 
5.4 Results 
 Focus Groups 5.4.1
Forty-eight mothers with children ages 12-23 months were eligible for 
enrollment.  Of these 48 mothers, 33 women consented to the study, eight were not at 
home when staff visited, six women refused participation, and one was not contacted. 
Three consented women did not attend the FGD.  The following results are for the 30 
women who consented and participated in the FGDs.   
 Maternal demographics and mobile phone ownership/literacy:  5.4.1.1
The majority of the mothers participating in the FGD were ages 20-24 years old, 
had some primary level education and were evenly distributed in the number of previous 
pregnancies (Table 5.1). Mobile phone literacy and characteristics of mother’s mobile 
phone are presented in Table 5.2. Twenty-eight mothers (93%) owned a mobile phone 
and 90% of mothers brought the mobile phone with them to the FGD.  For those that 
brought a mobile phone to the FGD, one-third of participants had less than 1 Kenyan 
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Schilling (KSH) of airtime on the phone and 41% had 1-5ksh (85ksh=$1.00 USD as of 
October 2014).  Approximately one-fourth of mobile phones had a battery charge of 76-
100%, while 22% had less than 25% charge.  Two-thirds of mothers were able to recall 
the password from the SMS sent one day prior to the FGD.  When sent an SMS during 
the individual questionnaire, 90% of mothers were easily able to open and read the 
message.  
The first FGD was conducted with 12 participants from 6 villages.  The second 
and third FGD were each conducted with 9 participants from 6 villages, respectively.  
Overall, the sample spanned 10 different villages. 
 Barriers to immunization coverage:  5.4.1.2
Mothers were asked to discuss perceived barriers in bringing their child for 
immunization.  Bus fare, long distance, lack of information, ignorance and the belief that 
clinics may be out of vaccine were common reasons that mothers indicated as barriers to 
immunization coverage. 
Long distance to the clinic and its associated travel costs were common explanations. 
Sometimes distance also becomes an issue but when I do not have 
bus fare can make me feel discouraged. Group 3-Participant 3 
But mothers also believe the effect of distance could be overcome if the importance of 
immunization was understood. 
What I can say about distance is that it depends on a person’s 
conviction. Sometimes it can be far but when you consider the 
importance of vaccinating a baby, you just make efforts of going. 
Group 3-Participant 5 
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Another commonly discussed barrier was ignorance in regards to vaccine’s 
effectiveness.   
Me, I want to say that first it is illiteracy or ignorance. This means 
that somebody assumes, or she is a person of the past or she did not 
go to school. So she will say that even them their parents did not go to 
school and they were not taken for vaccines and yet we exist and do 
not fall sick often. Today’s children are taken for vaccines and yet 
they still fall sick. Group 3-Participant 2  
….even in the past children survived without vaccines, so she doesn’t 
see the need to take her child for vaccination. Group 2- Participant 3 
Barriers to timely immunization:  The moderator explained timeliness of vaccination in 
relation to the EPI schedule and asked participants if these barriers were dissimilar to the 
barriers for immunization coverage.  Caregiver’s forgetfulness was a common barrier 
identified in all three focus groups. 
Some people forget, she stays until one day she hears that somebody 
is taking her child to clinic. That is when she remembers that she 
was supposed to take her child to clinic. Secondly, she does not know 
how to read the date which was written on the clinic card. Group 3-
Participant 2 
Some mothers may be reluctant to bring their child for immunization which 
hints at the potential of either incentives or reminders to ‘nudge’ mothers 
into bringing the child for vaccination earlier. 
Those who take their children late means somebody is just taking the 




And as seen with barriers to bringing children for any immunization, far 
distances to the clinic and unavailability of vaccines were identified as 
reasons for delayed immunization. 
….perhaps she got the message early but she is coming from a far 
place so she tried to look for transport money but did not find in 
time.” Group 2-Participant 1 
“Some people take them late because sometimes she takes a child in 
time but she is told that the vaccine is not available and so she 
should come back another time and perhaps that time the 
recommended time shall have passed. Group 2-Participant 2 
However, mothers remained optimistic and provided solutions to address timely 
immunization deficiencies. 
But how I perceive it, I think that when a person delivers at the 
health facility or when mothers are going to clinic when expecting, 
they usually take phone numbers. If only they can use those phone 
numbers to remind somebody then they can be of help because there 
are some who do not know dates. Surely, they totally do not know 
and some also assume. Therefore, if they can use the phone numbers 
to remind mothers it can be of great help. Group 3- Participant 2 
 Components and timing of an SMS reminder message:   5.4.1.3
Participants were informed that an SMS could serve as a reminder to immunize 
their child.  We then queried mothers on what components of an SMS reminder are 
essential to ensure the SMS prompts the mother to bring her child for vaccination.  Date 
of vaccination, location, child’s name, and the specific vaccine being reminded were 
components expressed in all three FGDs.  Some mothers suggested that the SMS 
reminder should stress the importance of vaccination. 
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Other than the meaning of vaccination, we request that you include 
the importance of the vaccine…that is what can make the mother 
take her child to the clinic. Group 2- Participant 1  
When asked about the timing of delivery of SMS reminders, 63% of participants reported 
that they would prefer reminders sent 2-3 days before the scheduled vaccination, while 
23% preferred reminders sent the day before.   
2-3 days is good because it allows for one to prepare early, so when 
the day comes one is ready such that if she was far away Group 1-
Participant 11 
No participants thought that the reminder should be sent on the day of vaccination 
When that [SMS] is sent on the same day [with the vaccine date] and 
sometimes on that day you do not have a phone within reach. So you 
cannot read the SMS….Sometimes you are on a journey or something 
is holding you. You can be sent the SMS but there is no way you can 
make it, therefore at least a day before is better. Group 1-Participant 2 
 Phrases and sayings in an SMS to motivate mothers to vaccinate their child:   5.4.1.4
The 12 phrases were compiled by asking KEMRI/CDC staff for common phrases 
in the local language and any other phrase that may prompt a mother to attend the 
immunization clinic.  The phrases were classified into 5 different categories; motivational 
(n=5), informational (n=2), religious (n=1), humorous (n=1) and local sayings (n=3), 
(Table 5.3). 
The results of mother’s individual rankings of phrases that could be attached at 
the end of an SMS reminder are presented in Table 5.4.  Phrase #1, “Vaccinations save 
the lives of Kenyan babies”, had the highest ranked weighted score (61 points), followed 
by Phrase #2, “Baby Thomas <personalized> is happy when healthy” (29 points), and 
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Phrase #3, “Most mothers in your area are getting their child vaccinated. Be one of 
them!” (26 points).  The preferred order was identical to the individual rankings (Table 
5.5).   
Overall, the participants preferred informational or motivational types of 
messages as compared to humorous or local sayings and proverbs. 
Me, I feel those proverbs or wise sayings cannot help because they can be sent but 
I do not understand. So I think we should go directly to the information Group 1- 
Participant 3 
And in regards to the most preferred phrase, “Vaccinations save the lives of Kenyan 
babies”. 
I chose it because when children get vaccinated, all of them it is good because 
sometimes yours gets vaccinated and another does not get vaccinated. If polio 
attacks the one not yet vaccinated you know yours can also contract polio. Group 
3- Participant 6 
I think it can be good because what is written here already makes the mother feel 
happy such if you add on to the message she can be happier and be anxious to 
take her child for vaccination Group 1- Participant 6 
 Incentives for immunization 5.4.1.5
  Twenty-seven percent of mothers said that 100 KSH, the first amount presented 
to the group, would motivate the mother to vaccinate her child.  A dose-response with 
increasing incentive amount and the mother bringing her child for vaccination was 
observed with the effect plateauing at 175 KSH where 90% of mothers indicated this 
incentive amount would be sufficient to motivate the mother to bring her infant for 
vaccination (Figure 5.1).  Fifty KSH (0.60 USD) was the smallest amount that 
participants thought would motivate the mother in the scenario. 
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When participants were asked to describe why they picked incentive amounts, in 
all three focus groups, the conversation centered on transportation costs. 
I think as so long as a person is given an amount which is enough for transport it 
is ok. So, even if you are given 50 KSH for fare, you are going to save life of your 
child. Group 2- Participant 9 
I come from Karapul and I want a motorcycle to take to clinic at a District 
hospital. The motorcycle rider will take 50 KSH such that I will remain with 
nothing meaning I will walk back on foot. Group 3- Participant 3 
200 KSH is good because sometimes, let us say the day for Thomas’s mother to go 
to clinic has come and maybe she had a job she needed to do because she does 
not have money. Now, if she was to be given 10 KSH, she will say let it be but if it 
is 200 KSH she can prioritize going to clinic because she is sure of getting that 
money. Group 1- Participant 3 
Some mothers expressed concern that giving too small of an incentive would be insulting. 
Thomas mother will wonder how much you despise her. That is despising because 
you have come from far and have spent even 100 KSH and you want to go back 
with 100 KSH and then somebody wants to give 50 KSH, I think he/she should just 
leave. Group 3- Participant 2 
Lastly, there were a few people who thought any incentive amount would be appropriate 
as bringing your child for vaccination is a good thing to do. 
I think whoever understands importance of vaccination should not despise amount 
that she is given because a child must be taken for vaccination and should 
appreciate amount that she is given. Group 2- Participant 3 
 Anticipated Challenges 5.4.1.6
Several challenges were identified across the three focus groups.  First, mothers 
expressed concern that messages would not be relayed to those who share a mobile 
phone.  Second, illiterate mothers would have difficulty benefitting from the intervention.  
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Instead, participants suggested calling mothers when vaccinations are due.  In two of the 
groups, mothers recommended including who the SMS was being sent by, as mobile 
operators tend to send many unwanted SMS.   
I cannot trust it because I do not know where it has come from and how it started. 
Nowadays messages are sent aimlessly to phones. You switch on your phone and 
find a message that you do not know its origin. Group 3- Participant 9 
Other challenges recognized were mobile phones not being adequately charged, the need 
for different languages, complex language, and sending an SMS to mothers who do not 
want to receive them. 
 Mobile Phone Ownership and SMS Utilization Survey 5.4.2
 Mobile Phone Ownership analyses 5.4.2.1
Mobile phone ownership and SMS utilization data were collected from, 2393 and 
452 mothers with infants aged 12-23 months old respectively.  Demographic variables 
were missing for 44 participants.    In a final sample of 2359 participants, 55% (n=1301) 
of mothers self-reported owning a mobile phone while 33.7% (n=794) and 4.9% (n=117) 
had access at the household and compound (Table 5.6).  Mothers that reported no 
ownership or access to a mobile phone was 6.2% (n=147). 
The results of bivariate logistic regression analyses for mobile phone ownership, as 
compared to not owning a mobile phone, are presented in Table 5.7.  Older mothers, 
ability to read English language, higher maternal education, and socioeconomic status 
were significant predictors of owning a mobile phone, as compared to not owning a 
mobile phone. Marital status, the number of children under five years old sleeping in the 
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household, and the size of the household were not significantly associated with the 
outcome 
In multivariate analysis, women aged 25 to 34 years (OR: 1.59; 95%CI 1.32-1.91) 
and women greater than 35 years old (OR: 1.90; 95%CI 1.40-2.58) were more likely to 
own a mobile phone than women aged 15 to 24 years.  Mothers with education greater 
than 12 years, (OR: 2.77; 95%CI 1.73-4.42), were more likely to own a mobile phone 
than mothers with less than eight years of education. Mothers who were in the upper 60% 
of socioeconomic status (OR: 1.80; 95%CI 1.52-2.14) were significantly associated with 
mobile phone ownership as compared to those in the lower 40%.  Both the inability and 
difficulty with reading English language was associated with not owning a mobile phone, 
(OR: 0.33; 95%CI 0.24-0.48) and (OR: 0.65; 95%CI 0.54-0.79), respectively.  Mothers in 
the largest households were also significantly associated with not owning a mobile phone 
as compared to mothers living in smaller households, (OR: 0.78; 95%CI 0.61-0.99).   
 Receiving SMS analyses 5.4.2.2
Of the 452 mothers with SMS utilization data, 76.1% reported regularly receiving 
SMS.  When stratified by phone ownership, 96.1% of those owning a mobile phone 
receive SMS compared to 49.7% who do not own a phone, p<0.0001 (Table 5.8). 
Approximately 97% of mothers received an SMS either immediately or within 1 day of it 
being received, if relayed. 
Bivariate analyses found that the mother’s ability to read English, higher maternal 
education, smaller household sizes, higher socioeconomic status, and mobile phone 
ownership were significantly associated with receiving SMS (Table 5.9). In multivariate 
logistic regression analyses for predictors of receiving SMS versus not receiving SMS, 
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only higher socioeconomic status (OR: 1.79; 95%CI 1.01-3.19), monogamous marriage 
(OR: 2.47; 95%CI 1.13-5.44) and mobile phone ownership (OR: 27.9; 95%CI 13.1-59.5) 
were associated with receiving SMS (Table 5.9).  Analyses with mobile phone ownership 
excluded from the multivariate model found that English literacy, maternal education, 
and high socioeconomic status were predictive of receiving SMS (Table 5.10).  
 Sending SMS analyses 5.4.2.3
Approximately 53.5% of the 452 mothers reported regularly sending SMS.  Similar 
to receiving SMS, the proportion of mothers that sent SMS was higher in those who own 
a mobile phone (68.5%) as compared to those who do not own a mobile phone (37.4%, 
Table 5.8). 
Bivariate analyses of predictors of sending SMS reveal that ability to read English 
language, higher maternal education, smaller number of children under five years old in 
household, higher socioeconomic status, and phone ownership were significantly 
associated with the outcome (Table 5.11). 
In multivariate logistic regression analyses for predictors of sending SMS, mothers 
inability to read English (OR: 0.26; 95% CI 0.08-0.82) as compared to the control, was 
associated with not sending SMS.  Mothers who completed 12 or more years of school 
(OR: 3.24; 95%CI 1.12-9.38), as compared to those who attempted less than eight years 
and mothers who owned a mobile phone ownership (OR: 2.78; 95%CI 1.86-4.15), as 
compared to those who do not, were both associated with sending SMS (Table 5.11).  
When mobile phone ownership was excluded from the multivariate model, English 




In order to ensure that SMS reminders, and mHealth interventions as a whole, are 
successful, qualitative research prior to implementation is critical to account for local 
context.  A range of qualitative studies within the United States has generally found that 
parental opinions of vaccination appointment SMS reminders to be accepted effective.27-
32  However, there is a paucity in research from lower income countries, with only two 
studies from Burkina Faso and Nigeria reporting on acceptance of SMS reminders for 
vaccination33, 34 and several other studies reporting on SMS acceptance for tuberculosis35, 
36, malaria37, 38, and HIV treatment.39, 40  This study attempts to address some of these 
gaps in qualitative literature surrounding mHealth interventions for immunization in 
lower income countries. 
In rural western Kenya, our focus group found that 77% of mothers thought 
providing 100KES and SMS reminders would be very helpful at encouraging mothers to 
bring their child for vaccination (Figure 5.2).  Previous studies from Burkina Faso and 
Nigeria report that, respectively, 100% (of n=142) and 77% (of n=399) of mothers would 
be willing to receive an SMS to remind them of their child’s immunization 
appointment.33, 34  Although we did not quantify whether focus group mothers would like 
to receive SMS, the proportion of mothers that believe SMS and incentive to be effective 
at getting infants vaccinated may serve as a proxy.  However, the participants indicated 
that high levels of mobile phone sharing, phones not routinely charged, language barriers, 
and not knowing the source of the SMS as potential challenges to implementing SMS-
based interventions.  To counteract low levels of mobile phone ownership, 55% in our 
baseline survey, SMS reminders could be personalized to ensure that the message is 
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correctly relayed.  Additionally, intended recipients should alert the mobile phone owner 
that reminders will be sent.  Our baseline data indicates that 50% of mobile phone sharers 
receive SMS suggesting that reminder programs or interventions may be feasible in areas 
with low mobile phone ownership. 
To address the issue of language barriers, but not literacy, the language of the 
recipient should be determined for targeted SMSs to that person.  Moreover, SMS 
reminders should be constructed using simple, concise wording and indicating who is 
sending the SMS.  Still there are some barriers that cannot be controlled for, such as 
uncharged mobile phones and people’s willingness to relay reminders and incentives.  
Lastly, caution should be taken if implementing a two-way SMS intervention.  In our 
study sample, the majority of mothers did not have enough airtime to send one SMS.  If a 
program or intervention requires participant feedback, providing toll-free communication 
lines or airtime may be needed. 
We explored the use of additional phrases to attach at the end of an SMS reminder 
because of quantitative 15 and qualitative work37 demonstrating that motivationally 
worded SMS reminders may increase the likelihood that messages are read.  Two of the 
top three preferred choices directly pertained to vaccination while the other was 
personalized and more broadly spoke about the child’s health.  These three additional 
phrases plus a phrase commenting on the vaccines availability will be included in SMS 
reminders used in the M-SIMU trial and will be randomized by dose to potentially 
determine, although underpowered, if any of these additional phrases were more effective 
at yielding timely immunization.   
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The timing of SMS reminder delivery is also important.  As revealed in the focus 
group, SMS reminders are preferred to be received before the date of vaccination.  
Broadly, sending reminders too early (i.e. day of scheduled vaccination) may not produce 
the desired behavior change because mothers may have planned commitments or, more 
likely in areas with low mobile phone ownership, not enough time is given for the 
reminder to be relayed to the intended recipient.  Previous qualitative work found that 
60% of Nigerian mothers prefer an SMS reminder sent one day before immunization visit 
and only 3% prefer the reminder on the same day as vaccination.33  Equally important, 
and mentioned in the focus group, is sending the reminder message too early as mothers 
may forget the reminder message. 
In regards to incentives, FGD mothers interpreted an immunization incentive as a 
transportation reimbursement.  Providing incentives specific to an individual’s transport 
cost is problematic for research trials and scaled programs.  To not disappoint, or even 
negatively influence the decision of, those whose transport costs are greater than the 
incentive, the incentive could be described as a reward for taking care of the child’s 
health.      
Our findings that older, more educated, literate, wealthier women were more 
likely to own a mobile phone is not surprising when compared to other estimates in 
Kenya24, 26 and globally.41  Historically, these predictors of mobile phone ownership are 
often similar to predictors of healthcare utilization.  Less educated, younger, 
impoverished women are individuals that would most likely benefit from mHealth 
interventions such as reminders and mobile-money based incentives, yet low levels of 
phone ownership complicates the delivery and receipt of intervention.  Somewhat 
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promising is that, despite low levels of ownership, 94% of mothers in our baseline survey 
indicated that they had access to a mobile phone at the compound level.  It is likely that 
the proportion with access is even higher as we did not ask about neighbors.  Still, this 
potential weakness needs to be acknowledged and addressed in future mHealth 
interventions. 
Our study had several limitations.  In regards to the focus group discussions, the 
largely positive findings may be a result of ‘courtesy bias’ in that the participants 
provided answers that they thought might please the moderator and research team.  To 
minimize this, the M-SIMU randomized controlled was only mentioned after the 
conclusion of focus groups.  Still, the participants knew that KEMRI/CDC was hosting 
the focus group and there is high population knowledge about KEMRI/CDC’s research 
agenda.  Pertaining to the mobile phone ownership and SMS behavior survey, we 
attempted to survey all caregivers with children 12-23 months of age.  To facilitate this, 
KEMRI/CDC provided us a census.  The provided census may have contained missing 
households as surveillance activities in Gem District recently resumed and the mapping 
of households may not be complete.  It is possible that these missing households are in 
remote locations which one would assume to have lower socioeconomic status.  
Therefore, it is possible that we have overestimated mobile phone ownership.  
Additionally, due to a supervisory oversight, the small sample size for SMS utilization 
prevents drawing strong conclusions about predictors of sending and receiving SMS.  As 
part of the larger Mobile Solutions for Immunizations (M-SIMU) trial, SMS utilization 
analyses will be revisited with a sample size of over 2000 mothers. 
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In conclusion, there is little formative research on willingness to receive, content 
of, and delivery timing of SMS reminders in resource-limited settings.  The optimization 
of these features, while also accounting for high levels of mobile phone sharing and 
phone ownership concentrated in wealthier more educated women, prior to project 
implementation will likely increase the probability of enacting positive behavior change.  
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5.6 Tables for Chapter 5 
Table 5.1 Demographics of Focus Group Discussion mothers with infant aged 12-23 
months in Siaya District, Kenya, 2013.   
Characteristic N (%) 
Maternal Age (years)  
20-24 16 (53%) 
25-29 8 (27%) 
30-37 6 (20%) 
Maternal Education 
(Highest level attempted) 
 
 None   2 (7%) 
Primary 14 (47%) 
Secondary   8 (27%) 
Post-secondary   6 (20%) 
Number of previous 
pregnancies 
 
0 10 (33%) 
1   6 (20%) 
2   4 (13%) 





Table 5.2 Mobile phone ownership and characteristics of Focus Group Discussion 
mothers with infant aged 12-23 Months in Siaya District, Kenya, 2013.   
Mobile Phone Access N (%) 
Own 28 (93%) 
Household   1 (3%) 
Compound   1 (3%) 
Phone brought to FGD  
Yes 27 (90%) 
No   3 (10%) 
Credit Amount on Phone (KSH)1,2  
0-0.99   9 (33%) 
1-5 11 (40%) 
5-20   7 (26%) 
Battery Charge on Phone (%)1,3  
0-25   6 (22%) 
26-50   1 (4%) 
51-75   7 (26%) 
76-100 13 (48%) 
Remember password sent 1 day 
before FGD 
 
Sent to wrong number   1 (3%) 
No   9 (30%) 
Yes 20 (67%) 
Can open and read SMS   
No, can’t open or read   2 (7%) 
Yes, with difficulty   1 (3%) 
Yes, easily 27 (90%) 
Abbreviations: FGD, focus group discussion; KSH, Kenyan Schilling; SMS, short message system 
 
1 Only asked of mothers who brought phone to focus group (N=27) 
2 85 KSH= 1 USD as of October 2014 




Table 5.3 Phrases to be attached at the end of an short message system (SMS) reminder 
to prompt mothers to vaccinate their child 
# Phrase Category 
1. Vaccinations save the lives of Kenyan babies. Informational 
2. Baby Thomas is happy when healthy Motivational 
3. It takes a village to raise a child Motivational 
4. Hope resides in Togetherness Motivational 
5.  Do not respond to a mosquito with a hammer. You will hurt 
yourself 
Humorous 
6. When a ripe fruit sees an honest man, it drops Motivational 
7.  A joyful heart is good medicine, But a broken spirit dries up the 
bones- Philippians 4:6-7 
Religious 
8. If you start early you won’t have to see a magician Local saying 
9. The brain makes the person Local saying 
10. An antelope is not anyone’s goat Local saying 
11. Most mothers in your area are getting their children vaccinated, be 
one of them! 
Motivational 




Table 5.4 Individually ranked mothers’ preferences for phrases to be included at the end 
of a short message system (SMS) reminder for pediatric immunizations   








1. Vaccinations save the lives of 
Kenyan babies 
17 (57%) 3 (10%) 4 (14%) 61 
2. Baby Thomas is happy when 
healthy 
  5 (17%) 6 (20%) 2 (7%) 29 
11. Most mothers in your area are 
getting their child vaccinated, be 
one of them! 
  3 (10%) 6 (20%) 5 (17%) 26 
3. It takes a village to raise a child   2 (7%) 5 (17%) 2 (7%) 18 
7. A joyful heart is good medicine, 
but a broken spirit dries up the 
bones- Philippians 4:6-7 
  1 (3%) 3 (10%) 4 (14%) 13 
12. 80% of children in this area get 
vaccinated 
  2 (7%) 1 (3%) 4 (14%) 12 
8. If you start early, you won’t have 
to see a magician 
 5 (17%) 2 (7%) 12 
5. Do not respond to a mosquito 
with a hammer.  You will hurt 
yourself 
 1 (3%) 1 (4%) 3 
4. Hope resides in togetherness   3 (10%) 3 
9. The brain makes the person   2 (7%) 2 
6. When a ripe fruit sees an honest 
man, it drops 
   0 
10. An antelope is not anyone’s goat    0 
1 Weighted score is the sum of rankings whereby 3 points were given for 1st choice, 2 points given for 
second choice, and 1 point given for 3rd choice.  
 




Table 5.5 Group ranked mothers’ preferences for phrases to be included at the end of a 
short message system (SMS) reminder for pediatric immunizations   








1. #1 Vaccinations save the lives of 
Kenyan babies 
14(47%) 6 (20%) 2 (7%) 56 
2. #2 Baby Thomas is happy when 
healthy 
6 (20%) 6 (20%) 10 (33%) 40 
11. #11 Most mothers in your area are 
getting their child vaccinated, be one 
of them! 
4 (13%) 7 (23%) 6 (20%) 32 
8. #8  If you start early, you won’t have 
to see a magician 
4 (13%) 2 (7%) 3 (10%) 19 
7. #7  A joyful heart is good medicine, 
but a broken spirit dries up the bones- 
Philippians 4:6-7 
1 (3%) 3 (10%) 3 (10%) 12 
3. #3 It takes a village to raise a child 1 (3%) 3 (10%) 1 (3%) 10 
12. #12   80% of children in this area get 
vaccinated 
 2 (7%) 5 (17%) 9 
4. #4  Hope resides in togetherness  1 (3%)  2 
1 Weighted score is the sum of the rankings whereby 3 points were given for 1st choice, 2 points given for 
second choice, 1 point given for 3rd choice.  
 
CAPTION: The top 6 phrases from the individual survey were used for each focus group discussion (FGD) 
and re-ranked in the group setting.  Phrases #1, #2, #3, and #11 were discussed in each FGD. Phrases #7 




Table 5.6 Demographics of rural western Kenyan mothers with infant ages 12-23 months 
old in mobile phone ownership survey 
Characteristic N % 
Phone Ownership   
Owns 1301  55.2% 
Access at household 794  33.7% 
Access at compound 117  4.9% 
None 147  6.2% 
Maternal Age (years)   
15-24 1109 47.0% 
25-34 1008 42.7% 
>35 242 10.3% 
Mother’s ability to read English   
Easily 1308 55.4% 
With Difficulty 870 36.9% 
Not At All 181 7.7% 
Maternal education (years)   
0-8 1282 54.4% 
9-12 944 40.0% 
>12 132 5.6% 
Marital Status   
Single/Divorced/Widowed 381 16.1% 
 Monogamous Married/Cohabitating 1719 72.9% 
Polygamous Married/ Cohabitating 259 11.0% 
Number of children under 5 years 
old in household   
< 1 968 41.0% 
2 1049 44.5% 
>3 342 14.5% 
Number of persons in household   
< 3 617 26.2% 
4-5 1139 48.3% 
6-14 603 25.5% 
Socioeconomic status quintile1   
Bottom 40% 943 40.0% 
Upper 60% 1416 60.0% 




Table 5.7 Bivariate and multivariate analyses for predictors of mobile phone ownership 






Unadjusted OR Adjusted OR 
 N % N % OR (95%CI) P value OR (95%CI) P value 
Maternal age          
15-24 years 555 52.5% 554 42.6% Ref. Ref. Ref. Ref. 
25-34 years 408 38.6% 600 46.1% 1.47 (1.24-1.75) <0.0001 1.59 (1.32-1.91) <0.0001 
>35 years 95 9.0% 147 11.3% 1.55 (1.17-2.06) 0.002 1.90 (1.40-2.58) <0.0001 
Mother reads English         
Easily 496 46.9% 812 62.4% Ref. Ref. Ref. Ref. 
With Difficulty 442 41.8% 428 32.9% 0.59 (0.50-0.70) <0.0001 0.65 (0.54-0.79) <0.0001 
Not At All 120 11.3% 61 4.7% 0.31 (0.22-0.43) <0.0001 0.33 (0.24-0.48) <0.0001 
Maternal education          
0-8years 639 60.4% 644 49.5% Ref. Ref. Ref. Ref. 
9-12years 394 37.2% 550 42.3% 1.39 (1.17-1.64) <0.0001 1.13 (0.94-1.36) 0.200 
>12years 25 2.4% 107 8.2% 4.25 (2.71-6.65) <0.0001 2.77 (1.73-4.42) <0.0001 
Marital status         
Single/Divorce 170 16.1% 211 16.2% Ref. Ref.   
 Monogamous Married 773 73.0% 946 72.7% 0.99 (0.79-1.23) 0.902   
Polygamous Married 115 10.9% 144 11.1% 1.00 (0.73-1.38) 0.957   
Children < 5 years 
old in house 
        
<1 421 39.8% 547 42.0% Ref. Ref.   
2 471 45.1% 572 44.0% 0.92 (0.77-1.10) 0.371   
>3 160 15.1% 182 14.0% 0.88 (0.68-1.12) 0.292   
Persons in household         
<3 270 25.5% 347 26.7% Ref. Ref. Ref. Ref. 
4-5 503 47.5% 636 48.9% 0.98 (0.81-1.20) 0.871 0.94 (0.76-1.16) 0.549 
6-14 285 27.0% 318 24.4% 0.87 (0.69-1.09) 0.219 0.78 (0.61-0.99) 0.041 
SES Quintile1         
Bottom 40% 515 48.7% 428 32.9% Ref. Ref. Ref. Ref. 
Upper 60% 543 51.3% 873 67.1% 1.93 (1.64-2.29) <0.0001 1.80 (1.52-2.14) <0.0001 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; SES, socioeconomic status 
 





Table 5.8 Short Message System (SMS) utilization and frequency by mobile phone 
ownership 
 
 Does not own 
phone 
Owns Phone P value 
Receives SMS 97 (49.7%) 247 (96.1%) P<0.0001 
How soon SMS received    P=0.001 
Immediately 60 (61.9%) 197 (79.8%)  
Within a day 30 (30.9%) 46 (18.6%)  
After 1 day 7 (7.2%) 4 (1.6%)  
Median SMS received per week 3 5 P=0.0534 
Sends SMS 73 (37.4%) 169 (65.8%) P<0.0001 
Median SMS sent per week 3 3 p=0.486 
 Abbreviation: SMS, short message system  
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Table 5.9 Bivariate and multivariate analyses for predictors of receiving SMS in the past 




Receive Unadjusted OR Adjusted OR 
 N % N % OR (95%CI) P value OR (95%CI) P value 
Maternal age          
15-24 years 52 58.2% 156 45.5% Ref. Ref.   
25-34 years 45 41.7% 150 43.7% 1.11 (0.70-1.75) 0.652   
>35 years 11 10.2% 37 10.8% 1.12 (0.53-2.36) 0.763   
Mother reads English         
Easily 52 48.6% 197 57.3% Ref. Ref. Ref. Ref. 
With Difficulty 42 39.3% 136 39.5% 0.85 (0.54-1.35) 0.505 1.52 (0.83-2.78) 0.178 
Not At All 13 12.2% 11 3.2% 0.22 (0.09-0.53) 0.001 0.48 (0.15-1.60) 0.234 
Maternal education          
0-8years 67 65.1% 162 47.9% Ref. Ref. Ref. Ref. 
9-12years 34 33.0% 152 45.0% 1.85 (1.16-2.95) 0.010 1.63 (0.54-2.76) 0.113 
>12years 2 1.9% 24 7.1% 4.96 (1.14-21.6) 0.033 6.70 (0.89-2.96) 0.089 
Marital status         
Single/Divorce 23 21.3% 52 15.1% Ref. Ref. Ref. Ref. 
 Monogamous Married 78 72.2% 260 75.6% 1.47 (0.85-2.56) 0.168 2.47 (1.13-5.44) 0.024 
Polygamous Married 7 6.5% 32 9.3% 2.02 (0.78-5.25) 0.148 3.33 (0.99-11.2) 0.051 
Children < 5 years old 
in house 
        
<1 44 41.1% 150 43.7% Ref. Ref.   
2 49 45.8% 131 38.2% 0.78 (0.49-1.25) 0.310   
>3 14 13.1% 62 18.1% 1.30 (0.66-2.54) 0.444   
Persons in household         
<3 22 20.6% 94 27.3% Ref. Ref. Ref. Ref. 
4-5 62 57.9% 152 44.2% 0.57 (0.33-0.99) 0.048 0.53 (0.26-1.07) 0.077 
6-14 23 21.5% 98 28.5% 1.00 (0.52-1.91) 0.993 1.21 (0.54-2.76) 0.641 
SES Quintile1         
Bottom 40% 57 53.8% 110 32.0% Ref. Ref. Ref. Ref. 
Upper 60% 49 46.2% 234 68.0% 2.47 (1.59-3.86) <0.0001 1.79 (1.01-3.19) 0.047 
Phone Ownership         
Share 98 90.7% 97 28.2% Ref. Ref. Ref. Ref. 
Own 10 9.3% 247 71.8% 25.0 (12.5-49.8) <0.0001 27.9 (13.1-59.5) <0.0001 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; SES, socioeconomic status 
 






Table 5.10 Bivariate and multivariate analyses for predictors of receiving SMS in the past 





Receive Unadjusted OR Adjusted OR 
 N % N % OR (95%CI) P value OR (95%CI) P value 
Maternal age          
15-24 years 52 58.2% 156 45.5% Ref. Ref.   
25-34 years 45 41.7% 150 43.7% 1.11 (0.70-1.75) 0.652   
>35 years 11 10.2% 37 10.8% 1.12 (0.53-2.36) 0.763   
Mother reads English         
Easily 52 48.6% 197 57.3% Ref. Ref. Ref. Ref. 
With Difficulty 42 39.3% 136 39.5% 0.85 (0.54-1.35) 0.505 1.14 (0.69-1.88) 0.602 
Not At All 13 12.2% 11 3.2% 0.22 (0.09-0.53) 0.001 0.38 (0.14-0.99) 0.047 
Maternal education          
0-8years 67 65.1% 162 47.9% Ref. Ref. Ref. Ref. 
9-12years 34 33.0% 152 45.0% 1.85 (1.16-2.95) 0.010 1.52 (0.92-2.52) 0.105 
>12years 2 1.9% 24 7.1% 4.96 (1.14-21.6) 0.033 9.57 (1.23-74.5) 0.031 
Marital status         
Single/Divorce 23 21.3% 52 15.1% Ref. Ref.   
 Monogamous Married 78 72.2% 260 75.6% 1.47 (0.85-2.56) 0.168   
Polygamous Married 7 6.5% 32 9.3% 2.02 (0.78-5.25) 0.148   
Children < 5 years 
old in house 
        
<1 44 41.1% 150 43.7% Ref. Ref.   
2 49 45.8% 131 38.2% 0.78 (0.49-1.25) 0.310   
>3 14 13.1% 62 18.1% 1.30 (0.66-2.54) 0.444   
Persons in household         
<3 22 20.6% 94 27.3% Ref. Ref. Ref. Ref. 
4-5 62 57.9% 152 44.2% 0.57 (0.33-0.99) 0.048 0.64 (0.26-1.07) 0.129 
6-14 23 21.5% 98 28.5% 1.00 (0.52-1.91) 0.993 1.21 (0.60-2.42) 0.593 
SES Quintile1         
Bottom 40% 57 53.8% 110 32.0% Ref. Ref. Ref. Ref. 
Upper 60% 49 46.2% 234 68.0% 2.47 (1.59-3.86) <0.0001 2.08 (1.29-3.35) 0.003 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; SES, socioeconomic status 
 






Table 5.11 Bivariate and multivariate analyses for predictors of sending SMS in the past 




Send SMS Unadjusted OR Adjusted OR 
 N % N % OR (95%CI) P value OR (95%CI) P value 
Maternal age          
15-24 years 91 43.2% 117 48.6% Ref. Ref.   
25-34 years 93 44.3% 102 42.3% 0.85 (0.58-1.26) 0.427   
>35 years 26 12.4% 22 9.1% 0.66 (0.35-1.24) 0.193   
Mother reads English         
Easily 101 48.3% 148 61.2% Ref. Ref. Ref. Ref. 
With Difficulty 89 42.6% 89 36.8% 0.68 (0.46-1.00) 0.053 0.90 (0.59-1.38) 0.626 
Not At All 19 9.1% 5 2.1% 0.18 (0.06-0.50) 0.001 0.26 (0.08-0.82) 0.021 
Maternal education          
0-8years 124 60.8% 105 44.3% Ref. Ref. Ref. Ref. 
9-12years 74 36.3% 112 47.3% 1.79 (1.21-2.65) 0.004 1.49 (0.98-2.28) 0.063 
>12years 6 2.9% 20 8.5% 3.94 (1.52-10.2) 0.005 3.24 (1.12-9.38) 0.030 
Marital status         
Single/Divorce 37 17.6% 38 15.7% Ref. Ref.   
 Monogamous Married 153 72.9% 185 76.5% 1.18 (0.71-1.94) 0.523   
Polygamous Married 20 9.5% 19 7.9% 0.93 (0.43-2.01) 0.523   
Children < 5 years 
old in house 
        
<1 80 38.3% 114 47.3% Ref. Ref.   
2 93 44.5% 87 36.1% 0.66 (0.44-0.99) 0.044   
>3 36 17.2% 40 16.6% 0.78 (0.46-1.33) 0.361   
Persons in household         
<3 49 23.4% 67 27.7% Ref. Ref.   
4-5 103 49.3% 111 45.9% 0.79 (0.50-1.24) 0.306   
6-14 57 27.3% 64 26.5% 0.82 (0.49-1.37) 0.452   
SES Quintile1         
Bottom 40% 93 44.7% 74 30.6% Ref. Ref.   
Upper 60% 115 55.3% 168 69.4% 1.84 (1.25-2.70) 0.002   
Phone Ownership         
Share 122 58.1% 73 30.2% Ref. Ref. Ref. Ref. 
Own 88 41.9% 169 69.8% 3.2 (2.17-4.73) <0.0001 2.78 (1.86-4.15) <0.0001 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; SES, socioeconomic status 
 




Table 5.12 Bivariate and multivariate analyses for predictors of sending SMS in the past 





Send SMS Unadjusted OR Adjusted OR 
 N % N % OR (95%CI) P value OR (95%CI) P value 
Maternal age          
15-24 years 91 43.2% 117 48.6% Ref. Ref.   
25-34 years 93 44.3% 102 42.3% 0.85 (0.58-1.26) 0.427   
>35 years 26 12.4% 22 9.1% 0.66 (0.35-1.24) 0.193   
Mother reads English         
Easily 101 48.3% 148 61.2% Ref. Ref. Ref. Ref. 
With Difficulty 89 42.6% 89 36.8% 0.68 (0.46-1.00) 0.053 0.87 (0.58-1.32) 0.513 
Not At All 19 9.1% 5 2.1% 0.18 (0.06-0.50) 0.001 0.25 (0.08-0.78) 0.017 
Maternal education          
0-8years 124 60.8% 105 44.3% Ref. Ref. Ref. Ref. 
9-12years 74 36.3% 112 47.3% 1.79 (1.21-2.65) 0.004 1.45 (0.96-2.19) 0.081 
>12years 6 2.9% 20 8.5% 3.94 (1.52-10.2) 0.005 3.86 (1.12-11.0) 0.011 
Marital status         
Single/Divorce 37 17.6% 38 15.7% Ref. Ref.   
 Monogamous Married 153 72.9% 185 76.5% 1.18 (0.71-1.94) 0.523   
Polygamous Married 20 9.5% 19 7.9% 0.93 (0.43-2.01) 0.523   
Children < 5 years 
old in house         
<1 80 38.3% 114 47.3% Ref. Ref.   
2 93 44.5% 87 36.1% 0.66 (0.44-0.99) 0.044   
>3 36 17.2% 40 16.6% 0.78 (0.46-1.33) 0.361   
Persons in household         
<3 49 23.4% 67 27.7% Ref. Ref.   
4-5 103 49.3% 111 45.9% 0.79 (0.50-1.24) 0.306   
6-14 57 27.3% 64 26.5% 0.82 (0.49-1.37) 0.452   
SES Quintile1         
Bottom 40% 93 44.7% 74 30.6% Ref. Ref.   
Upper 60% 115 55.3% 168 69.4% 1.84 (1.25-2.70) 0.002   
Abbreviations: OR, Odds Ratio; CI, Confidence Interval; SES, socioeconomic status 
 





5.7 Figures for Chapter 5 
Figure 5.1 Incentive amounts that would motivate mothers to bring baby for vaccination  
 
Abbreviation: KSH, Kenyan Schilling 
 
CAPTION: Mothers were asked to imagine a scenario where a mother was very busy working in the garden 
when a community health worker approaches her and tells her that her child is due for vaccination.  Study 
participants were asked what amount of money is needed to motivate mother to bring child for vaccination. 
Mothers answered privately.  The incentive amounts were presented in the following order: 100ksh, 25, 




Figure 5.2 Focus group participants ratings on helpfullness of  Short Message System 
(SMS) and incentives to increase immunization coverage 
 
Abbreviations: SMS, short message system; KSH, Kenyan Schilling 
 
CAPTION: Mothers with infants ages 12-23 months were asked to privately ranks how helpful SMS 
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Chapter 6. The Mobile Solutions for Immunization (M-SIMU) Trial: A 
preliminary analysis for a cluster randomized controlled trial that assesses the 
impact of mobile phone delivered reminders and incentives to improve timely 
childhood immunization in western Kenya 
6.1 Abstract 
Background:   
Short message system (SMS) reminders and incentives are two demand side interventions 
that have been shown to improve healthcare seeking behaviors in lower income countries.  
We sought to determine if these interventions could improve timeliness of routine 
pediatric immunizations in rural western Kenya. 
Methods:  
Data for this analysis come from the first 107 infants that had 12 month follow-up visits 
in the M-SIMU trial, which was a four-arm, 152 cluster (village) randomized controlled 
trial that enrolled caregivers of infants less than 35 days old who had not initiated the 
pentavalent vaccine series.    Villages were eligible for the study if they were within the 
KEMRI/CDC surveillance system and had no ongoing enhanced immunization programs 
or research studies.  Villages were randomized with constraints in a 1:1:1:1 ratio to one of 
four study arms; Control, SMS reminders only, SMS reminders plus a 75 Kenyan 
Schilling (KSH; 85KSH=$1.00 USD) incentive or, SMS reminders plus a 200 KSH 
incentive.  SMS reminders were sent to enrolled caregivers three days and one day before 
the scheduled immunization visit at 6, 10 and 14 weeks for polio and pentavalent 
(DTP/Hib/HepB) vaccines and at 9 months for measles vaccine.  Mobile-money based 
incentives were sent for each vaccination if participants brought their infant for 
vaccination within two weeks of scheduled date for each of the four vaccination visits.  
Participants were not blinded to their study arm.  The two primary outcomes, time to 
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pentavalent3 and time to measles vaccination were assessed using individual level data 
with adjustments for the cluster design. Inverse Kaplan-Meier (K-M) curves with log 
rank tests and Cox regression analyses were used to assess outcomes.  Primary outcomes 
were also stratified by travel time to clinic and mobile phone ownership and primarily 
conducted with intention-to-treat analyses. 
Results: Between September 30th to October 14th 2013, 107 caregivers from 53 clusters 
were enrolled to control (22 infants; 13 clusters), SMS (32 infants; 14 clusters), SMS plus 
75 KSH (27 infants; 14 clusters), and SMS plus 200 KSH arms (26 infants; 12 clusters).  
The inverse K-M curves were statistically significant for differences by study arms for 
pentavalent3 (p<0.01) but not measles (p=0.10).  Infants in the SMS plus 200 KSH were 
significantly associated with pentavalent3 (HR: 3.33; 95% CI: 1.71-6.47) and approached 
significance for measles vaccination (HR: 2.05; 95% CI: 0.95-4.41; p=0.07), as compared 
to controls.  The SMS only and SMS plus 75KSH were not significantly associated with 
either of the primary outcomes. 
Discussion: Infants of caregivers who received SMS reminders plus 200 KSH incentives 
($2.25) were significantly more likely to receive timely pentavalent3 and measles 
vaccines.  Monetary incentives and mobile phone technologies may improve timely 





The decade from 2010-2019 has been dubbed the “Decade of Vaccines” with 
renewed focus on immunization by major international groups like WHO, UNICEF, the 
Global Alliance for Vaccines and Immunizations (GAVI) and the Bill and Melinda Gates 
Foundation.1-3  A key component in the Global Vaccine Access Plan (GVAP) is the 
recognition that both demand and supply side deficiencies need to be addressed in order 
to achieve universal immunization.4  Ensuring more infants receive timely vaccination is 
a major component in efforts to reduce child mortality by two-thirds and achieve 
Millennium Development Goal 4.5  Every year, immunization programs are estimated to 
save over 2.5 million lives globally6 with the majority of deaths averted occurring in 
Africa.7 
Kenya’s Division of Vaccine and Immunization (DVI) recommends infants 
receive bacillus Calmette–Guerin (BCG) vaccine at birth, three doses of polio and 
pentavalent (diphtheria, tetanus toxoid, pertussis, hepatitis B, and Haemophilus 
influenzae Type B antigens) vaccines at 6, 10, and 14 weeks of age, and the measles 
vaccine at nine months of age.8   Data from successive Kenyan Demographic and Health 
Surveys (DHS) found improvements in pentavalent3 coverage from 72% in 2003, to 86% 
in 2009.9  As global pentavalent coverage estimates continually improve10, 11, timely 
vaccination is garnering more attention.12, 13  Recent study site estimates found that 24% 
and 29% of infants had delays greater than one month for pentavalent3 and measles 
vaccination (Chapter 4 of dissertation). 
Timely vaccination, although often overlooked in routine immunization reporting 
systems, is important for several reasons.  First, pediatric vaccines protect against 
203 
 
diseases that often have highest morbidities and mortalities at earlier stages of life. 
Delays in vaccination have been associated with cases of pertussis, hepatitis B, and 
Haemophilus influenzae type b.14-17  Second, delayed vaccination lessens the population’s 
theoretical maximal herd immunity.18  Herd immunity is important because it protects 
those that are too young to be vaccinated, are medically contraindicated, or do not 
produce a successful to immune response to vaccination.19  Lastly, numerous studies have 
found that United States infants with delayed first vaccination are at higher risk of not 
receiving future vaccinations20-23, with the finding being recently replicated in Kenya 
where infants receiving the first dose of pentavalent vaccine four weeks late were 
approximately 5 and 2 fold times higher to not be vaccinated with pentavalent3 and 
measles, respectively (Chapter 4 of dissertation) 
Two potential demand-side strategies that could address deficiencies in 
immunization coverage and timeliness are short message system (SMS) immunization 
appointment reminders and small monetary incentives conditioned on timely vaccination.  
SMS reminders for pediatric and adolescent immunizations have been found to modestly 
improve immunization uptake in an urban New York City population.24-26  In sub Saharan 
Africa, SMS reminders have been shown to improve HIV treatment adherence27, 28, HIV 
testing29, treatment of pediatric malaria30, antenatal care attendance31, institutional 
delivery32, and post-circumcision clinic visits33, but have not been tested for their efficacy 
on pediatric immunization uptake.   In regards to incentives and immunization, two 
studies conducted in India and Pakistan found that providing either small food rations or 
food coupons improved timely immunization.34, 35 
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The objectives of this pilot analysis of a cluster randomized controlled trial are to 
test whether mobile phone short SMS reminders, either with or without mobile-phone 
based incentives, can improve the timeliness for third dose of pentavalent vaccine 
(pentavalent3) and measles vaccine.  
6.3 Methods 
 Study Setting 6.3.1
The study was conducted in Gem and Asembo Districts of Nyanza Province, 
Kenya.  Gem and Asembo are two of three districts that the Kenyan Medical Research 
Institute and Centers for Disease Control and Prevention (KEMRI/CDC) Health and 
Demographic Surveillance System (HDSS) operate in.  The HDSS has systematically 
collected information on births, deaths, migration, morbidity and demographics every 
four months for a population of over 220,000 people since 200136.  The HDSS has 
previously served as a platform for other scientific studies, including randomized 
controlled trials for bed-net and rotavirus vaccine efficacies.37, 38 
  The study area has high levels of HIV transmission, malaria, and tuberculosis.39, 40  
Primary occupations include fishing, subsistence farming, and wage labor.  Historically, 
Nyanza Province has the worst health and socio-economic status of Kenya’s seven 
provinces.9  The landscape is comprised of slowly rolling hills, pockmarked with 
compounds, consisting of two to six households, and surrounded by personal farm plots.      
  This research trial was a collaborative effort of members at the International 
Vaccine Access Center (IVAC) at Johns Hopkins Bloomberg School of Public Health 
and the Kenyan Medical Research Institute and Centers for Disease Control and 
Prevention (KEMRI/CDC).  
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 Study Design and Participants 6.3.2
The study is a four-arm cluster randomized controlled trial whose primary outcome 
is to compare the efficacy of the interventions on pentavalent3 and measles vaccination.  
Villages, as defined by the KEMRI/CDC HDSS, are the clusters that were randomized.  
Villages were included in the trial if they were located in Gem or Asembo District and 
did not have any current immunization studies or other programs that may influence 
health care seeking behavior.  
One hundred and fifty two villages were randomized to one of four study arms in a 
1:1:1:1 allocation ratio (Figure 6.1).  The study arms include: (1) Control; (2) SMS 
reminders; (3) SMS reminders plus 75 Kenyan Schillings (KSH); and (4) SMS reminders 
plus 200KSH (85 KSH=1USD as of October 2014).  SMS reminders were sent both three 
days and one day before immunization doses scheduled at 6 weeks, 10 weeks, 14, weeks, 
and 9 months.  Incentives were delivered to the participant’s mobile phone if the 
participant’s child was brought for immunization within two weeks of the scheduled date.  
All eligible mothers/caretakers residing within a study village were be assigned to the 
study arm that the village was allocated.  
Eligible caregivers and their newborns were identified by village reporters who are 
casually employed by KEMRI/CDC HDSS to identify births, deaths, and pregnancies 
within their community.  For each birth notification, KEMRI/CDC community 
interviewers visited the newborn’s compound to explain the trial and screen the 
mother/caretaker.  Mothers-infant pairs were eligible if the infant was less than 35 days at 
age of enrollment, a self-identified resident of a study village, willing to attend an M-
SIMU clinic, did not intend to out-migrate from the study area in the next six months, and 
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if the infant had not received the first dose of pentavalent vaccine or measles vaccine. 
Mobile phone ownership was neither an inclusion nor exclusion criteria.  For cases where 
mother did not own a mobile phone, she was asked to provide a phone number where 
SMS reminders and incentives, if applicable, could be sent. 
Both oral and written informed consent was sought by community interviewers for 
eligible and willing mothers.  The study protocol received ethical clearance from the 
Scientific Steering Committee (SSC), the KEMRI-Nairobi Ethical Review Committee 
(ERC; SSC#2409), the Johns Hopkins University Bloomberg School of Public Health 
(deferred to KEMRI ERC); and the Centers for Disease Control and Prevention (deferred 
to KEMRI ERC). The M-SIMU cluster randomized controlled trial was conducted, and 
its results reported, using the Consolidated Standards of Reporting Trials (CONSORT) 
guidelines adapted for cluster randomized trials.41 
 Randomization and masking 6.3.3
The 152 villages were equally randomized to the four study arms in a public 
ceremony attended by village chiefs and community members September 12, 2013.  The 
constrained randomization was conducted by a statistician at Johns Hopkins University 
Bloomberg School of Public Health.  The randomization program iterated until 5000 
acceptable randomizations were found that met the following criteria: 
+/- relative 10% over all 152 villages for the means of the variables:  full immunization 
coverage, phone ownership, distance to the nearest clinic, and village population of 
children 12-23 months old; where full immunization coverage (FIC) was defined as 
infants that received BCG, three doses of polio and pentavalent, and measles vaccine 
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+/- relative 25% within each region (Asembo, Gem) for the means of the variables:  full 
immunization coverage and phone ownership. 
The randomization was also stratified on region such that each study arm 
contained 32 villages from Gem and eight villages from Asembo region.  Data for the 
randomization came from a baseline survey conducted within the study area in March-
April 2013 (Dissertation Chapters 4 and 5). 
A simple random sample of n=1000 was taken from the 5000 valid randomization 
sequences.  The 1000 sequences were labeled with a 3-digit number, 000 to 999.  Each 
sequence allocated 38 villages to one of four groupings (A, B, C, D).  Nine soccer balls 
were labeled with numbers 0-9 and placed in a cloth sack.  Three village chiefs each drew 
one labeled ball, with replacement, such that a 3 digit number was generated.  Villages 
were placed into four groups based on the allocation sequence number drawn.  Then, four 
soccer balls labeled with the study arms (#1.control, #2.SMS, #3. 75KSH, and #4. 
200KSH) were placed in a different cloth sack.  A representative from each of the four 
groupings drew one ball, without replacement, to determine the study arm assigned to all 
villages within the grouping.  
Due to the nature of the intervention, participants and study staff were not blinded 
to participant allocation. 
 Procedures 6.3.4
Upon provision of informed consent, a community interviewer texted an enrollment 
SMS to the RapidSMS server, a free and open-source program, that contained the 
mother’s village and compound number, the phone number that the mother would like to 
receive study SMSs, the enrolled caregiver’s child’s date of birth, the preferred language 
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to receive SMS’s (English, Kiswahili, or Dholuo), and the enrolled caregiver’s baby’s 
first and last name.  For mothers that did not own a mobile phone, study staff urged these 
mothers to notify the owner of the mobile phone that they would be receiving SMS 
reminders and incentives for their infant’s immunization visit.  After the enrollment SMS 
was sent, enrolled caregivers received a personalized SMS sent from the RapidSMS 
server that welcomed the mother to the study.  
If mothers were randomized to the SMS only, SMS plus 75 KSH, or SMS plus 
200 KSH arm, SMS reminders were sent to mother’s identified mobile phone on both 
three days and one day before the scheduled immunization visits at 6, 10, and 14 weeks 
for the three doses of pentavalent vaccine and at 9 months for measles as per Kenyan 
Expanded Programme on Immunization (KEPI) guidelines (Figure 6.2).42  If a 
pentavalent vaccination was given later than the scheduled date, then SMS reminders for 
the subsequent pentavalent dose were reprogrammed to occur at four weeks from the date 
of vaccine receipt, as per KEPI guidelines.   
SMS reminders contained personalized wording indicating which vaccine the 
infant was due to receive.  If the participant was in an incentive arm, the reminder also 
included the amount of money the caretaker would receive for vaccinating her child 
(within two weeks of the scheduled due date).   Motivational sayings were attached at the 
end of the SMS.  These sayings were selected as a result of focus group discussions and 
were randomized for each vaccine dose. 
If mothers were randomized to either SMS plus 75 KSH or SMS plus 200 KSH 
arm, mobile phone-based monetary incentives were delivered to mother’s identified 
mobile phone for each timely dose of pentavalent and measles vaccine, defined as within 
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two weeks of the scheduled date (i.e., pentavalent1 at 6 weeks, pentavalent2 and 
pentavalent3 four weeks after the previous dose and measles at 9 months (272 days).  If 
the infant received vaccination two weeks after the scheduled date, no incentive was 
transferred.  Incentives were delivered through the participant’s choice of mobile network 
and delivered within 24 hours of vaccine receipt.  The incentive amount transferred for 
timely vaccination was 75 KSH for those in the SMS plus 75 KSH arm and 200 KSH for 
those in the SMS plus 200 KSH arm.  Mothers residing in control arm villages received 
only a welcome SMS upon enrollment.  No additional SMSs or incentives were sent to 
mothers in the control arm.   
KEMRI/CDC health facility recorders were stationed at 24 clinics to document 
enrolled infant’s immunization. After infants were immunized, health facility recorders 
sent an SMS message to the RapidSMS server, which automatically calculated whether 
vaccine was received within two weeks of scheduled date. At the end of each working 
day, a KEMRI/CDC employee downloaded that day’s list of incentive arm participants 
whose infants received timely vaccination and uploaded the file to the KEMRI Bill Pay 
system where the appropriate incentive was then dispensed.  When infants reached 12 
months of age, community interviewers conducted in-home follow up visits to document 
immunization coverage using either maternal and child health booklet (MCH) or verbal 
report. 
 Data Collection 6.3.5
Over the course of the trial, participants were interviewed up to six times.  
Interviews occurred at enrollment, twelve month follow up, and at each of the 
immunization visits for clinics staffed by M-SIMU personnel.  
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Enrollment surveys were collected by community Interviewers using ODK 
Collect software loaded on a simple smart mobile phone (Huawei Ascend Y200 model) 
(Appendix 10).  Information collected at enrollment includes mobile phone literacy, 
demographics, vaccine perceptions, transportation, and socioeconomic status.  
Community interviewers transmitted completed surveys to a secure server at 
KEMRI/CDC using the local mobile phone network.   
At immunization visits, health facility recorders interviewed enrolled mothers 
after their infant’s immunization using netbook computers programmed by KEMRI/CDC 
staff.  These surveys were designed to collect information relating to financial and non-
financial costs associated with the clinic visit.  Additionally, previous vaccinations were 
recorded if a mother presented to clinic with infant’s maternal and child health booklet.  
Weekly, field supervisors collected the health facility recorder’s netbooks and 
downloaded the data to a portable hard drive that was then brought to KEMRI/CDC 
Kisumu headquarters and stored on a secure server. 
When infants were aged 11 to 12 months, community interviewers conducted in-
home follow-up visits to ascertain immunization status and collect information on 
mothers’ perceptions of intervention.  Similar to enrollment surveys, the data was 
collected on mobile phones equipped with ODK collect software. 
The RapidSMS system was programmed to generate daily logs of SMSs sent and 
received.  Daily, quality control checks confirmed validity of the enrollment and 
immunization receipt.  Potential errors discovered were given to the field supervisors and 
followed up at the field.  Routinely, the logs of SMS reminders sent to mothers were 
examined to ensure that the intervention was being delivered in line with the protocol. 
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 Dependent variable definitions 6.3.6
The two primary outcomes are pentavalent3 vaccination by 24 weeks of age and 
measles vaccination by 10 months of age.   Data for primary outcomes were collected at 
follow-up visits when infant was between 11-12 months. A child was defined as 
vaccinated for either vaccine if there was written confirmation independent of the M-
SIMU prospectively collected data from immunization clinics.  Infants with maternal and 
child health booklet at follow-up was sufficient for determining primary outcomes, unless 
there was discrepancy with dates from immunization SMS records, in which case, the 
clinic immunization log book was used to resolve date differences.  For those that orally 
reported at follow-up, clinic records were searched and immunization date recorded. 
The infant’s age at vaccination was calculated by subtracting the infant’s date of 
birth from the date of vaccination.  Infant were considered vaccinated with pentavalent3 
by 24 weeks of age if the infant received the three dose pentavalent sequence before the 
infant aged to 168 days (24 weeks).  Infants were considered vaccinated with measles 
vaccine by 10 months of age if the infant received measles vaccine by 302 days of age 
(10 months).  The measles primary outcome was independent of child’s pentavalent3 
status.  
 Data Analysis 6.3.7
The data for this analysis came from a preliminary cohort of M-SIMU infants 
which includes the first 107 infants who had a 12 month follow-up visit completed. A 
priori, these infants were excluded from the formal analysis of the 2042 infants in the M-
SIMU trial.  This cohort was established to assess the readiness of the automated SMS 
and incentive delivery systems.  Participants in this cohort underwent all study 
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procedures as those in the larger trial.  Analyses were conducted using intention-to-treat 
(ITT) for delivery of SMS reminders.  Per protocol analyses were conducted to 
corroborate ITT analyses.43  For ITT analyses, the full sample of infants was analyzed for 
pentavalent3 and measles vaccination.  Per protocol analyses of pentavalent3 vaccination 
were conducted for the sample of infants that had SMS reminders delivered per protocol 
for pentavalent1, pentavalent2, and pentavalent3 vaccines.  Per protocol analyses of 
measles vaccination was conducted for the sample of infants that had SMS reminders 
delivered correctly for measles vaccine. 
Cluster level and individual level estimates of baseline variables were generated for 
each study arm and visually inspected to see if there were any differences in study arms.  
Due to the large number of clusters per study arm, individual level analyses were favored 
over cluster level analyses due to the improved efficiency and ease of adjusting for 
covariates in a single step.44 
Inverse Kaplan-Meier curves were created for the pentavalent3 and measles 
primary outcomes as performed elsewhere.45-47  Infants that were alive and had not 
migrated from the study area were censored at 24 weeks for pentavalent3 and 302 days 
for measles if the vaccine was not received by the respective time points.  Infants that 
died or migrated from study area before the vaccine was given were censored at age of 
death or migration if this occurred before 24 weeks for pentavalent3 and 302 days for 
measles vaccines. For statistical purposes, infants entered the study, or in other words 
were at risk for vaccination, at 12 weeks for pentavalent3 vaccine (2 weeks before 
pentavalent3 is recommended) and at 180 days for measles (measles can be given as early 
as 6 months in HIV+ infants).  Log rank tests with trend option were used to assess the 
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global equality of inverse survival curves and differences in trends across the four study 
arms.48  To assess the proportional hazards assumption for Kaplan-Meier survival 
analysis, log-log plots were created and visually assessed for parallel curves.49  
Additionally, the proportional hazard assumption for Cox regression models was tested 
based on examination of Schoenfeld residuals and log-log plots.50   
Unadjusted hazard ratios for study arms on pentavalent3 vaccination and measles 
vaccination were obtained by Cox regressions51 and included adjustment for the cluster 
design of the trial by use of robust variance estimates of immunization status at village 
level.52  For adjusted Cox regression analyses, a priori, mobile phone ownership, region, 
and time to clinic were included in models using the ‘strata’ option to allow for different 
baseline hazards of covariates. Additional variables were included in adjusted Cox 
regressions if there were differences in their distribution by study arm and if their 
unadjusted Cox regression estimates were statistically significant. A priori, unadjusted 
and adjusted effect estimates for pentavalent3 and measles vaccine receipt were presented 
stratified separately by mobile phone ownership and time to clinic.  An alpha of 0.05 was 
used for all hypothesis testing.  Analyses were performed using STATA/IC, version 11.2 
(Stata Corp, College Station, Texas).   
6.4 Results 
Enrollment for the pilot sample occurred from September 30th to October 14th 2013, 
where 138 birth notifications from 61 villages were received by study staff.  Twenty-six 
mother-infant pairs did not meet eligibility criteria, 3 mothers refused, and 2 infants died 
before study staff could approach mothers for enrollment (Table 6.1).  A total of 107 
mothers with eligible infants from 53 villages were included in the preliminary cohort 
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(Figure 6.1).  The number of infants (clusters) enrolled in control, SMS, SMS plus 75 
KSH, and SMS plus 200 KSH arms were 22 infants (13 clusters), 32 infants (14 clusters), 
27 infants (14 clusters), and 26 infants (12 clusters), respectively.  The average cluster 
size of enrolled infants for control, SMS, SMS plus 75 KSH, and SMS plus 200 KSH 
arms were 2.3, 3.1, 2.6, and 2.6 infants respectively.  One infant in the 200 KSH arm 
migrated from the study area and could not have immunization records confirmed and 
was considered lost to follow up.  The following are results for 106 infants with 
independently confirmed immunization status. 
 Baseline Characteristics 6.4.1
The present sample represents infants from 53 of the 152 villages that were 
randomized with restrictions on village size, socioeconomic status, mobile phone 
ownership levels, and full immunization coverage levels.  The variables that were 
restricted for randomization come from a baseline survey conducted in March of 2013.  
Cluster estimates, weighted for number of infants, of mobile phone ownership, full 
immunization coverage, socio-economic status, and straight line distance to the nearest 
clinic were similar across the four study arms (Table 6.2).  The control arm had a higher 
cluster proportion of infants from villages in Asembo District (50%) as compared to the 
SMS (78%), lower incentive (85%), and higher incentive (76%) arms.  The SMS arm had 
smaller average cluster size (17 infants), defined as the 2012 birth cohort for that village, 
as compared to the control (26 infants), lower incentive (27 infants), and higher incentive 
(23 infants) arms. 
Individual baseline characteristics of the sample are presented in Table 6.3. 
Maternal age, maternal education, marital status,  number of antenatal visits in last 
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pregnancy, number of children under 5 years old regularly sleeping in the household, 
number of people in the household, and age of infant at enrollment were similar across 
the four study arms (intention-to-treat).  Infants in the lower and higher incentive arms 
had lower levels of health facility deliveries, 56% and 64% respectively as compared to 
control and SMS arms, 82% and 75% respectively. Additionally, infants in the lower and 
higher incentive arms had lower levels of mobile phone ownership, 37% and 40% 
respectively as compared to control and SMS arms, 73% and 69% respectively.   The 
higher incentive arm had a higher proportion of female infants, 76%, as compared to 
control (46%), SMS only (38%) and lower incentive arms (48%).  Infants in SMS only 
and higher incentive arms had higher proportions of travel time to the clinic exceeding 
thirty minutes, 50% and 28% respectively, than those in the control and lower incentive 
arm, 9% and 11% respectively. Baseline SMS behavior, which included regularly 
receiving and sending SMS, and the number of messages sent or received per week were 
similar across the study arms (Table 6.4). 
 Delivery of SMS reminders 6.4.2
 
Overall, for the 84 infants who were in SMS only and SMS plus incentive arms, 
92.6% of SMS reminders were delivered per protocol for the pentavalent1, pentavalent2, 
pentavalent3, and measles vaccines (Table 6.5). Vaccine specific estimates found that 
96%, 86%, 94%, and 96% were delivered per protocol for pentavalent1, pentavalent2, 
pentavalent3, and measles vaccines, respectively.  There was little difference in per 
protocol delivery of SMS reminders by study arm, with 95%, 92%, and 91% of reminders 
in SMS only, SMS plus 75KSH, and SMS plus 200KSH delivered correctly.     
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The number of vaccinations that were correctly sent reminders is presented in 
Table 6.6.  Overall, 69 of the 84 infants (82%) in SMS and incentive arms had reminders 
delivered as intended, with 8 (10%) of infants having reminders delivered for three of the 
four vaccines. Four infants (5%) had reminders delivered correctly for two of the four 
vaccines and 3 infants (4%) had reminders delivered correctly for one vaccine.  At least 
one reminder was delivered correctly to all infants.  The distribution of correctly 
delivered SMS reminders was similar by study arm.  For SMS only, SMS plus 75 KSH, 
and SMS plus 200 KSH, 85%, 81%, and 80% of infants had all reminders delivered 
protocol.   
 Effect of interventions on timely pentavalent3 6.4.3
Intention-to-treat analyses utilized the full sample of 106 infants for pentavalent3 
vaccination by 24 weeks.  Per protocol analyses utilized data from 91 infants; 15 infants 
were excluded because SMS reminders were not delivered correctly for all three doses of 
pentavalent vaccines.     
Log-log plots were assessed for violation of proportional hazards assumption 
(Figure 6.3). There was an overall significant difference in inverse Kaplan-Meier curves 
by study arm for time to pentavalent3 vaccination in both intention-to-treat (Figure 6.4) 
and per protocol analyses for delivery of SMS reminders (Figure 6.5), with a significant 
trend in survival curves, going from control, to SMS only, to SMS plus 75 KSH, to SMS 
plus 200 KSH (p<0.01).  The SMS plus 200 KSH inverse survival curve was 
significantly different than the SMS plus 75 KSH curve with no difference in curves 
between the SMS and control arms in both per protocol and ITT analyses. The median 
ages for pentavalent3 vaccination by study arm were: SMS plus 200 KSH (101 days, 
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95%CI 99-103 days), SMS plus 75 KSH (107 days, 95%CI: 103-110 days), control (111 
days, 95%CI: 101-119 days), and SMS arm (116 days, IQR: 106-120 days).  Control arm 
infants had greatest variance in median days to pentavalent3 vaccination. There was no 
difference in survival curves of pentavalent3 vaccination for potential covariates and 
stratified variables (Appendix 11).  In infants that reached 24 weeks of age, pentavalent3 
coverage was 95.5% (77.1%-99.9%), 89.7% (72.6%-97.8%), 88.9% (70.8%-97.6%), and 
100% (85.8%-100.0%), in control, SMS only, SMS plus 75KSH, and SMS plus 200KSH 
arms, respectively. 
  Cox regression analysis of pentavalent3 vaccination found that participants in 
the SMS plus 200 KSH arm were more likely to receive pentavalent3 than infants in 
control arms in unadjusted (HR: 2.95; 95% CI: 1.69-5.16) and adjusted (aHR: 3.33; 95% 
CI: 1.71-6.47) intention-to-treat analyses (Table 6.7).  Those enrolled in SMS only and 
SMS plus 75 KSH arms were not significantly more likely to receive pentavalent3 than 
control arm infants.  The results of per protocol adjusted analyses had similar statistical 
findings to ITT analyses, SMS plus 200KSH (aHR: 3.89; 95%CI: 1.88-8.02). 
 Effect of timely interventions on measles vaccination 6.4.4
Intention-to-treat analyses utilized the full sample of 106 infants for measles 
vaccination by 10 months of age.  Per protocol analyses utilized data from; five infants 
were excluded from per protocol analyses of measles coverage because reminders were 
not delivered for measles vaccine correctly.   
There was no significant difference in time to measles vaccination by study arm 
in intention-to-treat (p=0.10) and per protocol analyses (p=0.14), (Figure 6.6 and 6.7) The 
median age for measles vaccination in study arms were: control (279 days, 95%CI: 273-
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295), SMS only (285 days, 95%CI: 275-295), SMS plus 75KSH (283 days 95%CI: 275-
297), SMS plus 200 KSH (277 days, 95%CI: 275-282). There was no difference in 
survival curves of measles vaccination for potential covariates and stratified variables 
(Appendix 12).  In infants that reached 10 months of age, measles coverage was 81.8% 
(59.7%-94.8%), 71.4% (51.3%-86.8%), 72.0% (50.6-87.9%), and 95.8% (78.9%-99.9%), 
in control, SMS only, SMS plus 75KSH, and SMS plus 200KSH arms, respectively. 
Although, there were no significant findings for unadjusted Cox regression 
analyses of measles vaccination by study arm in intention-to-treat analyses (Table 6.8), 
infants in the SMS plus 200 KSH arm trended towards statistical significance as 
compared to control (HR: 1.57; 95% CI: 0.86-2.89; p=0.14).  Similarly, estimates 
approached statistical significance in adjusted ITT analyses (aHR: 2.05; 95% CI: 0.95-
4.41; p=0.07) and adjusted per protocol analyses (aHR: 2.01; 95% CI: 0.95-4.26; 
p=0.07).  SMS only and SMS plus 75KSH were not significant in unadjusted and 
adjusted models. 
 Subgroup analyses 6.4.5
In stratified analyses of mobile phone ownership, we found some evidence for 
effect modification of pentavalent3 vaccination (Table 6.9).  Infants in the SMS plus 75 
KSH arm were significantly associated with pentavalent3 vaccination in adjusted ITT 
analyses of mobile phone owners (aHR: 2.83; 95%CI 1.19-6.72) but not for those without 
a mobile phone (aHR: 1.05; 95%CI 0.37-3.00; p=0.93).  Effect estimates of those in SMS 
plus 200 KSH arms were similar for those that own a mobile phone (aHR: 4.48; 95%CI 
2.05-9.75) and those that do not (aHR: 3.89; 95% CI 1.22-12.4).  Infants in SMS only 
arm did not have significant effects in either those that own mobile phones or those that 
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do not, although statistical significance was approached in per protocol analyses of 
mobile phone owners (aHR: 0.55; 95%CI: 0.28-1.08; p=0.09). 
In stratified analyses of travel time to clinic (Table 6.10), we found some evidence 
for effect modification of pentavalent3 vaccination.  Infants living less than 30 minutes 
from clinic and in the SMS plus 200 KSH arm were significantly associated with 
pentavalent3 receipt in unadjusted (HR:3.60; 95% CI: 1.91-6.76) and adjusted ITT 
analyses, (aHR:3.47; 95% CI: 1.67-7.20), but were not significant if living greater than 
30 minutes away. There was no effect in SMS only and SMS plus 75 KSH in either of the 
time to clinic categories, although infants in SMS only and living greater than 30 minutes 
from clinic trended towards non-vaccination (aHR: 0.31; 95% CI 0.08- 1.22; p=0.10. 
In stratified analyses of mobile phone ownership and measles vaccination (Table 
6.11), we found some evidence for effect modification.  Infants in the higher incentive 
arm with caregivers that owned mobile phones were more likely to receive measles 
vaccination in unadjusted, (HR: 2.84; 95% CI: 1.37-5.88), and adjusted ITT analyses, 
(aHR: 3.02; 95%CI 1.49-6.14), with null findings in those that do not own mobile 
phones. There was no effect in either of mobile phone ownership categories for infants in 
SMS only and SMS plus 75KSH arms.   
In stratified analyses of travel time to clinic and measles vaccination, we found 
some evidence for effect modification (Table 6.12). Infants living less than 30 minutes 
from clinic and in the SMS plus 200 KSH arm were significantly associated with measles 
receipt in unadjusted, (HR:2.12; 95% CI: 1.15-3.90), and adjusted ITT analyses, 
(HR:2.41; 95% CI: 1.11-5.23), but were not significantly associated with measles 
vaccination in infants that live greater than 30 minutes from the clinic. There were no 
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significant findings for SMS only and SMS plus 75 KSH infants in either those that live 
closer or farther from a clinic. 
6.5 Discussion 
 
In this cluster randomized controlled trial, SMS immunization reminders coupled 
with the higher 200 KSH incentive was significantly associated with pentavalent3 
vaccination and approached statistical significance for measles vaccination.  Stratified 
analyses found a positive effect of the higher incentive arm for pentavalent3 in those who 
own and those who do not own a mobile phone, and in mothers who live less than 30 
minutes to the clinic.  The higher incentive arm, in stratified analyses, also showed a 
significant effect on measles outcome in those who own mobile phones and those who 
live closer to the health facility.   For infants of villages randomized to SMS plus the 
lower 75 KSH incentive, there was no effect on either of the primary pentavalent3 and 
measles outcomes, however, there was an observed effect modification for mobile phone 
ownership. Infants of villages randomized to the SMS only arm showed no significant 
associations in primary and stratified analyses of pentavalent3 and measles vaccines with 
the exception of stratified analyses of pentavalent3 where infants living greater than 30 
minutes from the clinic were significantly less likely to be vaccinated as compared to 
controls in adjusted per protocol analyses.  
There is substantial evidence that small incentives can produce positive behavior 
change in developed countries53-55, including strong evidence for adult immunizations54, 
with insufficient evidence for pediatric56, 57 and adolescent vaccines.58 Our finding that 
the provision of financial incentives improved timely immunization is consistent with 
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results from developing countries and also from the few studies that employed monetary 
and non-monetary incentives, such as food rations or vouchers, to yield positive behavior 
change in lower income countries.34, 35, 59, 60 
Although the 200 KSH incentive arm showed positive associations with most of 
the primary and stratified outcomes, the 75 KSH arm did not.  A previous study in rural 
Malawi randomized individuals to vouchers ranging from $0 to 3 USD that were 
redeemable if HIV test results were obtained from a testing clinic.59  The authors found 
that very small incentives (e.g. <$0.20) induced high uptake of HIV test results (>65%) 
as compared to controls (35%) and that there were marginal gains in testing uptake with 
increasing incentives beyond $1.00. A trial from rural Kenya randomized uncircumcised 
males to control groups, $2.50 USD incentive, $8.75 incentive, and $15.00 incentive, 
where incentives were given if the participant was circumcised within two months.60  The 
authors found no effect of the smallest incentive on circumcision uptake, but found 
significant effects in those receiving the $8.75 and $15.00 incentives. Our study results 
are more consistent with the latter study’s as the provision of smaller incentive amount 
did not elicit behavior change, while the higher incentive did.   
Far distances to the clinic have frequently been associated with poor 
immunization coverage levels.61-72  The purpose of incentives in this trial was to help 
alleviate the burden of transport costs associated with longer travel by serving as a form 
of travel subsidy.   In the Malawi HIV testing study, there was some evidence that the 
incentives’ efficacy was greater in those living farther distances from the testing site, than 
those living closer.59  Our study yielded conflicting results, with the highest incentive 
only effective in those living closest to the health facility.  Our null finding for longer 
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travel times may be explained by the incentive amount not sufficient to cover transport 
costs, thus not reducing the direct and opportunity costs in caregiver’s internal cost-
benefit calculations of whether to bring their infant for immunization.  Moreover, 
behavioral economics reveals that individuals place greater value and emphasis on cost-
benefits that are immediate, such as treatment, as compared to those that are delayed, 
such as preventive medicine.73   
This trial was designed and implemented as an effectiveness study, with mobile 
phone ownership not being a prerequisite for enrollment, unlike other SMS reminder 
randomized controlled trials conducted in sub Saharan Africa.27, 33, 74, 75  Mobile phone 
ownership in low income countries is growing rapidly76, 77, yet ownership is still 
concentrated in wealthier, more educated, men.78-80  Study site-specific data from March 
2013 indicate that access to a mobile phone within the compound approached 100%, but 
only approximately half of mothers own a mobile phone, with older, more educated, 
wealthier females more likely to own a phone than to share (Dissertation Chapter 5).   In 
light of low mobile phone ownership levels, we still intentionally decided to enroll 
mothers independent of mobile phone ownership, with the expectation that the ‘local 
economy’ would sort itself out and that mothers not owning a mobile phone would find 
someone they know to relay SMS reminders and incentives. 
The findings of mobile phone ownership level and being immunized were mixed. 
The effect estimates for the higher incentive arm in mobile phone owners and sharers 
were similar for pentavalent3 while infants in the smaller incentive arm were only 
significantly associated with mobile phone owners.  Similar to the explanation for the 
null finding of stratified travel time analyses, it is possible that the 75KSH incentive was 
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too small to motivate individuals to relay the reminder message and incentive to enrolled 
mothers who do not own a mobile phone, with the 200KSH incentive amount being 
sufficiently high enough to promote the relaying of reminders and incentives. 
 For measles vaccine, the higher incentive was associated with mobile phone 
ownership, but not mobile phone sharing in stratified analyses.  Unlike pentavalent3, 
there was no effect of the smaller incentive in both mobile phone owners and mobile 
phone sharers. Since the pattern of results is different in pentavalent3 and measles, it is 
possible that the vaccine schedule may have impacted the results.  Briefly, if someone 
receives pentavalent3, it is possible they had already received two incentive payments for 
timely vaccination of pentavalent1 and pentavalent2.  Moreover, these incentives would 
have been received between 6 and 10 weeks of age, with infants’ average age at 
enrollment being 3 weeks. Where pentavalent3 benefits from a combination of both a 
short time from enrollment to the pentavalent vaccine series and successive incentives in 
a short period, the measles vaccine is given at 9 months of age, or 6 months after a timely 
pentavalent3 dose, which may be a long enough time for the effect of incentives to be 
‘unlearned’ by both mobile phone owners and sharers and potentially may explain why 
incentives were associated with mobile phone owners for pentavalent3, but not measles.  
The lack of significant association between those in SMS only arms and the 
primary outcomes in ITT and per protocol analyses contradicts with the majority of 
findings for SMS reminder randomized controlled trials conducted in sub Saharan Africa.  
Of these ten trials, with health outcomes ranging from HIV treatment adherence to 
antenatal care attendance, eight studies found small, but significant effects of SMS 
reminders as compared to controls.27-33, 81   Acknowledging the heterogeneity in health 
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behaviors studied, participants randomized to SMS reminders had absolute differences 
between SMS and control arm ranging from 6 to 24%. Two studies found no significant 
effect of SMS reminders.74, 75  In one study, SMS reminders had no effect on early 
resumption of sexual activities following voluntary male circumcision75. The second 
study found no effect of SMS reminders on HIV treatment adherence74, but two other 
studies with similar outcome found a pooled 22% reduction in treatment adherence 
failure significant in those randomized to SMS reminders.27, 28, 82  
The success of SMS reminders to illicit a behavior is likely multifactorial; the 
content of the message, the type of behavior being reminded, indirect and direct costs 
incurred, literacy level, and other contextual factors all being potential explanatory 
factors. SMS reminders may also not be effective, or even not needed, when the targeted 
population places high importance on the behavior and already has high levels baseline 
levels. A baseline survey of 1748 mothers with immunization cards for infants ages 12-23 
month old found high coverages of pentavalent1 (99%), pentavalent3 (95%), and measles 
(83%) vaccine with respective proportions of infants immunized within 1 month of the 
scheduled date being 90%, 76%, and 71% (Dissertation Chapter 4).  SMS reminders 
target the caregiver’s forgetfulness of infant’s immunization appointments or provide 
knowledge if the vaccination schedule is not known.  With high coverage and adequate 
levels of timeliness, there are likely other explanatory variables of not being immunized 
that SMS reminders cannot address.   
We favored the use of a cluster randomization over an individual randomization 
for several reasons.  In an individually randomized trial, neighbors, or even people living 
in the same compound could receive different payment amounts or no incentive at all. 
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The cluster design should minimize this source of discord.  Similarly, in the scenario of 
neighbors where one receives an incentive and the other nothing, the provision of an 
incentive may serve as a disincentive for the decision to bring infants for vaccination by 
mothers who received nothing.  Moreover, the cluster design lessens the chance of study 
arm contamination. 
We chose to use survival curves and Cox regression as our primary method of 
analysis because it most robustly captures the time-to-event data.  Relative risk or odds 
ratio at 24 weeks for pentavalent3 and 10 months for measles vaccination would result in 
a loss of all the individual time point-events before the cut-off point.  An important 
consideration in the interpretation of the hazards ratios presented here is that because of 
some minor violations in the assumption of proportional hazards, and particularly located 
in the tail of the curves, the estimates considered an ‘average hazard ratio’ for the length 
of follow-up time.83  Relative risks for coverage estimates of pentavalent3 vaccination at 
24 weeks and measles vaccination at 10 months, as well as risk ratios for vaccination 
within two weeks of the scheduled date for all pentavalent vaccines and measles vaccine 
are located in appendices 13-15. 
This study has several strengths.  First, SMS reminders were sent according to 
protocol for the majority of infants which makes interpretation of results more 
generalizable.  Second, by enrolling infants at birth, selection bias was minimized when 
compared to enrolling from the clinic.  Enrollment of infants before their first vaccination 
ensures the population was validly represented by including infants who might not go for 
any vaccines.  If we had enrolled from the clinic, this subset of the population would not 
have been represented.  Lastly, this trial was conducted in a way such that the results 
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could be interpretable if brought to scale within Nyanza Province.  Mother-caregiver 
pairs were enrolled independent of mobile phone ownership and there was minimal 
interference with participant’s care seeking behaviors as household visits were only 
conducted at enrollment and 12 month follow-up. 
 The study also had several limitations.  The parent M-SIMU trial requires 1972 
infants to have sufficient power to detect an absolute 15% difference level in proportions 
of fully immunized children (BCG, 3 doses of polio, 3 doses of pentavalent, and measles 
vaccine) in comparison of intervention to control arms.  The present pilot analysis is 
limited by its small sample size and therefore its findings should be interpreted 
cautiously.  For pentavalent3 and measles vaccination, we had approximately 50% power 
to detect a hazard ratio of at least 2.0 for primary outcomes (Dissertation Chapter 3).  
Second, although we have records of SMS reminders being delivered correctly, we do not 
have complete information on whether SMS reminders were received and opened, or 
relayed in the case of those sharing mobile phones.  This information would be useful for 
per protocol analyses, although not as important when considering the trial was designed 
to be an effectiveness study.  Third, this study would benefit from either individual or 
group discussions of caregivers’ opinions about receiving SMS reminders and incentives.  
This information would be useful in explanations for why SMS reminders were not 
effective at improving timely immunization.  Lastly, caution should be taken when 
generalizing these results to other countries and settings. Our rural study area has high 
baseline immunization levels, moderate levels of mobile phone ownership79, and a 
widespread mobile-money network.84, 85  Although SMS reminders alone were not 
effective in this pilot analysis, SMS reminders may be effective in areas with lower levels 
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of immunization coverage, as forgetfulness and lack of knowledge surrounding 
vaccination schedule may be more important.   
Similarly, some may question the feasibility of replicating this trial in settings 
where mobile phone ownership is lower and mobile-money systems are lacking.  We 
counter that the components of the intervention can be disaggregated into individual 
modules (SMS reminders, incentives, and mobile-money) and be applied based on a 
country’s available technology.  For example, instead of transferring cash via mobile-
money, incentives can be given by providing mobile phone airtime or even cash 
vouchers.  Mobile money was used in this trial because of its widespread acceptance and 
it replaces the need to have physical cash at a health facility where it may either be lost or 
stolen.   
As the use of economic incentives becomes more widespread, there have been 
considerable discussions regarding the ethics of incentivese86-89, with arguments both 
for90 and against their use.91  The incentive amounts in this study are small, less than one 
day’s working wage60, and for the majority of participants, did not fully cover 
transportation costs.  Moreover, our use of incentives was not aimed at a risky or 
dangerous behavior, as pediatric immunization is a routine, healthy behavior and is 
standard of care.  If incentives can drastically improve immunization coverage and 
timeliness, the subsequent higher herd immunity levels would confer health and 
economic benefits (associated from not needing to go to the clinic for a vaccine-
preventable disease) to other people who do not receive incentives. Recent economic 
analyses argue that increasing access and coverage levels of six pediatric vaccines 
(pneumococcal, Haemophilus influenzae type b, rotavirus, pertussis, measles, and 
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malaria) in seventy two lower income countries, 6.4 million lives of children could be 
saved92 with economic savings associated with treatment cost and productivity loss 
totaling over 200 billion US dollars.93  
A common critique of incentives centers on sustainability and scalability 
concerns. To address these concerns, first, additional highly powered studies are needed 
before recommending incentives as a panacea for improving immunization rates.  If 
incentives are not effective, or are modestly effective but cost-effective analyses argue 
against their use, then incentives should not be brought to scale.  Aside from the 
economic benefits associated with treatment cost and loss of productivity93, the use of 
incentives, at least in our study area, could theoretically be cost-effective, or even cost-
neutral, by savings in labor and transport costs associated with a reduction in monthly 
vaccination camps, catch-up campaigns, and other supplemental routine immunization 
activities if incentives improve clinic attendance for routine vaccinations.  Moreover, 
economic incentives could be selectively targeted to districts with poor immunization 
rates or to caregivers of infants who are late for first dose of pentavalent vaccine.  
Previous work from this study site has found that in the 10% of infants who received 
pentavalent1 4 weeks late, these infants had a 2 fold increase in risk of not receiving all 
routine immunizations as compared to those who were received pentavalent1 timely 
(Dissertation Chapter 4).  A targeted approach of delivering incentives within Kenya is 
not novel.  The Government of Kenya’s Cash Transfer for Orphans and Vulnerable 
Children (Kenya CT-OVC), active since 2007, provides $20 USD monthly to poor 
households of orphans or chronically ill parents.94 
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Lastly, there is some concern about a potential negative rebound effect in 
immunization rates if incentives are no longer given (i.e. will immunization rates 
decrease after incentives are no longer provided).  This concern is grounded on the notion 
that the extrinsic reward of incentives crowds out the intrinsic reward of bringing your 
infant for immunization because it is healthy for the infant.  Although there is some 
evidence for this effect in higher income settings95, we believe it may not hold true for 
immunization seeking behavior in rural Kenya.  First, incentives are used for all vaccines 
an enrolled infant would receive. The study is set within the KEMRI/CDC surveillance 
system which affords an opportunity to examine immunization rates of subsequent 
children who are not incentivized.  Second, the behavior incentivized is routine.  Third, 
focus group discussions and high baseline immunization levels suggest that caregivers 
place high intrinsic value in immunizing their infants.  Fourth, the consequences of not 
vaccinating are very real for our study participants, evidenced by high levels of under 5 
year mortality caused by vaccine preventable diseases.96 Still, caution on use of 
incentives is required and their implementation should be carefully monitored.   
 In conclusion, small monetary incentives delivered to caregivers of infants upon 
completion of timely immunization led to timelier vaccination for pentavalent3. While 
the smaller incentive, $0.85 (75KSH) did not strongly elicit changes in immunization 
seeking behaviors, the provision of a $2.25 incentive (200KSH) did, with the effect 
observed in caregivers who own mobile phones and of those who share.  Although SMS 
reminders were not observed to have significant effects on timely pentavalent3 and 
measles vaccination rates, their future use in other populations should not be discounted 
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6.6 Tables for Chapter 6 
Table 6.1 Summary of enrollment, refusals and exclusions for pilot phase of M-SIMU trial 
 Control SMS 75 KSH1 200 KSH1 Total 
 n % n % n % n % n % 
Households Visited 28 100 38 100 35 100 37 100 138 100 
Enrolled 22 78.6 32 84.2 27 77.1 26 70.3 107 77.5 
Refusals 0 0.0 0 0.0 2 5.7 1 2.7 3 2.2 
Excluded 5 17.9 5 13.2 6 17.1 10 27.0 26 18.8 
Child >35 days 3 10.7 4 10.5 6 17.1 7 18.9 20 14.5 
Doesn't live in study village 0 0.0 0 0.0 0 0.0 2 5.4 0 0.0 
Won't bring to M-SIMU clinic 2 7.1 1 2.6 0 0.0 1 2.7 2 1.4 
Received pentavalent1 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 
Moving in next 6 months 0 0.0 0 0.0 0 0.0 0 0.0 4 2.9 
Died before screening 1 3.6 1 2.6 0 0.0 0 0.0 2 1.4 
Abbreviations: SMS, short message system; KSH, Kenyan Schilling; M-SIMU, mobile solutions for immunization 
 













Number of clusters 13 14 14 12 
































































Abbreviations: SMS, short message system; KSH, Kenyan Schilling 
 
1 85 KSH= 1 United States Dollar as of October 2014 
2 Number of infants enrolled in the cluster (village) 
3 Proportions and 95% confidence intervals 
4 Full immunization coverage is proportion of infants receiving BCG, three doses of polio and pentavalent, and measles vaccines. 
5 Socioeconomic status derived using Principal Components Analysis of household possessions 




Table 6.3 Baseline characteristics of  study participants enrolled in Mobile Solutions for 
Immunization (M-SIMU) trial using intention-to-treat analysis 
 








Variable n % n % n % n % 
Villages 13 24.5% 14 26.4% 14 26.4% 12 22.7% 
Region         
     Asembo 11 50.0% 7 21.9% 4 14.8% 6 24.0% 
     Gem 11 50.0% 25 78.1% 23 85.2% 19 76.0% 
Mother’s age (yrs)2 27.1 1.3 25.6 1.1 24.8 1.1 22.8 1.2 
Mother’s education (yrs)2 9.4 0.6 8.3 0.4 8.5 0.5 9.0 0.5 
Antenatal care visits 2 4.4 0.4 3.5 0.2 3.2 0.3 4.0 0.4 
Place of last delivery         
     At home 4 18.2% 8 25.0% 12 44.4% 9 36.0% 
     Health Facility 18 81.8% 24 75.0% 15 55.6% 16 64.0% 
Marital Status         
     Single 2 9.1% 7 21.9% 6 22.2% 6 24.0% 
     Married/Cohabitating 20 90.9% 25 78.1% 21 77.8% 19 76.0% 
Mobile phone access         
     Shares phone 6 27.3% 10 31.3% 17 63.0% 15 60.0% 
     Owns phone 16 72.7% 22 68.8% 10 37.0% 10 40.0% 
Children under 5 in house2 2.0 0.1 1.9 0.1 1.8 0.1 1.7 0.2 
People in house2 4.9 0.2 4.9 0.3 5.0 0.3 4.3 0.2 
Age infant enrolled (d)2 20.1 1.8 19.0 1.7 17.7 1.7 22.1 1.5 
Maternal English Reading 
Literacy 
        
     Easily 11 50.0% 13 40.6% 8 29.6% 9 36.0% 
     With difficulty/None 11 50.0% 19 59.4% 19 70.4% 16 64.0% 
Infant’s gender         
     Female 10 45.5% 12 37.5% 13 48.2% 19 76.0% 
     Male 12 54.6% 20 62.5% 14 51.8% 6 24.0% 
Travel time to clinic         
     <30 min 20 90.9% 16 50.0% 24 88.9% 18 72.0% 
     >30 min 2 9.1% 16 50.0% 3 11.1% 7 28.0% 
Abbreviations: ITT, intention-to-treat; SMS, short message system; KSH, Kenyan Schilling; d, days 
 
1 85 KSH= 1 United States Dollar as of October 2014 
2Mean and standard errors  
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Table 6.4 Short message system (SMS) behavior baseline characteristics of study 









Variable N % N % N % N % 
Receives SMS weekly         
     No 7 31.8% 7 21.9% 7 25.9% 9 36.0% 
     Yes 15 68.2% 25 78.1% 20 74.1% 16 64.0% 
SMS received/ week2 3.3 0.4 2.6 0.2 2.7 0.2 3.3 0.3 
Sends SMS weekly         
     No 11 50.0% 18 56.3% 13 48.2% 9 36.0% 
     Yes 11 50.0% 14 47.7% 14 51.9% 16 64.0% 
SMS sent/ week2 2.8 0.4 2.7 0.4 2.9 0.3 2.4 0.2 
Abbreviations: ITT, intention-to-treat; SMS, short message system; KSH, Kenyan Schilling 
 
1 85 KSH= 1 United States Dollar as of October 2014 









































































Abbreviations: Penta1, first dose of pentavalent vaccine; Penta2, second dose of pentavalent vaccine; Penta3, third dose of pentavalent vaccine;  SMS, short 
message system; KSH, Kenyan Schilling 
 
1 Number of infants that received SMS reminders per protocol for all three doses of pentavalent.  This is the per protocol sample for all analyses 
2Cumulative number of doses, i.e. number of infants in study arm multiplied by the number of vaccines (4) 







Table 6.6 Number of correct short message system (SMS) reminders delivered per 
protocol for infants by study arm 


























































Abbreviations: SMS, short message system; KSH, Kenyan Schilling 
 
1 85 KSH= 1 United States Dollar as of October 2014 
 
CAPTION: The column headers indicate the cumulative total of vaccine doses that received SMS 
reminders per protocol. For example, 3 correct indicates that for three vaccines, the SMS reminders were 








Table 6.7 Crude and adjusted hazard ratios for pentavalent3 coverage  
 
  Study Arm 










No. of participants2 22 29 27 24 
Vaccinated2     
     No. 21 26 24 24 
     %  (95% CI) 95.5 (77.1-99.9) 89.7 (72.6-97.8) 88.9 (70.8-97.6) 100 (85.8-100.0)4 
Unadjusted      
     HR (95% CI) 1 (Reference) 0.83 (0.48-1.44) 1.17 (0.64-2.16) 2.95 (1.69-5.16) 
     P value  0.506 0.609 0.001 
Adjusted3     
     HR (95% CI) 1 (Reference) 1.00 (0.50-1.98) 1.15 (0.55-2.44) 3.33 (1.71-6.47) 







No. of participants2 22 24 22 19 
Vaccinated2     
     No. 21 21 21 19 
     %  (95% CI) 95.5 (77.1-99.9) 87.5 (67.6-97.3) 95.5 (77.1-99.9) 100 (82.4-100.0)4 
Unadjusted      
     HR (95% CI) 1 (Reference) 0.74 (0.41-1.32) 1.49 (0.75-2.98) 3.23 (1.76-5.92) 
     P value  0.304 0.254 0.001 
Adjusted3     
     HR (95% CI) 1 (Reference) 0.91 (0.41-2.03) 1.50 (0.71-3.61) 3.89 (1.88-8.02) 
     P value  0.829 0.260 0.001 
Abbreviations: SMS, short message system; KSH, Kenyan Schilling; HR, hazard ratio 
 
1 85 KSH= 1 United States Dollar as of October 2014 
2  Pentavalent3 vaccination by 24 weeks of age in those who reached 24 weeks of age 
3 Adjusted for phone ownership, time to clinic, and region a priori 
4 One sided, 97.5% confidence interval 
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Table 6.8 Crude and adjusted hazard ratios for measles coverage  
  Study Arm 










No. of participants2 22 28 25 24 
Vaccinated2     
     No. 18 20 18 23 
     %  (95% CI) 81.8 (59.7-94.8) 71.4 (51.3-86.8) 72.0 (50.6-87.9) 95.8 (78.9-99.9) 
Unadjusted      
     HR (95% CI) 1 (Reference) 0.81 (0.41-1.58) 0.85 (0.45-1.62) 1.57 (0.86-2.89) 
     P value  0.530 0.633 0.142 
Adjusted3     
     HR (95% CI) 1 (Reference) 0.99 (0.49-2.02) 1.00 (0.47-2.12) 2.05 (0.95-4.41) 







No. of participants2 22 27 23 22 
Vaccinated2     
     No. 18 19 17 21 
     %  (95% CI) 81.8 (59.7-94.8) 70.4 (49.8-86.2) 73.9 (51.6-89.7) 95.5 (77.1-99.9) 
Unadjusted      
     HR (95% CI) 1 (Reference) 0.78 (0.40-1.53) 0.94 (0.48-1.87) 1.56 (0.85-2.88) 
     P value  0.471 0.871 0.154 
Adjusted3     
     HR (95% CI) 1 (Reference) 0.96 (0.47-1.95) 1.11 (0.51-2.45) 2.01 (0.95-4.26) 
     P value  0.905 0.781 0.069 
Abbreviations: SMS, short message system; KSH, Kenyan Schilling; HR, hazard ratio 
 
1 85 KSH= 1 United States Dollar as of October 2014 
2  Measles vaccination by 10 months of age in those who reached 10 months of age 




Table 6.9 Crude and adjusted hazard ratios for pentavalent3 coverage stratified by phone ownership  
Analysis 
Type 





















Control Ref.  Ref.  Ref.  Ref.  
SMS 0.64 (0.37-1.11) 0.109 0.70 (0.34-1.44) 0.327 1.24 (0.37-4.17) 0.724 2.13 (0.64-7.07) 0.217 
75 KSH2 2.95 (1.47-5.93) 0.002 2.83 (1.19-6.72) 0.019 0.92 (0.33-2.55) 0.878 1.05 (0.37-3.00) 0.933 
200 KSH2 4.48 (2.08-9.65) 0.001 4.48 (2.05-9.75) 0.001 2.22 (0.89-5.59) 0.089 3.89 (1.22-12.4) 0.022 
Per 
Protocol 
Control Ref.  Ref.  Ref.  Ref.  
SMS 0.56 (0.32-0.97) 0.039 0.55 (0.28-1.08) 0.085 1.23 (0.31-4.89) 0.771 2.67 (0.71-9.93) 0.144 
75 KSH2 2.90 (1.41-5.97) 0.004 3.05 (1.18-7.90) 0.021 1.21 (0.44-3.33) 0.710 1.82 (0.66-5.04) 0.248 
200 KSH2 5.42 (2.20-13.3) 0.001 5.58 (2.06-15.1) 0.001 2.21 (0.87-5.61) 0.094 4.93 (1.43-17.0) 0.012 
Abbreviations: SMS, short message system; KSH, Kenyan Schilling; HR, hazard ratio 
 
1 Adjusted for region and self-reported time to clinic 






























Control Ref.  Ref.  Ref.  Ref.  
SMS 1.21 (0.55-2.62) 0.634 1.22 (0.57-2.62) 0.613 0.20 (0.05-0.78) 0.020 0.31 (0.08-1.22) 0.096 
75 KSH2 1.14 (0.62-2.11) 0.666 1.05 (0.49-2.24) 0.899 1.10 (0.26-4.61) 0.901 1.37 (0.18-10.1) 0.761 
200 KSH2 3.60 (1.91-6.76) 0.001 3.47 (1.67-7.20) 0.001 1.12 (0.27-4.54) 0.872 1.61 (0.21-12.1) 0.646 
Per 
Protocol 
Control Ref.  Ref.  Ref.  Ref.  
SMS 1.15 (0.47-2.85) 0.756 1.17 (0.50-2.75) 0.718 0.12 (0.03-0.53) 0.005 0.19 (0.04-0.93) 0.040 
75 KSH2 1.46 (0.73-2.91) 0.289 1.35 (0.58-3.15) 0.486 0.98 (0.24-3.92) 0.975 1.84 (0.22-15.6) 0.573 
200 KSH2 3.92 (1.88-8.17) 0.001 3.74 (1.62-8.63) 0.002 1.11 (0.28-4.42) 0.880 2.20 (0.27-18.1) 0.462 
Abbreviations: SMS, short message system; KSH, Kenyan Schilling; HR, hazard ratio 
 
1Adjusted for region and mobile phone ownership 





Table 6.11 Crude and adjusted hazard ratios for measles coverage stratified by phone ownership  
 
  Phone Ownership Phone Shared 
Analysis 




















Control Ref.  Ref.  Ref.  Ref.  
SMS 0.96 (0.52-1.78) 0.906 1.10 (0.60-2.03) 0.756 0.49 (0.09-2.52) 0.391 0.68 (0.17-2.81) 0.596 
75 KSH2 1.65 (0.81-3.36) 0.171 1.33 (0.59-2.99) 0.490 0.41 (0.10-1.71) 0.222 0.46 (0.14-1.59) 0.221 
200 KSH2 2.84 (1.37-5.88) 0.005 3.02 (1.49-6.14) 0.002 0.81 (0.23-2.85) 0.745 1.20 (0.41-3.50) 0.743 
Per 
Protocol 
Control Ref.  Ref.  Ref.  Ref.  
SMS 0.91 (0.50-1.68) 0.773 1.02 (0.57-1.85) 0.941 0.49 (0.10-2.52) 0.396 0.74 (0.18-2.98) 0.666 
75 KSH2 1.92 (0.92-4.05) 0.084 1.57 (0.59-3.61) 0.287 0.46 (0.11-1.93) 0.290 0.54 (0.16-1.75) 0.299 
200 KSH2 2.80 (1.34-5.88) 0.006 2.94 (1.45-5.98) 0.003 0.79 (0.22-2.78) 0.709 1.36 (0.40-4.66) 0.625 
Abbreviations: SMS, short message system; KSH, Kenyan Schilling; HR, hazard ratio 
 
1 Adjusted for region and self-reported time to clinic 




Table 6.12 Crude and adjusted hazard ratios for measles coverage stratified by time to clinic 
 
  < 30 minutes from clinic > 30 minutes from clinic 
Analysis 
Type Study Arm 



















Control Ref.  Ref.  Ref.  Ref.  
SMS 1.11 (0.53-2.30) 0.781 1.14 (0.53-2.43) 0.735 0.38 (0.12-1.25) 0.111 0.38 (0.10-1.51) 0.171 
75 KSH2 0.93 (0.48-1.78) 0.825 1.04 (0.50-2.16) 0.922 0.38 (0.09-1.69) 0.203 0.43 (0.04-4.22) 0.468 
200 KSH2 2.12 (1.15-3.90) 0.015 2.41 (1.11-5.23) 0.027 0.65 (0.19-2.21) 0.490 0.72 (0.07-7.25) 0.780 
Per  
Protocol 
Control Ref.  Ref.  Ref.  Ref.  
SMS 1.05 (0.50-2.19) 0.897 1.08 (0.50-2.31) 0.844 0.38 (0.12-1.25) 0.111 0.38 (0.10-1.51) 0.171 
75 KSH2 1.05 (0.52-2.15) 0.891 1.17 (0.55-2.51) 0.683 0.38 (0.09-1.69) 0.203 0.43 (0.04-4.22) 0.468 
200 KSH2 2.14 (1.15-3.97) 0.016 2.33 (1.10-4.97) 0.028 0.65 (0.19-2.21) 0.490 0.72 (0.07-7.25) 0.780 
Abbreviations: SMS, short message system; KSH, Kenyan Schilling; HR, hazard ratio 
 
1 Adjusted for region, and mobile phone ownership 




6.7 Figures for Chapter 6 
Figure 6.1 CONSORT study flow diagram for M-SIMU trial  
Villages Assessed for Eligibility (n=221) 
Villages excluded (n=69) 
♦   Villages not meeting inclusion (n=56) 
♦   Other reasons (n=13) 
 Not needed for statistical purposes 
SMS (n=15 villages) 
32 infants enrolled 
6 infants excluded 
0 infants refused 
 
Control (n=13 villages) 
22 infants enrolled 
6 infants excluded 




Villages Randomized (n=152) 
SMS +75 KSH (n=17 villages) 
27 infants enrolled 
6 infants excluded 
2 infants refused 
   
  SMS +200 KSH (n=16 villages) 
  26 infants enrolled 
  10 infants excluded  
  1 infant refused 
 




14 villages  
32 infants 
PP1: 




0 infants LTF 
 
0 infants LTF 
 
1 infant LTF 
 
ITT: 
14 villages  
27 infants 
PP1: 




13 villages  
22 infants 
PP1: 




12 villages  
25 infants 
PP1: 
10 villages  
20 infants 
 
Abbreviations: SMS, short message system; KSH, Kenyan Schilling; LTF, loss-to-follow up; ITT, intent-to-treat; PP, per protocol 
1 Per protocol for pentavalent3 
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Abbreviation: KSH, Kenyan Schilling; SMS, short message system 
 




Figure 6.4 Inverse Kaplan-Meier curves for time to pentavalent3 by study arm using 
intention to treat delivery of short message system (SMS) reminders 
 
Abbreviations: ITT, intention-to-treat; SMS, short message system; ksh, Kenyan Schilling 
 
CAPTION: Infants censored at 24 weeks of age if pentavalent3 vaccine not received.  Infants censored at 
age of death or age migrated if pentavalent3 not received and age was less than 24 weeks.  Vertical 
reference lines at 14 and 16 weeks indicate time range that incentives are given if infants in incentive arm 
are vaccinated.  Overall the inverse survival curves were statistically significant using log rank test for 
equality of curves (p=0.0001).  The 200 Kenyan Schilling (ksh) curve was significantly different than the 
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Figure 6.5 Inverse Kaplan-Meier curves for time to pentavalent3 by study arm using per 
protocol delivery of of short message system (SMS) reminders 
 
Abbreviations: SMS, short message system; ksh, Kenyan Schilling 
 
CAPTION: Infants censored at 24 weeks of age if pentavalent3 vaccine not received.  Infants censored at 
age of death or age migrated if pentavalent3 not received and age was less than 24 weeks.  Vertical 
reference lines at 14 and 16 weeks indicate time range that incentives are given if infants in incentive arm 
are vaccinated.  Overall the inverse survival curves were statistically significant using log rank test for 
equality of curves (p<0.01).  The 200 Kenyan Schilling (ksh) curve was significantly different than the 75 
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Figure 6.6 Inverse Kaplan-Meier curves for time to measles vaccination by study arm 
using intention to treat delivery of of short message system (SMS) reminders 
 
Abbreviations: ITT, intention-to-treat; SMS, short message system; ksh, Kenyan Schilling 
 
CAPTION: Infants censored at 10 months of age (304 days) if measles vaccine not received.  Infants 
censored at age of death or age migrated if measles vaccine not received and age was less than 10 months.  
Vertical reference lines at 272 and 286 days indicate time range that incentives are given if infants in 
incentive arm are vaccinated.  Overall the inverse survival curves were not statistically significant using log 
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Figure 6.7 Inverse Kaplan-Meier curves for time to measles vaccination by study arm 
using per protocol delivery of of short message system (SMS) reminders 
 
 
Abbreviations: SMS, short message system; ksh, Kenyan Schilling 
 
CAPTION: Infants censored at 10 months of age (304 days) if measles vaccine not received.  Infants 
censored at age of death or age migrated if measles vaccine not received and age was less than 10 months.  
Vertical reference lines at 272 and 286 days indicate time range that incentives are given if infants in 
incentive arm are vaccinated.  Overall the inverse survival curves were not statistically significant using log 
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Chapter 7. Conclusions  
This dissertation had several objectives.  First, we sought to describe the study 
area’s gaps in vaccination estimates with the implicit intention that interventions to 
improve timely immunization coverage are needed.  Second, we assessed a rural Kenyan 
populations’ preparedness for potential mHealth interventions by describing the 
epidemiology of mobile phone ownership and texting behavior while also receiving 
thoughts and opinions from caregivers who may receive such interventions.  Lastly, we 
conducted a preliminary analysis of the Mobile Solutions for Immunization (M-SIMU) 
cluster randomized controlled trial, to determine the effect of SMS reminders with or 
without monetary incentives to improve timely pentavalent3 and measles immunization.. 
7.1 Summary of results 
 
The key findings from the three manuscripts are presented below. 
1. Immunization coverage levels were high and consistent with previous estimates, yet a 
substantial proportion of infants received vaccines with delay 
We found high immunization coverage levels for routinely administered pediatric 
vaccines in a sample of 1746 infants with immunization card.   Approximately 99.6%, 
94.5%, and 83% were vaccinated for pentavalent1, pentavalent3, and measles, 
respectively. These estimates were similar to recent analyses conducted by others1, and 
showed a marked improvement from 2003 study site estimates of vaccination coverage 
levels for pentavalent1 (95% coverage), pentavalent3 (68%), and measles vaccine 
(50%).2  In regards to timely vaccination, similar improvements with time were observed. 
In 2003, proportions of timely vaccinated infants for pentavalent1, pentavalent3, and 
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measles were 44%, 27%, and 18%, respectively with corresponding timeliness proportion 
of 90%, 76%, and 71% in 2013.  Measles vaccine was most likely to be delayed and also 
showed longest lengths of delay. 
2. Predictors for pentavalent3, measles vaccine, and FIC were similar, with delayed 
pentavalent1 vaccine strongly predictive of those not receiving immunizations  
Socio-demographic variables, including maternal age, maternal education, mobile phone 
ownership, and literacy levels, were similar for predicting both failure to receive and 
timely vaccinations for pentavalent3, measles, and FIC.  Infants that received 
pentavalent1 four weeks late had highest point estimates for failure to receive 
pentavalent3, measles vaccine and not be fully immunized as compared to infants that 
received pentavalent1 on time.  Sensitivity analyses that reduced definition of delay from 
four to two weeks found similar estimates for pentavalent3, with slight attenuations in 
point estimates.  
3. Caregivers think mHealth interventions offer promise for immunization, but uneven 
distribution of  phone ownership across socio-demographic characteristics exists 
The majority of focus group participants thought that delayed immunization was still 
problematic in western Kenya and that mHealth-based interventions could be effective at 
promoting timely immunization.  Participants identified several challenges with the 
adoption of mHealth technologies, including high levels of mobile phone sharing, phones 
not routinely charged, language barriers, and receiving SMS from unidentified sources.  
Baseline survey results found that 55% (n=1301) of mothers own a mobile phone, while 
33.7% (n=794) and 4.9% (n=117) had access at the household and compound.  Results 
from multivariate logistic regression analyses found several factors associated with 
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mobile phone ownership in women; these included: older age, more education, higher 
socioeconomic status, English literacy, and smaller household size. 
  Although mobile phone ownership is highly predictive of sending and receiving SMS, 
there is a substantial proportion of mothers who do not own mobile phones and text 
Overall, 76% of mothers had received an SMS in the past week.  Mothers that were 
married, as compared to single or divorced, and of higher socioeconomic status were 
associated with receiving SMS. The proportion of mothers that sent an SMS in the past 
week (53.5%) was lower than the proportion who received SMS.  Mothers that could read 
English easily and were of the highest education were more likely to have sent an SMS in 
the past week. Although mobile phone ownership was strongly predictive of receiving 
and sending SMS, there were moderate levels of receiving SMS (49.7%) and sending 
SMS (37.4%) in mothers who do not own a mobile phone.  
4. Caregivers who were randomized to receive 200 KSH incentive ($2.25), as compared 
to controls, were more likely to bring infants for pentavalent3 vaccination, but not 
measles, with no effect observed for pentavalent3 or measles vaccine in those who 
were in SMS only or SMS plus 75 KSH incentive ($0.85) arms 
We found that mothers randomized to receive SMS reminders plus a 200 KSH incentive 
were more likely than control participants to have infants vaccinated with pentavalent3.  
Although statistical significance was not achieved, the higher incentive arm trended 
towards significance for measles vaccination (p=0.07). Mothers that received SMS 
reminders only or SMS reminders plus the smaller incentive were no more likely than 




5. Effect modification of mobile phone ownership level on vaccination is dependent on 
the vaccine and intervention arm 
The significant finding of higher incentive arm infants and increased pentavalent3 
vaccination did not differ by mobile phone ownership level; mothers who owned or did 
not own a mobile phone were both strongly associated with infant’s pentavalent3 
vaccination status. However, effect modification of mobile phone ownership in higher 
incentive arm participants was observed for measles vaccination.  Caregivers that 
received the highest incentive and owned a mobile phone were more likely to have 
infants vaccinated for measles with no significant effect found in those that do not own a 
mobile phone.. 
We also found evidence for effect modification of mobile phone ownership on 
pentavalent3 vaccination in infants randomized to receive SMS reminders plus a 75KSH 
incentive; with the significant effect only observed for caregivers that owned a mobile 
phone. No significant findings for timely measles vaccination were found in those that 
received SMS plus 200KSH in either mobile phone owners or those who do not have a 
phone.  
6. Effect modification of travel time to clinic on vaccination is dependent on the 
intervention arm  
We found evidence for effect modification of travel time to clinic on pentavalent3 
vaccination in infants who received SMS reminders plus 200 KSH incentive as compared 
to control arm infants; whereby a significant effect was observed for only infants living 
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less than 30 minutes from the clinic.  A similar effect modification was observed for 
timely measles vaccination in those who received SMS plus 200 KSH incentive. We 
found no significant effects of SMS reminders only or SMS plus 75KSH study arms on 
pentavalent3 or measles vaccination in stratified analyses of time to clinic.  
7.2 Implications 
 
The results of this dissertation have implications for policies and programmatic 
interventions that target immunization systems and in the application of mHealth 
technologies in rural western Kenya and elsewhere. 
1. Recommendations for inclusion of timely and delayed immunization estimates in 
routine reports of immunization systems. 
In Gem District, Nyanza Province, high immunization coverage estimates were 
observed for the routinely administered pediatric vaccinations, yet many of the vaccines 
were not administered in line with the KEPI recommended schedule.3   In higher income 
countries, timely vaccination estimates have been studied4-8, with estimates of delay and 
timeliness recently being reported for lower-income settings.2, 9-24  As global 
immunization coverage levels continually improve25, 26, focus must shift from counting 
the number of children vaccinated, to counting the number of infants that are vaccinated 
on time and quantifying delay in vaccination.  This is achievable through the inclusion of 
a measure of timely vaccination, where the estimate could be as simple as the proportion 
of infants that were vaccinated within four weeks of the scheduled date. 
The inclusion of timely or delayed estimates in routine reporting systems is important 
for several reasons.  First, delayed vaccinations lower the population’s herd immunity27, 
265 
 
thereby increasing the risk of exposure and possible transmission of potentially fatal 
pathogens.  If these immunologically susceptibles are clustered, there is the potential for 
a vaccine-preventable disease outbreak.  This is particularly important for measles 
vaccination, where the baseline survey indicated that only 53% of infants were 
vaccinated for measles by ten months of age.   Measles outbreaks have occurred in 
settings with population immunity that reached 90%28, which indicates how highly 
contagious the measles virus is.29   Moreover, from the baseline survey, it was observed 
that infants vaccinated with pentavalent1 greater than four weeks from the recommend 
date were at greatest risk of failure to be immunized for future doses in the KEPI 
schedule.  Although immunization timeliness and immunization coverage have 
traditionally been conceptualized as separate estimates, this finding highlights the 
interconnectedness of the two measures. 
In summary, the routine reporting of immunization timeliness allows policy makers to 
immediately target underimmunized communities with Supplemental Immunization 
Activities (i.e. a measles vaccine campaign) to avert a potential outbreak.  In the long 
term, delayed vaccination estimates can be used to identify communities with poor 
immunization estimates so that resources can be allocated to strengthen the routine 
immunization system. 
2. Recommendations to target infants with delayed pentavalent1 vaccination as a means 
of improving immunization coverage. 
Delayed pentavalent1 vaccination was most strongly associated with failure to be 
immunized for subsequent doses in a risk factor analysis of baseline data conducted in 
March of 2013 (n=1748).   Although this finding has not been replicated in other low-
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income countries, several studies conducted in the United States have also observed that 
infants with delayed first vaccination were at higher risk of not receiving future 
vaccinations.30-33  This finding affords opportunities for programmatic interventions and 
policies to target this sub-population (10.2%, n=176) so that future immunizations are 
received.  
Several interventions that can be selectively targeted to those with delayed 
pentavalent1 include small monetary incentives, SMS reminders, and clinic-based 
education of infant’s caregivers.  The preliminary analysis of M-SIMU, found that 
mother-infant pairs randomized to receive SMS reminders with a 200 KSH incentive 
($2.25 USD) were more likely to receive pentavalent3 vaccination than infants who 
received the usual standard of care.  Previous studies conducted in resource-constrained 
settings have shown that small incentives increased immunization rates34, 35, HIV testing 
uptake36, and adult male circumcision.37  Although M-SIMU infants that were 
randomized to only receive SMS immunization appointment reminders were not 
significantly associated with measles or pentavalent3 vaccination, the vast majority of 
randomized trials conducted within sub Saharan Africa have found positive gains 
associated with SMS reminders across a range of different forms of health care 
utilization.38-46  Lastly, clinic-based education that centers on benefits of vaccination and 
potential illnesses that an un-vaccinated infant could contract can be targeted to 
caregivers of infants with delayed first dose of pentavalent series. This approach may be 
more sustainable than SMS reminders or monetary incentives and has improved DTP3 
completion rates in other areas.47 
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3. Recommendations for assessment of the ‘mobile phone’ landscape prior to the 
investment of time and resources needed to bring mHealth projects to scale.  
Globally, more and more people own a mobile phone with each passing year.48, 49 
Certainly, mHealth technologies offer opportunities to advance the delivery of healthcare, 
improve treatment outcomes, and target the traditionally hard-to-reach populations in 
lower-income countries.50, 51  With rightful optimism for mHealth as a game-changer in 
global efforts to reduce maternal and child mortality levels, caution and careful 
assessments of populations intended to receive mHealth intervention are needed before 
mHealth programmatic interventions are brought to scale.   
Kenya is one of the leading sub Saharan African countries in mobile phone ownership 
levels.52 However, a baseline survey of 2359 Kenyan mothers with infants aged 12-23 
months found near uniform access to a mobile phone, but only 55% of mothers owned 
one.  For interventions that target caregivers in rural Kenya, expectations for 
effectiveness of mHealth technologies to improve maternal and child health outcomes 
may need to be tempered because of the moderate level of mobile phone ownership.  
Moreover, mobile phone ownership was observed to be unevenly distributed across 
socio-demographic variables, with caregivers of higher economic status, older maternal 
age, higher literacy level, and higher education more likely to own a mobile phone.  
These socio-demographic variables were also predictive of immunization timeliness and 
coverage in the M-SIMU baseline survey (Chapter 4), which implies that mHealth 
interventions may be targeting caregivers that do not need any intervention for infant’s 
immunization status.   Similarly, stratified analyses of the M-SIMU trial found evidence 
that the effect of the incentive on pentavalent3 and measles vaccination was modified by 
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mobile phone ownership level, but studies that randomized SMS reminders for HIV 
treatment adherence39 and skilled delivery found no such effect modification.41  
In summary, although there are high levels of mobile phone sharing across Kenya, the 
desired effect of mHealth interventions may be contingent on whether the intended 
recipient owns a mobile phone.  The type of mHealth intervention (treatment, monitoring, 
adherence, etc.) and its intended recipient (health care worker, caregiver, husband, etc.) 
need to be considered when implementing mHealth trials or programs. 
4. Considerations for the use of small monetary incentives to promote immunization 
coverage and timeliness. 
The finding that 200KSH incentives coupled with SMS reminders improved 
pentavalent3 vaccination rates and trended towards significance for measles vaccination, 
as compared to control infants, affords promise for the potential of incentives to improve 
timely immunization in rural western Kenya and other settings.  The null finding for the 
75 KSH incentive should be interpreted cautiously as the preliminary sample was 
underpowered to detect differences less than three-fold from the control arm.  
In light of the small sample size and lack of cost-effectiveness analyses, it is prudent 
to not make any recommendations for wide spread use of incentives until the full M-
SIMU sample is analyzed and other replication studies are conducted.  However, if the 
present results hold true, there are several points of consideration that merit discussion.  
First, potential populations that would potentially benefit from incentives need to be 
identified.  As seen in Chapter 4’s immunization estimates, many mothers do not need 
economic incentives for immunization seeking behavior as immunization timeliness is 
moderate, and immunization coverage is high.  Rather, and as discussed previously, 
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financial incentives could be targeted to caregivers of infants that present to clinic with 
delayed pentavalent1.  This sub-population is quite small (about 10%) and these infants 
were found to be at higher risk for not receiving additional immunizations. 
However, there is some concern that this targeted approach may have unintended 
consequences.  By targeting infants that present with delay to clinic, financial incentives 
may dis-incentivize caregivers to bring their infant for vaccination.  Plainly, caregivers 
may intentionally delay their infant’s immunization in order to receive financial benefit.  
Rather than target sub-populations within a community and risk a de-incentivizing of 
vaccination, incentives could be applied uniformly in administrative regions with poor 
indicators of immunization.  Moreover, instead of focusing on different populations, an 
alternative approach would be to uniformly incentivize vaccines with low coverage 
estimates or are given at later ages of life.  Two vaccines that fit these criteria are measles 
and HPV vaccines.  High vaccination coverage is needed to control measles transmission.  
If incentives improve routine delivery of measles vaccination, the need for catch-up 
campaigns may lessen. HPV vaccine has recently become available for the majority of 
Kenyan girls aged 9 to 13 years old.53  To date, the uptake of HPV vaccine has been low; 
with many people unaware the vaccine is offered.54  Additionally, the schedule for the 
vaccine is unlike other routine immunizations that are giving during infancy.  A single 
national campaign that is well publicized and provided incentives for HPV vaccination 
could distinctly improve HPV coverage estimates in a short period of time. 
5. Recommendations to not discount future use of SMS reminders as a tool to improve 
immunization timeliness and coverage. 
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Preliminary analyses of the M-SIMU trial found no significant effect of those 
randomized to receive only SMS immunization appointment reminders as compared to 
controls.  SMS reminders have been shown to improve immunization rates in the United 
States55-58 and other healthcare seeking behaviors in sub Saharan Africa.38-46  In regards 
to immunizations, SMS reminders target a caregiver’s forgetfulness of infant’s 
immunization appointments or alert parents that vaccines are due if the vaccination 
schedule is not known.  Since the present study site has high vaccination coverage and 
adequate levels of timeliness, and SMS reminders were not found to be effective, one 
could posit that forgetfulness and lack of awareness about the vaccination schedule do 
not explain the majority of underimmunization cases.  
7.3 Strengths and limitations 
This set of studies had several strengths and weaknesses. In regards to the baseline 
survey for immunization coverage and mobile phone ownership estimates, the sample 
was sufficiently large and representative.  Selection bias was minimized by our attempt to 
survey all caregivers with infant aged 12-23 months residing within one of the 120 
villages in Gem District. Moreover, we collected data on a wide range of variables that 
have been associated with immunization coverage and mobile phone ownership in other 
settings, which gives the analyses generalizability.  Secondly, due to the low proportion 
of caregivers who provided verbal report and were excluded from analyses, our results 
are more protected against selection bias as compared to other studies where proportions 
of verbal report were much higher.2, 22, 59  Additionally, the high proportion of caregivers 
with maternal and child health cards allowed for a detailed analysis of immunization 
timeliness.  Furthermore, the risk factors obtained through the primary log-binomial 
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model were corroborated with multiple linear regression model that examined days 
delayed for each vaccine as a continuous variable.  Lastly, we concurrently identified 
estimates of immunization coverage, immunization timeliness, and severely 
underimmunized, in addition to their respective risk factors, in a single sample.  The 
majority of previous studies have typically examined either immunization coverage, or, 
less frequently, immunization timeliness, separately. 
A particular strength of the focus group discussions was the inclusion of individual, 
private responses within the group setting.  These responses were recorded before group 
discussion resumed in an attempt to minimize the effect of dominant personalities in the 
group discussion.  Furthermore, the moderator limited the effect of dominant 
personalities by requesting input from each focus group discussant.  
The M-SIMU cluster randomized controlled trial had several strengths that aid in 
the interpretation of the study results and minimized potential biases. First, we restricted 
our enrollment to infants that were too young to have initiated the pentavalent vaccine 
sequence.   This enrollment strategy sought to minimize selection bias as compared to an 
alternative enrollment strategy where caregivers would be enrolled from the 
immunization clinic.  Mothers enrolled from the clinic have already shown a propensity 
to bring their child for immunization.  Since we enrolled infants before their first 
vaccination, we were able to capture mother-infant airs that may never go for 
immunization.  This sub-population is important to include in our sample because it 
allows us to examine whether reminders, with or without monetary incentives, are 
effective at bringing infants to clinic for vaccination that would otherwise not be 
vaccinated if the interventions were absent.   
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A second strength of the M-SIMU trial pertains to our use of the RapidSMS 
system to deliver SMS reminders.60  This is a free, open source system that has served as 
a platform for automated delivery of SMS reminders in other studies.61-63 With the 
RapidSMS system, SMS reminders were delivered correctly for the majority of the trial’s 
participants.  Intention-to-treat-analyses (ITT) that included caregivers who did and not 
correctly receive SMS reminders found significant effects of SMS plus 200KSH and 
represent the effectiveness of the intervention.64  Supplemental per protocol analyses 
found similar findings to the ITT analyses, which gives more confidence in the results.65   
In line with the use of ITT analyses, this trial was conducted with effectiveness in 
mind.  First, there was minimal contact with trial participants and clinic staff so as to not 
disrupt participant’s routine care seeking behavior and clinic’s routine delivery of care.  
Caregivers were only approached by study staff at enrollment, 12 month follow-up visit, 
and if caregivers brought their child for immunization, a short survey was conducted.  
Second, mother-caregiver pairs were enrolled independent of mobile phone ownership, 
which is an important consideration in light of baseline survey estimates that found only 
55% of caregivers possessed a mobile phone. 
This set of studies had several limitations that merit a thorough discussion.  In 
regards to the mobile phone ownership and immunization coverage survey, a limitation is 
that all eligible mothers may not have been surveyed. KEMRI/CDC provided a census of 
all known mothers with infants aged 12-23 months old.   The provided census may have 
contained missing households as surveillance activities in Gem District recently resumed 
and the mapping of households may not be complete. If these missing households were 
systematically different than those included in the baseline survey, the results could be 
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biased.  If these households were in more remote locations, it is likely that the socio-
demographic characteristics of its occupants were poorer than those that were identified.  
This would potentially cause overestimates of mobile phone ownership and timely 
immunization coverage. 
 A similar selection bias concern exists for the M-SIMU trial.  Overall, 15% of 
infants were ineligible because they were identified after 35 days of age (Table 6.1).  
Approximately 10% of control and SMS only arms were excluded due to overage 
compared to 17% 19% of infants in SMS plus 75KSH and SMS plus 200KSH arms.  If 
infants that were excluded due to overage were systematically different across study arms 
in covariates that were predictive of delayed immunization, the results may be 
overestimated.  Of note, the high percentage of infants excluded because of overage was 
due to the commencement of the trial.  Village reporters were asked to send SMS 
notifications for all births identified in the past month.  The large backlog of birth 
notifications meant that some children had already aged to 35 days since they were first 
identified.  Omitting preliminary analysis infants, the proportion of infants excluded due 
to overage in the full M-SIMU samples was approximately 3% (58 infants excluded from 
1995 households visited; Data not shown).  
Another avenue for selection bias in the M-SIMU trial stems from the cluster 
design and consequent decision to not blindly allocate participants to study arm as 
separate consent forms were used to enroll mothers in each of the four arms. Selection 
bias could be present if there was selective drop-out or refusal in those residing in control 
arm villages.  This is less of a concern as no participants withdrew from the study and 
only three individuals refused (two in the 75 KSH arm and one in the 200 KSH arm).  
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However, since allocation was known by study staff, it is possible that there may be 
ascertainment bias in our collection of immunization information at the twelve month 
follow-up visit, where community interviewers may be more likely to mark an 
ambiguous vaccination date in intervention arms as timelier than controls.  This would 
inflate our estimates of intervention effects.  As discussed previously, our prospective 
immunization data collection from the clinic is compared to data recorded from twelve 
month follow-up visits. If there were differences in dates, a field investigation was made 
to resolve the discrepancy. 
Potential selection bias may also be found in the analysis of immunization 
timeliness and coverage.  The sample only consisted of mothers that had a written history 
of infant’s immunization status (i.e. the maternal and child health booklet).  Mothers who 
provided verbal report of infant’s immunization history were excluded from analysis. 
Previous studies have found several characteristics associated with retention of 
immunization booklet, including but not limited to, younger infants, less people in a 
household, delivery at a health facility, and male infants.66-68  If the characteristics of 
caregivers who provided verbal report systematically differed from those who provided 
written records, and those characteristics were associated with underimmunization, the 
estimates of immunization coverage and timeliness may be overestimated.  However, the 
analysis of risk factors for verbal reporting, as compared to maternal child health card 
present at time of survey, found that female infants, households greater than two 
kilometers from the clinic, and older infants were associated with a caregiver’s provision 
of verbal immunization history.  Although distances to clinic and infant’s gender were 
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not associated with any of the immunization outcomes, older infants were associated with 
decreased immunization coverage and increased immunization delays.    
The primary purpose of the baseline survey was to obtain current estimates of 
immunization coverage, mobile phone ownership, and other demographic variables that 
were used for M-SIMU sample size and randomization.  As such, our analyses may suffer 
from unmeasured confounding bias69 as we did not collect a comprehensive list of socio-
demographic variables that have been found to be associated with mobile phone 
ownership and immunization coverage in other studies.  Specifically, community health 
worker interactions1, antenatal care seeking behavior19, 24, paternal demographics9, and 
place of delivery13 have been associated with immunization coverage in other studies, but 
were not assessed in our analyses.  The omission of these variables may result in changes 
of point estimates and significant risk factors for immunization coverage and timeliness. 
In regards to the M-SIMU trial, randomization should ensure that both known and 
unknown covariates of timely immunization are equally distributed across study arms.  
Still, we conducted unadjusted and adjusted analyses to assess the effect of interventions 
on timely pentavalent3 and measles vaccination.  Moreover, primary outcomes were 
stratified by mobile phone ownership and travel time to clinic to assess the potential for 
effect modification.  
The present studies are also at risk for non-differential measurement bias which 
would bias results towards the null. The recording of immunization history is most likely 
to suffer from this bias as immunization booklets in older infants are often in poor 
condition; making it more difficult to accurately transcribe immunization dates.  We 
sought to minimize this bias through the use of quality control measures preprogrammed 
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into data collection instruments.  Moreover, we extensively cleaned immunization data 
prior to analysis.  Questionable data points were relayed to the field team for follow-up.    
In the M-SIMU trial, the likelihood of measurement bias in the immunization dates is 
much lower than the immunization dates from the baseline immunization timeliness and 
coverage survey because of the prospective data collection of vaccination dates.   For 
mobile phone ownership, participants may have indicated that they owned a mobile 
phone when they actually did not because of possible feelings of embarrassment.  This 
would have led to over estimates of mobile phone ownership and an attenuation of the 
effect size observed for predictor variables associated with mobile phone ownership.  
An additional limitation of the M-SIMU preliminary analysis is the small sample 
size.  This cohort of enrolled mother-infant pairs was created so that the study 
investigators could assess the readiness of both the automated SMS delivery system and 
mobile phone based data collection tools; it was not designed with a statistical analysis in 
mind and therefore was underpowered.  Power analyses found that the study had 
approximately 50% power to detect a hazard ratio of 2.0 in both pentavalent3 and 
measles vaccination primary outcomes.  The results presented in this dissertation, 
particularly the null findings of SMS only and SMS plus 75KSH interventions should be 
interpreted cautiously.   
In regards to our three focus group discussions, there was potential for interviewer 
bias.   We sought to minimize this bias through the use of a semi-structured questionnaire 
that was used in all three groups.  This questionnaire ensured that all key talking points 
were discussed in each group.  Moreover, the focus group moderator and assistants were 
extensively trained in focus group techniques.  Additionally, although we did not mention 
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to focus group participants that the FGD’s purpose was to inform the M-SIMU trial, 
‘courtesy bias’ may potentially explain the positive thoughts on mHealth interventions of 
our FGD.     
7.4 Generalizability of results 
There are some concerns about the external validity, or generalizability, of this 
dissertation’s results that stem from the population’s characteristics and the M-SIMU 
study design and implementation.  Our baseline survey indicated high levels of 
immunization coverage and moderate levels of vaccination delays.  This finding may 
impact the generalizability of several observed results.  First, our finding that delayed 
pentavalent1 vaccination was associated with infants that did not receive pentavalent3 
and measles vaccine, may only be applicable for this study site.  Second, the observed 
null finding that infants randomized to receive only SMS reminders showed no difference 
in vaccination status as compared to control infants may be a study-site specific finding.  
With high value placed on vaccination in this community, evidenced by high 
immunization rates, SMS reminders may not target the major determinants of 
underimmunization.  The use of SMS reminders to improve immunization timeliness and 
coverage should not be discounted for other settings.   
In regards to the M-SIMU study design; there are concerns that the design and 
implementation of this study can only be conducted within Kenya because of its high 
penetration of mobile phone ownership and ubiquitous mobile money system.  Therefore, 
this study could not be replicated in other less technologically advanced settings.  
However, the components of the interventions in M-SIMU can be disaggregated into 
individual modules (SMS reminders, incentives) and can be applied based on a country’s 
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available technology.  For example, instead of transferring cash via mobile-money, 
incentives can be given by providing mobile phone airtime or cash vouchers.  
Lastly, the M-SIMU study was conducted within the KEMRI/CDC Health and 
Demographic Surveillance System.  The results may not be generalizable because the 
community is keenly aware of KEMRI/CDC’s research agenda and participate in 
quarterly household visits to collect socio-demographic information.  Moreover, the 
infrastructure of KEMRI/CDC allows for early identification of newborns, which other 
study sites may not have. 
 
7.5 Recommendations for future research 
 
There are several avenues of additional research that could be pursued based on the 
findings and methodology of this dissertation.  Several of these studies address concerns 
about generalizability.  First, additional immunization surveys conducted in Kenya and 
other lower income countries should be conducted to obtain estimates of timeliness and 
to test whether the finding that delayed pentavalent1 vaccine predicts immunization drop-
out holds true in other settings.  If this finding is valid in other settings, interventions and 
policies could target caregivers of infants with delayed vaccination to prevent future 
drop-out.  In regards to M-SIMU, a replication study is needed.  Preferably, this study 
would be conducted in a setting where estimates of immunization coverage and 
timeliness are poorer than the present study site.  In such settings, SMS reminders may 
show a positive effect on immunization rates.   
There are several other studies that alter the M-SIMU study design to answer 
scientific questions not related to generalizability.  First, one could conduct a study 
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similar to M-SIMU but instead of providing incentives for every timely vaccination, 
participants would have pre-established odds of receiving an incentive, such as in lottery 
systems.  There is some evidence from behavioral economics that lottery based systems 
may be more effective than providing fixed incentives.70, 71  Moreover, if a lottery system 
is employed, incentive amounts could be increased since participants are not being paid 
every dose.  As found in our pilot analysis, the larger incentive was much more effective 
than the smaller incentive at eliciting timely immunization.  Second, rather than changing 
incentive structure, future trials could consider providing a mobile phone as the 
intervention.  As global awareness and efforts to improve immunization systems are at its 
highest levels72-74, countries are scaling efforts to improve routine immunization 
reporting estimates.  In the dissertation’s study area, clinic nurses call some mothers 
whose infants have defaulted on their immunization schedule.  The provision of a mobile 
phone may be sufficient to improve immunization rates.  This trial could be designed 
with either efficacy or effectiveness in mind.  An efficacy trial would entail training 
clinic staff to identify immunization defaulters and call the caregiver’s mobile phone to 
remind them that vaccinations are overdue.  An effectiveness trial would only provide the 
mobile phone with no clinic training.  Moreover, a mobile phone only study arm could be 
included in other M-SIMU replications where mothers randomized to this arm receive a 
mobile phone but do not receive SMS reminders or incentives.     
A more pragmatic approach to M-SIMU replication studies, which builds off the 
delayed pentavalent1 vaccine predicting immunization drop-out finding, would be to 
randomize infants who present to the clinic for pentavalent1 delayed to control, SMS 
reminders, and SMS reminders plus incentive arm for their future immunization doses.   
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There are several other questions surrounding incentives and SMS reminders that 
this dissertation did not address.  Qualitative studies of enrolled caregivers would be 
helpful in understanding participant’s perceptions on receiving SMS and incentives for 
immunization and how these interventions were received if participants did not own 
mobile phones (i.e. someone relayed them reminder messages and payments).  This 
qualitative study would offer tremendous insight as to why SMS reminders were not 
effective at improving immunization timeliness and also may address some of the 
potential barriers if the intervention was brought to scale. 
 Equally important to qualitative studies, cost-effective analyses are needed prior 
to scalability and sustainability discussions.  The calculation of intervention costs is 
straight forward, but the definition of benefits will require consideration.  The ideal 
definition of benefit is a reduction in disease morbidity and mortality, but our study only 
captured immunization coverage.  Advanced modelling could extrapolate how changes in 
immunization coverage reduce disease morbidity and a cost-benefit estimate for dollars 
per case averted calculated.  An additional analysis would be to compare the cost of 
immunization for one child through outreach activities versus the intervention. 
 As discussed previously, there is some concern about a negative rebound effect 
associated with removal of incentives.  The discontinuation of incentives might result in 
immunization coverage levels that were lower than baseline.  Comparisons of 
immunization history in subsequent born infants of M-SIMU enrolled caregivers would 
address this concern. 
 Two additional studies are possible because of the high-quality, prospectively-
collected immunization data in the M-SIMU trial.  Immunization history is often 
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collected retrospectively and can be prone to multiple biases and sources of error.75-77  
The first proposed study would compare M-SIMU enrolled infant’s immunization history 
using three data sources; the prospectively collected SMS records from M-SIMU; the 12 
month M-SIMU follow-up visit; and KEMRI/CDC Health and Demographic 
Surveillance data that is collected every four months for infants under five years of age.   
 Accurate vaccination history is important for national immunization programs so 
that resources can be relocated to poor performing areas if needed.  However, these 
estimates do not reflect the actual percentage of individuals that are truly protected from 
disease as vaccines do not produce an immunological/protective response in all 
individuals. Serum based assays are the gold standard to measure whether infants are 
immunologically protected.  However, bringing these methods to scale is unrealistic 
because a costly and time-consuming venous blood draw is required. Instead, non-
invasive collected body fluids, such as oral fluid or dry blood spots from finger pricks, 
could be used to test for the presence of immune-markers, which are biological correlates 
of an infant’s immunological protection to vaccine preventable diseases.   
Although the immune marker field is in its infancy, early results are promising.78-81 
As we are one of the few groups with rigorous, prospectively collected immunization 
data, we have been awarded a grant to develop field-friendly methods to assess effective 
vaccination coverage in young children for measles and tetanus vaccines.  Knowing with 
certainty whether a vaccine was given, and if given, the precise date of immunization, is 
the key component needed in order to validate our dried blood spot and oral fluid samples 
with blood serum and to determine differences in antibody levels by number of doses 
received and their timing. 
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Lastly, additional cross-sectional surveys of mobile phone ownership and SMS 
behavior should be conducted.  As mobile phone ownership levels continually grow in 
lower-income countries rapidly48, 49, estimates become obsolete by the time they are 
published.  Baseline levels of mobile phone ownership are important parameters to 
consider when implementing or scaling-up mHealth interventions. 
7.6 Overall conclusions 
Approximately 6.3 million children died before their fifth birthday in 2013, with 
many of the leading causes of death attributed to vaccine-preventable diseases.82 
Pneumonia and diarrhea accounted for about 1.5 million deaths in children under five 
years old, with measles, pertussis, tetanus, and meningitis, four other vaccine preventable 
diseases, responsible for an additional 362,000 deaths. 
Since the creation of the Expanded Programme on Immunization (EPI) in 1974, 
there has been remarkable progress in raising global immunization coverage levels25, 26 
with subsequent gains in reductions of childhood morbidity and mortality from vaccine 
preventable diseases.83, 84  Still, there are populations that neither receive all of the 
scheduled vaccines85 nor receive vaccines in a timely manner.11, 86  In rural western 
Kenya, we found that 99%, 95%, and 83%, of Kenyan infants received pentavalent1, 
pentavalent3, and measles vaccines, respectively, with delays in vaccination most likely 
for pentavalent3 and measles vaccines. 
As mobile phone ownership becomes more common in low-income countries48, 49, 
the use of mobile health tools to enhance or supplement delivery of proven interventions 
becomes more realistic.51  Short message system (SMS) reminders87-89 and incentives 
conditioned on completion of positive behavior34-37 have been found to be effective for 
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other outcomes, but have not been rigorously studied in sub Saharan Africa until this 
dissertation. 
In our study area, where approximately 55% of mothers own a mobile phone, but 
there is near uniform access to one, we conducted a village randomized controlled trial to 
test the efficacy of SMS reminders and monetary incentives conditioned on timely 
vaccination.  We found that infants of caregivers who received SMS reminders plus a 
200KSH incentive ($2.25) were significantly more likely to receive pentavalent3 and 
measles vaccines as compared to control arms, with no significant effects on primary 
outcomes for infants randomized to receive SMS reminders only or SMS reminders plus 
a 75KSH.  This positive finding of $2.25 incentives hints at the potential for financial 
incentives and mobile phone technologies to improve timely immunization coverage 
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Chapter 8.  
Appendix 1. Baseline survey of immunization coverage, mobile phone ownership, 


















16. How many CHILDREN UNDER 5 YRS of AGE, slept in this house last night?  
[__][__]  
17. How many persons are sleeping in the household regularly?   
(Includes children under 5) [___][___]    
18. Does the mother of the infant own a mobile phone? YES….NO 
If no to 18, 
18.1 Does someone in your household own a mobile phone? YES…NO 
If no to 18.1, 





Appendix 2.  Focus Group discussion individual survey 
1.1.Age of mother (YEARS………………………………..[____|____] 
1.2.Mother’s highest level of edu attempted?NONE……PRIM….SEC….POST-SEC 
1.3.Mother’s highest class/form/year attempted (Circle 
One)…1…..2…..3…..4….5….6…..7…..8 
1.4.Number of mother’s previous pregnancies …………………. [     ] 
1.5.Do you own a mobile phone (Circle One)……YES……NO…. If Yes, go to 1.6 
1.5.1 Does someone in household own a mobile phone you could use?   
(Circle One)………..YES…….NO If Yes, go to 1.6 
1.5.2 Does someone in compound own a mobile phone you could use? 
 (Circle One)…YES…..NO 
1.6   Did you bring a mobile phone with you today?..YES….NO… 
If No, go to 1.7 
 1.6.1  How much credit/airtime is on the phone? [    ][    ][    ]KSH  
1.6.2 How much battery charge is on the phone?.. 
0-25%....26-50%.....51-75%....76-100% 
1.7 Password__________ Is this correct?   YES….NO 
1.8. Send mother a text message---“How are you today?”-  
 Can she open and read the text message? (Circle one) …… 
YES, EASILY…………YES, WITH DIFFICULTY………….NO 
1.8 Top 3 Sayings for SMS in Rank Order (1=First, 3=Third) 
1.  [     ] [     ] 2.  [     ] [     ] 3.  [     ] [     ] 
1.8.1. Other sayings?    ______________________________________ 






Appendix 3. Focus group Semi-structured questionnaire guide 
1. In this area about 3 out of every 10 mothers do not get their children vaccinated. 
What do you think are the biggest reasons why mothers do not bring their kids for 
immunization? 
[If no responses, prompt with religion/forgetfulness/money/distance from clinic] 
[After a reason is brought up, ask group how much they agree or disagree with 
the reason as a barrier. Hand out blank pieces of paper and have participants mark 
1= strongly disagree 2=somewhat disagree 3= no feeling/neutral 4=somewhat agree 
5= strongly agree 
2.  What do you think are the biggest reasons why mothers might not bring their kids 
on time for immunization?  Do you think these reasons are the same as the reasons 
for children not receiving any vaccinations? 
[Explain timeliness in relation to EPI schedule] 
a. Do you think clinics and health facility staff are doing a good job about 
reminding children for immunizations?  Could this be improved?  
3. We are thinking about using SMS reminders to notify mothers when children’s 
vaccinations are used.  If SMS messages were used to send immunization 
appointment reminders, how should the messages be worded?  What components 
would be necessary?   
[Prompt with names? Dates? Location? What about Motivational/ Informational/ 
Humorous/ proverbs] [Recorders note key areas brought up] 
 
4. We will now give you 1  example SMS message. [pass out piece of paper with 
Please bring baby Thomas for vaccination in 3 days at the nearest clinic]  
Please open the message and read it.  The aim of the message is to remind Mama 
Thomas that Thomas is supposed to receive a vaccination soon and to encourage 
Mama Thomas to bring Thomas in for his vaccination. What are some ways the 
message could be improved so as to ensure that Mama Thomas understands the 
message and also to encourage Mama Tom to bring Tom in for his vaccinations?   
[Discuss that we need to consider the SMS message limit – for Safaricom it is 160 
characters per message. The ‘template’ message is 74 characters. If the message is 
longer than 160 characters, the message will be broken up] [RECORDERS: WRITE 
DOWN KEY TOPICS] 
 
5. We will now give you pieces of paper with the top 5 phrases from our individual 
conversations that could be placed at the end of the SMS message.  Select the 
message that you think will be the most effective at getting mothers to bring their 
child for immunization and place it in BIN 1.  Select the second most effective SMS 
and place it in BIN 2. Select the third most effective SMS and place it in BIN 3.   
[Provide Mother’s cutouts of each SMS message…SEE NEXT PAGE FOR SMS 




a. Do you think adding these phrases would be helpful? 
b. Why did you pick that phrase? [RECORDERS: WRITE DOWN KEY TOPICS] 
c. Which type of phrase would you prefer? Motivational? Religious? Humorous? 
Informational 
d. Are there any phrases you really do not like? 
e. Do you have any other phrases you think mothers would appreciate? 
f. Do you think most mothers would like getting reminders about their child’s 
immunization appointments? 
g. Do you think you would like getting reminders about your child’s 
immunization appointments? 
h. What do you think some of the problems would be in sending SMS 
reminders? [Any problems with Mothers who do not have mobile phones and 
receiving SMS messages?] 
6. [Follow up for when mothers say phone ownership]  Do you think the message 
should be phrased differently for those that rely on getting messages from someone 
else’s phone  
7. We will now give you 5 pieces of paper with different numbers on them (0-Day of 
immunization, 1 Day before immunization, 2-3 days before, 4-6 days before, 7 days 
before).  These are the days before an immunization visit that SMS reminder 
messages could be sent.  Place the piece of paper that you think has the time range 
that will be most effective at prompting mothers to bring their child for 
immunization in BIN 1  
[Tally results in front of mothers] 
a. What was your reasoning for this timing? [If needed, is there too early of a 
time and why, is there too late of a time and if so, why] 
8. Imagine that Mama Thomas had been told by the community health 
worker/nurse/clinical officer/doctor that she should take Thomas to the clinic for 
vaccination today. But today Mama Thomas has other work to do such as washing 
clothes, going to the market and cooking. We will now ask you about motivating 
Mama Thomas by giving her different amounts of money only if she brings baby 
Thomas to the clinic.  For each amount, write yes or no to the question, would this 
amount motivate Mama Thomas.  [The order is 100ksh, 25, 200,50, 125, 10, 75, 
150, 175]  




a. Did everyone pick an amount that would motivate Mama Thomas?  Why did 
you choose that amount of money as the tipping point?  Is there an amount of 
money that is too high? 
b. Do you think providing a small amount of money (50 ksh) to mothers would 
be helpful to get more children immunized [Clarify money would be sent after 
the mother attends the clinic].   
c. What do you think some of the problems would be with providing mothers a 
small amount of money for vaccination? 
9. On a scale of 1 to 5, how helpful do you think the following would be to get more 
children immunized where 1 is not at all helpful and 5 is very helpful [Have 
mothers respond individually on piece of paper for each] 1. SMS messages 
reminding mother of the immunization date, 2. Giving mothers 100 Ksh after 
she brings her child for immunization, and 3. SMS messages and 100 KSH 
a. Why did you choose that answer?   
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Appendix 6. Informed consent forms for focus group discussion 
KEMRI/CDC AND JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 
 
Study Title: Randomized Controlled Trial of the Impact of Mobile Phone Delivered 
Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates 
and Timeliness in western Kenya 
Investigators: Daniel Feikin, Principal Investigator, Johns Hopkins School of Public 
Health/International Vaccine Access Center; CDC/National Center of Emerging and 
Zoonotic Infectious Diseases; Frank Odhiambo, KEMRI/CDC; Benard Ochieng, 
KEMRI/CDC; Dustin Gibson, Johns Hopkins School of Public Health/International Vaccine 
Access Center; David Obor, KEMRI/CDC; Danet Opot, KEMRI/CDC; Kayla Laserson, 
Center for Disease Control and Prevention; Amanda Glassman, Center for Global 
Development; Andrew Zeitlin, Georgetown Public Policy Institute and Center for Global 
Development, Dagna Constenla, Johns Hopkins School of Public Health/International 
Vaccine Access Center; Orin Levine, Bill and Melinda Gates Foundation; Tabu Collins, 
Kenya Ministry of Public Health and Sanitation, Division of Vaccines and Immunizations.   
Study Location: Siaya County and neighboring villages 
PI Version Date:  11 February 2013   
English language version  
Introduction 
My name is <insert name> and I am working with researchers from KEMRI/CDC and 
Johns Hopkins School of Public Heath, USA.  I am going to give you information and 
invite you to be in some research. If there is anything you do not understand please ask 
me to stop and I will take time to explain.    
 
Purpose of the research 
This study is trying to figure out if we can use mobile phones to get more children 
vaccinated. We are asking you to give your thoughts on this topic along with SMS 
messages and mobile-money. 
 
We will have 3 discussion groups with women and village reporters within the 
KEMRI/CDC HDSS area, where we plan to do a study of this subject.  Each discussion 
group will include between 8 and 10 people. 
  
Description of the research 
We are asking you to help us understand if it is possible to use mobile phones as a way 
to get more infants vaccinated. We will ask questions about SMS messages and M-PESA.  
If you agree to take part we will have a discussion that will last up to 2 hours. During this 
discussion, we will have one person asking questions to lead the discussion in the local 




using a tape recorder to remind us of the details of the discussion later on. We will turn 
off the tape recorder at any time that you request us to do so.  
 
At the end of the discussion we will record your age, years of education, number of 
previous pregnancies, and whether you own a mobile phone.  
 
Potential Harm, Injuries, Discomforts or Inconvenience, Risks:  The risks of this study 
are low.  There is a small risk your opinions might not be kept private if someone from 
the group shares the discussion, but we will discuss the importance of confidentiality at 
the beginning of the session. 
 
Potential Benefits 
There is no direct benefit to you from joining this study.  Your opinions will be used to 
help design a research study that uses mobile phones to increase the number of kids 
getting vaccines.    ) 
 
Confidentiality 
During the discussion we will take handwritten notes and also tape record the session. 
We will not record participants’ names during note taking. Instead we will assign 
numbers to individuals that will be matched against the responses. The notes will be 
translated into English if needed, and entered into a computer. No names will be 
entered into the computer. Tapes will be translated and transcribed. The tapes will then 
be destroyed.  Where we use quotes from the discussions they will be designated by 
number. No quotes will be traceable to a specific person.  All study materials will be 
kept in a locked cabinet or password protected computer at the KEMRI/CDC center in 
Kisian. Your name and identity will not be shown in any reports about this study. 
 
Reimbursement 
We will give you Ksh 300 to help pay for your time and travel costs.  We will also provide 
refreshments during the session. 
 
Participation 
You do not have to take part in this study.  You can decide to stop being part of this 
study at any time after you start.   You don’t have to answer any questions you don’t 
want to. Before deciding whether you want to take part, please feel free to ask any 
questions.  The health care you receive at area clinics, including the vaccines your child 
gets, will not be affected by your decision to take part, or not take part, in this study 
today 
If you have any further questions or concerns 
If you have questions or complaints as a result of being in this study please contact Dr. 




Box 1578 40100 or call 057-2022929 EXT 413, 0711-444333.  If you feel you have been 
harmed in any way, or if you have questions about your rights as a research subject, and 
want to talk about the study with someone who is not directly involved in this research 
project, please contact The Secretary, KEMRI Ethics Review Committee, P.O. Box 54840-
00200, Nairobi; Tel: 020-2722541, 0722205901, 0733400003; Email address: 
erc@kemri.org 
 
Do you have any questions for me? Do you want to take part in this research study? 
 
 
Your signature (or mark) on this form means: 
• I have been informed about the study’s purpose, procedures, possible benefits, and 
risks. 
• I have been given the chance to ask questions before I sign. 
• I have agreed to be in this study of my own free choice. 
 
Name of Parent/Guardian:         
              
Signature of Parent/Guardian:    _____   Date:__________  
(Put “X” if cannot sign name) 
--------------------------------------------------------------------------------------------------------------------- 
Name of Person administering the consent:   _________ ____     
Signature of person administering consent: _____________________     Date: 
_______________ 
(For those who are not able to read, a witness, who is not a family member or study 
staff, must verify and sign below.) 
I have read and explained the consent form to the person named above and watched 
them indicate consent with a mark.  
Name of Interpreter/Witness: ________________________ 
Signature of Interpreter/Witness: _____________________Date ________________ 




Appendix 7. Informed consent for the randomized controlled trial 
KEMRI/CDC AND JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 
 
Study Title: Randomized Controlled Trial of the Impact of Mobile Phone Delivered 
Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates 
and Timeliness in western Kenya 
Investigators: Daniel Feikin, Principal Investigator, Johns Hopkins School of Public 
Health/International Vaccine Access Center; CDC/National Center of Emerging and 
Zoonotic Infectious Diseases; Frank Odhiambo, KEMRI/CDC; Benard Ochieng, 
KEMRI/CDC; Dustin Gibson, Johns Hopkins School of Public Health/International Vaccine 
Access Center; David Obor, KEMRI/CDC; Danet Opot, KEMRI/CDC; Kayla Laserson, 
Center for Disease Control and Prevention; Amanda Glassman, Center for Global 
Development; Andrew Zeitlin, Georgetown Public Policy Institute and Center for Global 
Development, Dagna Constenla, Johns Hopkins School of Public Health/International 
Vaccine Access Center; Orin Levine, Bill and Melinda Gates Foundation; Tabu Collins, 
Kenya Ministry of Public Health and Sanitation, Division of Vaccines and Immunizations.   
Study Location: Siaya County and neighboring villages 
PI Version Date: 11 February 2013 
Flesch-Kincaid readability level: 7.2  
English version  
Introduction 
My name is __________________ and I am working with researchers from KEMRI/CDC 
and Johns Hopkins School of Public Health; USA.  We are here to find out if you would 
like to be in a research study that tries to get more infants vaccinated.   I am going to 
give you some information about what we are doing. If there is anything you don’t 
understand please ask me to stop and I will take time to explain.  There will be time at 
the end for you to ask questions.  After answering your questions, I will ask you if you 
want to join the study.  
 
Purpose of study 
We are doing this study because many Kenyan infants get their vaccines late or not at 
all.  We are studying if we can use mobile phones to encourage mothers to bring 
children on time for their first three vaccines.  This study is important because vaccines 
can protect infants from getting sick and dying.  We want to explore ways to get more 
children vaccinated. 
 
Why you are being asked to take part 
 We are asking you to join this study because you have a child who was born in the last 
month, is due to get his/her regular vaccines at 6 weeks of age and you live in one of the 






• You will be randomized to one of four groups. Randomization means it will be 
selected by chance, like using a coin flip. You will have an equal chance of being 
in each of the four groups.  Your village and community leaders were part of the 
assigning of villages to the four groups to make sure it was done fairly.  You 
cannot change the group you are in because it is based on the village where you 
live now.  This means all mothers and children from your village will be in the 
same group.  Each group will have a different way of using mobile phones to 
encourage immunization.  We want to compare the 4 groups to see which is the 
best way to get children their vaccines on time.   
 
If you join this study, this is what will happen during the next 9 months: 
• Today, you will provide your child’s name and date of birth. 
• Today, we will ask for your mobile phone number or that of someone who has a 
phone that you have easy access to. 
• Today, you will get a SMS message congratulating you for joining our study. 
• Today, you will get a list of places that offer child immunizations in the area 
where the study takes place. 
• Within the next 3 weeks, someone from the study team will come to your home 
and ask you questions about vaccines, mobile phones, and mobile-money. We 
may also take your infant’s height and weight. This visit should take about 30 
minutes.  
• When you bring your child to the clinic for the first 3 doses of vaccine, scheduled 
to be given at 6, 10 and 14 weeks of age, we will collect some information.  You 
should bring your MCH booklet with you.  This will take about 5 minutes each 
time. 
• When your child is 6 months old, we will come to your house.  We will ask 
questions about your child’s vaccinations, health, your household, SMS 
messages, and how you liked this study.  We will weigh and take the height of 
your child. We will look at your maternal and child health card. This should take 
about 30 minutes.   
• When your infant is between 9-12 months old, we will then come to your house 
to ask questions about immunizations.  We will look at your maternal and child 
health card. This should take about 10 minutes. 
• If your household is part of the HDSS, we will link these data to the HDSS data.  
• Your village is in Group 4. We will send you 2 SMS reminders before each of 
the first 3 scheduled vaccine visits.  We will send the first SMS 3 days before 
the vaccine is due and the second SMS on the day before the vaccine is due.  
When you bring your infant for vaccine, we will write down that your infant 
was vaccinated.  If you bring your infant within 2 weeks of the expected 
immunization date, you will be given 200 Ksh by the mobile-money network of 




one of the clinics on the list where the study is working.  If you bring your child 
in for vaccines later than 2 weeks after the expected date, you will not get the 
200 Ksh.  We will help you sign up for an account for mobile-money if you do 
not have one already. 
 
Potential Harms, Injuries, Discomforts, Inconveniences or Risks  
The risks from being in this study are small.  Some people might find the questions 
asked of them take too much time out of their day.  Vaccine jabs might cause brief pain 
to your child, as usual.  But no new or experimental vaccines will be given in this study – 
only the regular, safe vaccines usually given by the Ministry of Health.  There is a small 
chance your personal information may be revealed to people not in the study. We will 
do our best to prevent this. 
 
Potential Benefits 
Possible benefits to your child include getting him/her vaccinated on time.  Vaccines can 
prevent disease and death.  We will refer you to nearest clinic if your child does not 
have all vaccines by 6 months of age, but will not provide transportation or pay for any 
healthcare costs. We will give the results of the study to Ministry of Health to help 
improve child vaccinations in Kenya.  The results might also help other African children 




We will try to keep your personal information as private as possible.  After you decide to 
take part, you will receive a study number.  This number will be used to label all study 
materials, rather than using your name.  All study materials will be kept in a locked 
cabinet or password protected computer at the KEMRI/CDC center in Kisian. Your name 
and identity will not be shown in any reports about this study.  We will not share your 




You do not have to take part in this study.  You can decide to stop being part of this 
study at any time after you start.   You don’t have to answer any questions you don’t 
want to.  The health care you receive at area clinics, including the vaccines your child 
gets, will not be affected by your decision to take part, or not take part, in this study 
today.  Before deciding whether you want to take part, please feel free to ask any 
questions.  
 
Who do I call if I have questions or complaints? 
If you have questions or complaints as a result of being in this study please contact Dr. 
Frank Odhiambo, head of the KEMRI/CDC Kisian DSS, off of Kisumu-Busia Highway, P.O. 




harmed in any way, or if you have questions about your rights as a research subject, and 
want to talk about the study with someone who is not directly involved in this research 
project, please contact The Secretary, KEMRI Ethics Review Committee, P.O. Box 54840-
00200, Nairobi; Tel: 020-2722541, 0722205901, 0733400003; Email address: 
erc@kemri.org 
 
Do you have any questions for me? Do you want to take part in this research study? 
 
Your signature (or mark) on this form means: 
• I have been informed about the study’s purpose, procedures, possible benefits, and 
risks. 
• I have been given the chance to ask questions before I sign. 
• I have agreed to be in this study of my own free choice. 
 
Name of child:       Date of birth: 
______________                                   
 
Name of Parent/Guardian:         
              
Signature of Parent/Guardian:       Date:__________  
(Put “X” if cannot sign name) 
--------------------------------------------------------------------------------------------------------------------- 
 
Name of Village Reporter/Person administering the consent:   _________
 ____     
 
Signature of person administering consent: _____________________     Date: 
_______________ 
(For those who are not able to read, a witness, who is not a family member or study 
staff, must verify and sign below.) 
I have read and explained the consent form to the person named above and watched 
them indicate consent with a mark.  
Name of Interpreter/Witness: ________________________ 
Signature of Interpreter/Witness: _____________________Date ________________  




Appendix 8. Bivariate and multivariate analyses for predictors of severely 
underimmunized infants as compared to infants receiving all vaccinations on 
time1 
Characteristic Crude RR (CI) p value Adj RR (CI) p value 
Mother’s age (years)     
15-24 Ref.  Ref.  
25-29 1.46 (1.08-1.98) 0.015 1.40 (1.04-1.89) 0.029 
>30 2.64 (2.05-3.41) <0.001 2.17 (1.67-2.84) <0.001 
Mother’s education (years)     
 0-8 Ref.  Ref.  
9-12 0.53 (0.41-0.68) <0.001 0.69 (0.53-0.90) 0.006 
13+ 0.21 (0.08-0.55) 0.001 0.30 (0.12-0.79) 0.015 
Mother’s English reading ability     
Not at all Ref.  Ref.  
With Difficulty 0.66 (0.50-0.86) 0.002 0.96 (0.75-1.22) 0730 
Easily 0.37 (0.28-0.50) <0.001 0.78 (0.57-1.05) 0.105 
Marital status     
Single/Divorced/Widowed Ref.  Ref.  
 Monogamous Married/Cohabitating 1.46 (1.03-2.06) 0.034 1.23 (0.88-1.72) 0.217 
Polygamous Married/ Cohabitating 1.82 (1.17-2.82) 0.007 1.35 (0.91-2.00) 0.131 
Children < 5 years old in house     
< 1 Ref.  Ref.  
2 1.50 (1.17-1.92) 0.001 1.17 (0.92-1.50) 0.205 
>3 1.43 (1.01-2.01) 0.044 1.02 (0.72-1.42) 0.930 
Household size (no. of people)     
<4 Ref.  Ref.  
>4 1.62 (1.29-2.02) <0.001 1.20 (0.94-1.52) 0.136 
Socioeconomic status2     
Bottom 40% Ref.    
Upper 60% 0.81 (0.65-1.01) 0.060   
Mother’s mobile phone ownership     
Owns Phone Ref.  Ref.  
Has Access/None 0.56 (0.44-0.70) <0.001 0.69 (0.55-0.86) 0.001 
Distance to clinic (km)     
< 2 Ref.    
>2 1.25 (0.99-1.56) 0.351   
Child’s age (months)     
12-18 Ref.    
>18 - 24 1.10 (0.88-1.37) 0.390   
Child’s gender     
Female Ref.    
Male 0.96 (0.77-1.20) 0.730   
Abbreviation: RR, risk ratio 
 
1 Severely underimmunized infants had greater than 90 days underimmunized and were delayed for three of 
five vaccines (BCG, pentavalent1, pentavalent2, pentavalent3, measles).  Comparison group  is infants 
receiving all vaccines on time (n=655) 




Appendix 9. Simple and multiple linear regressions for days vaccine delayed 
 Pentavalent11 Pentavalent3 1 Measles1 
 













15-24 Ref.  Ref. Ref. Ref.  
25-29 2.57 (1.45)  2.56 (2.41) 1.97 (2.48) -0.03 (2.82)  
>30 2.83 (1.47)  11.8 (2.45) 9.95 (2.56) 4.63 (2.91)  
Mother’s education        
 0-8 years Ref.  Ref.  Ref.  
9-12 years -1.50 (1.26)  -8.01 (2.08)  -5.37 (2.44)  
13+ years -3.98 (2.77)  -10.4 (4.46)  -16.6 (5.22)  
Mother’s English 
reading  
      
Not at all Ref. Ref. Ref. Ref. Ref. Ref. 
With Difficulty -4.26 (2.30) -4.26 (2.30) -9.52 (3.92) -8.32 (4.14) -10.2 (4.66) -9.69 (4.86) 
Easily -5.70 (2.23) -5.70 (2.23) -15.8 (3.78) -13.5 (4.04) -15.2 (4.48) -14.7 (4.69) 
Marital status       
Single/Divorced Ref.  Ref.  Ref.  
 Monogamous Married 0.34 (1.67)  1.61 (2.77)  -0.41 (3.20)  
Polygamous Married 0.01 (2.36)  6.71 (3.94)  4.23 (4.63)  
Children < 5 years old 
in house 
      
< 1 Ref.  Ref. Ref. Ref.  
2 1.75 (1.29)  6.17 (2.16) 5.49 (2.21) 2.25 (2.53)  
>3 3.51 (1.88)  5.86 (3.14) 3.98 (3.23) 5.27 (3.70)  
Household size        
<4 people Ref.  Ref.  Ref.  
>4 people 2.46 (1.20)  5.12 (2.01)  4.26 (2.36)  
Socioeconomic status2        
Bottom 40% Ref.  Ref. Ref. Ref.  
Top 60% -1.86 (1.23)  -5.20 (2.05) -5.34 (2.09) -2.13 (2.40)  
Mother’s mobile 
phone  
      
Has Access/None Ref.  Ref.  Ref.  
Owns Phone  -2.50 (1.20)  -4.13 (2.02)  -4.86 (2.36)  
Distance to clinic (km)       
< 2 Ref.  Ref. Ref. Ref. Ref. 
>2 1.02 (1.25)  5.78 (2.08) 4.74 (2.08) 5.86 (2.42) 5.49 (2.42) 
Child’s age (months)       
12-18 Ref.  Ref. Ref. Ref. Ref. 
>18 - 24 1.12 (1.20)  6.44 (2.00) 6.33 (2.05) 13.48 (2.33) 13.79 (2.40) 
Child’s gender        
Female Ref.  Ref.  Ref.  
Male -1.04 (1.20)  -0.23 (2.01)  -1.09 (2.35)  
Abbreviations: MLR, multiple linear regression; SLR, simple linear regression; yrs, years 
1 Days delayed are continuous. Infants timely vaccinated have 0 days delay. Excludes infants who did not 
receive vaccination. Bolded beta coefficients and confidence intervals indicate p<0.05 




Appendix 10. Mobile Solutions for Immunization (M-SIMU) enrollment and 
screening form 
 
1.1Village #(from study ID)________  1.2  Compound#(from study ID)____  
1.3 Compound Name: [__][__] [__][__] [__][__][__][__][__][__][__][__][__][__] [__][__] 
[__][__][__][__][__][__][__] 
1.4 Study ID: [__][__][__]---[__][__][__][__]---[__][__] 
1.5 Child First Name: [__][__] [__][__] [__][__][__][__][__][__][__][__][__][__] 
1.6 Child Juok Name: [__][__] [__][__] [__][__][__][__][__][__][__][__][__][__] 
1.7 Child Last Name: [__][__] [__][__] [__][__][__][__][__][__][__][__][__][__] 
1.8 Is Child’s HH currently living in within DSS borders?  YES….NO… 
 1.8.1 IF YES, Child’s Location ID (FOR HH CURRENTLY LIVING IN): [__][__][__]---
[__][__][__][__]---[__][__]---[__] 
 1.8.2 IF NO, provide village name and describe where located 
1.9 GPS Coordinates:_______________________ 
1.10 Child’s DOB according to Mother/caretaker [__][__] / [__][__] / [__][__][__][__] 
1.11   Is enrolled mother/caregiver still alive?  ALIVE AND PRESENT……MOVED  
AWAY…….DEAD…..DK 
 1.11.1 If ALIVE to 1.11, Mother First Name: 
[__][__][__][__][__][__][__][__][__][__] 
1.11.1.a Mother Last Name: [__][__]  [__][__] 
[__][__][__][__][__][__][__][__] 
1.11.1.b Phone number used in MSIMU 
[__][__][__][__][__][__][__][__][__][__] 
1.11.2 If MOVED AWAY OR DEAD to 1.11, what is relationship of new primary 
caregiver  
to infant (Circle one)…. MOTHER….FATHER…. GRANDMOTHER…  
……….STEPMOTHER…….AUNT…...NA…OTHER (SPECIFY) _________ 
1.11.3 If DK to 1.11, elaborate on why DK was picked (open-
ended)_____________ 
1.12 Is enrolled child (Circle One): ALIVE…..DEAD…..UNKNOWN   
1.12.1 If DIED, date of death? [__][__] / [__][__] / [__][__][__][__] 
1.12.2 If ALIVE OR UNKNOWN, Did infant move from compound in the study ID?   
YES……NO……CANT FIND CHILD 







2.4 Where card is available, fill the "FROM CARD" column Only using the information 
from the card, in the table below. If a card is not available or does not have a specific 
vaccination, obtain from the verbal report and mark "verbal report" column. Fill HF using 
codes  
 FROM CARD VERBAL  
Vaccine Given: Yes/No Date Received Given:Yes/No/DK Age at vaccination  Health Facility 
where given 
BCG     weeks  
Polio-Birth     weeks  
Polio1     weeks  
Polio2     weeks  
Polio3     weeks  
Penta1     weeks  
Penta2     weeks  
Penta3     weeks  
PCV1     weeks  
PCV2     weeks  
PCV3     weeks  
Measles      
2.5 If measles vaccine given late (age received >10 months)), what are reasons for 
delay?.........COST WAS HIGH…..CLINIC TOO FAR…….DIDN’T KNOW VAC DATE….FORGOT 
ABOUT VACCINATION….TRAVELLING….…. …..VACCINES NOT IMPORTANT VACCINE NOT 
IN STOCK …..OTHER (SPECIFY)__________ 
 









2.8 What factor was most important in determining which clinic you brought your infant 
to for immunizations?...  
….COST….DISTANCE….STAFF TREAT ME WELL… VACCINES ALWAYS IN 
STOCK…..NEW CAREGIVER, DID NOT BRING………OTHER (SPECIFY)_____ 
2.9 How far is the nearest Mpesa/mobile money agent from your compound in walking 
time?.....<10 minutes……10-21 minutes…..20-40 minutes….41-60 minutes….> 1 
hour….DK 
2.11 Are you registered with MPESA/ORANGE/YU/or other mobile money 
network?....YES…NO….DK 
If YES to 2.11, when did you register for the mobile money network?  <1 MONTH  
AGO…..1-3 MONTHS AGO….3-6 MONTHS AGO….6-12 MONTHS 
AGO…> 1 YEAR AGO  
2.12 (Aside from SMS and small money…Only say this for those in intervention arms), 
what motivated you to bring your child in for immunization?.....FAMILY TOLD 
ME….VACCINE GOOD FOR KID….OTHER MOTHERS DO IT….CHW TOLD ME…..CLINIC 
STAFF TOLD ME… ….OTHER_____ 
 
 
For those in arm 1 (control), skip to question 7.1 








5.1 Did you receive SMS reminders for ANY OF your child’s immunization appointments?  
...YES…NO….NEW PRIMARY CAREGIVER…DON’T REMEMBER   
5.1.1 If NO to 5.1, why do you think you did not receive REMINDERS?  NEW 
PRIMARY CAREGIVER…..PERSON WHO OWNED PHONE DID NOT GIVE…..KEMRI 
DID NOT SEND…I MOVED AWAY….PERSON WHO OWNED PHONE MOVED AWAY 
…OTHER (SPECIFY)_________THEN SKIP TO Q6.1 
5.1.2  IF DON’T REMEMBER OR NEW PRIMARY CAREGIVER for 5.1, SKIP TO Q6.1 
5.2  For MEASLES vaccine, whose mobile phone were reminders sent to?  
MINE….SOMEBODY ELSE 
5.2.1 If MINE for 5.2, how many SMS reminders did you receive for Measles 
vaccine …0…1……2…..3…. DK  
5.2.1.a If <2 SMS for Measles, Why do you think you did not receive some 
of the SMS messages?.... I WAS AWAY….PHONE NOT 
CHARGED….LOST/BROKE PHONE…KEMRI DID NOT SEND…VACCINATED 
AFTER RECEIVING FIRST REMINDER…VACCINATED INFANT BEFORE ANY 
REMINDER received…OTHER (SPECIFY)____ 
5.2.2 If SOMEBODY ELSE for 5.2, how many SMS reminders did you receive for 
Measles vaccine? ...0..1..2..3..DK 
5.2.2.a If <2 SMS for Measles, Why do you think you did not receive some 
of the SMS messages?.... OWNER OF PHONE AWAY….OWNER OF PHONE 
FORGOT TO TELL ME…..I WAS AWAY….PHONE NOT CHARGED….LOST 
PHONE…KEMRI DID NOT SEND……OTHER (SPECIFY)____ 
5.3 Overall, did the SMS reminders influence your decision to bring your child for 
immunization? YES….NO….DK 
5.4 Overall, what did you think of the number of SMS sent to you?  TOO MANY…..TOO 
LITTLE….JUST RIGHT….MOBILE PHONE SHARED…..DK  
5.5 How did you find the length of the SMS reminders….TOO SHORT, RIGHT LENGTH, 
TOO LONG…MOBILE PHONE SHARED….DK 
5.6 What was your opinion of the small phrase at the end of the reminder?  ENJOYED 
IT….DIDNT LIKE IT…DON’T REMEMBER IT…MOBILE PHONE SHARED….NO OPINION 
FOR THOSE IN ARMS 3 and 4 (75ksh and 200ksh) 
6.2 Did you receive any payments through mobile money as part of this 
study....YES….NO…DON’T REMEMBER…NEW PRIMARY CARE GIVER 
6.2.1 If NO, why do you think you did not receive payment?  NEW PRIMARY 
CAREGIVER…..PERSON WHO OWNED PHONE DID NOT GIVE…..KEMRI DID NOT 
SEND…I MOVED AWAY….PERSON WHO OWNED PHONE MOVED AWAY……  DID 
NOT VACCINATE INFANT…..INFANT VACCINATED LATE …OTHER 




6.2.2 IF DON’T REMEMBER OR NEW PRIMARY CAREGIVER for 6.2, SKIP TO Q7.1 
6.3 For Measles vaccine, whose mobile phone was money sent to?  MINE….SOMEBODY 
ELSE 
6.3.1 If MINE for Q6.3, Did you receive the payment for measles vaccine?: 
YES…NO…DON’T REMEMBER…. 
6.3.1.a If YES for 6.3.1, when did you cash out the incentive?  SAME 
DAY…..1-3 DAYS….>3 DAYS…..NOT CASHED OUT 
6.3.1.a If NO for 6.3.1, why do you think you didn’t receive a payment…. 
….PHONE WAS LOST/BROKE….KEMRI DID NOT SEND….MY CHILD WAS 
VACCINATED LATE… DIDN’T RECEIVE MEASLES VACCINE 
YET….DK….OTHER(SPECIFY)_______ 
6.3.2 If SOMEBODY ELSE for Q6.3, Did you receive the payment for measles 
vaccine?: YES…NO…..DON’T REMEMBER 
6.3.1.a If YES for 6.3.2, when did you cash out the incentive?  SAME 
DAY…..1-3 DAYS….>3 DAYS…..NOT CASHED OUT 
6.3.1.a If NO for 6.3.1, why do you think you didn’t receive a 
payment….OWNER OF PHONE AWAY…OWNER OF PHONE WITHHELD 
MONEY ….PHONE WAS LOST….KEMRI DID NOT SEND….MY CHILD WAS 
VACCINATED LATE….DK….OTHER (SPECIFY) 
6.4 Did our telling you that you would receive small money  influence your decision to 
bring your child for immunizations?...... YES…NO… ….DK……NOT PRIMARY CAREGIVER 
….DIDNT KNOW WOULD RECEIVE PAYMENT  
6.5  What did you use the MPESA for?”  with Answers TRANSPORT 
COST…FOOD…AIRTIME…HOUSING EXPENSES…SCHOOL EXPENSES….MEDICINE…NOT 
USED BY MOTHER…..OTHER….DK  (Select all that apply) 
 
6.6 How was your experience in receiving cash through Mpesa/ZAP/Orange/Yu-Cash 
and KEMRI/CDC?..... VERY  
POSITIVE….SOMEWHAT POSITIVE…..NEUTRAL….SOMEWHAT NEGATIVE….VERY 
NEGATIVE 
6.9 For future vaccines for this child or other children, would you be more/less/same 
likely to bring them in for vaccination if you do not get any small money?.......... MORE 
LIKELY……….LESS LIKELY………THE SAME……DK 
6.10 Would you have preferred to receive airtime over mobile-money cash (Same KSH 
for both)?....YES….NO…DK…. 
6.11 Between SMS reminders and incentives, what influenced you most in bringing your 






****FOR ALL STUDY PARTICIPANTS 
7.1 Does your child usually sleep under an INSECTICIDE treated 
bednet?.....YES…..NO……DK 
 7.1.1 If YES for 7.1, Did your child sleep under an INSECTICIDE treated bed net 
last night? ....... YES…..NO…..DK 
 7.1.2 If NO to 7.1, Does your child usually sleep under a bed net? ....... 
YES…..NO…..DK 
  7.1.2.b If YES for 7.1.2, Did your child sleep under an bed net last night? 
....... YES…..NO…..DK 
7.2 How many times has your infant been to the health facility for an illness (e.g. fever, 
respiratory problem, diarrhea) in the last 2 weeks (excluding immunization visits)? 
[__][__] 
7.3 How many times has your infant been hospitalized in the last 1 month (e.g. fever, 
respiratory problem, diarrhea) (excluding immunization visits)?...[__] [__] 
7.4 FOR CI: Are you able to take child’s height? (CIRCLE ONE)….YES…..NO 
 If YES, Child’s Height (cm) [__] [___] [___] . [ __] 






Appendix 11. Inverse Kaplan-Meier curves for time to pentavalent3 by 
selected demographic variables using intention-to-treat delivery of short 
message system (SMS) reminders 
 
Abbreviation: KM, Kaplan-Meier 




Appendix 12. Inverse Kaplan-Meier curves for time to measles by selected 
demographic variables using intention-to-treat delivery of short message 
system (SMS) reminders 
 
Abbreviation: KM, Kaplan-Meier 
 




Appendix 13. Unadjusted and adjusted risk ratios for vaccination within two weeks 
of schedule 
  Study Arm 
  Control SMS SMS + 75 
KSH1 








No. of participants2 22 31 27 24 
No.Vaccinated2 21 27 26 23 
     %  (95% CI) 95.5 (77.2-99.9) 87.1 (70.2-96.4) 96.3 (81.0-99.9) 96.0 (79.7-99.9) 
Unadjusted      
     RR (95% CI) 1 (Reference) 0.91 (0.77-1.08) 1.01 (0.91-1.12) 1.01 (0.90-1.12) 
     P value  0.281 0.868 0.920 
Adjusted3     
     RR (95% CI) 1 (Reference) 0.95 (0.85-1.05) 1.02 (0.91-1.12) 1.03 (0.92-1.16) 








No. of participants2 22 30 27 24 
No. Vaccinated2 20 26 24 24 
     %  (95% CI) 90.9 (70.8-98.9) 86.7 (69.3-96.2) 88.9 (70.8-97.6) 100 (85.7-100.0)4 
Unadjusted      
     RR (95% CI) 1 (Reference) 0.95 (0.75-1.21) 0.98 (0.82-1.16) 1.10 (0.97-1.25) 
     P value  0.694 0.801 0.146 
Adjusted3     
     RR (95% CI) 1 (Reference) 0.91 (0.69-1.21) 0.95 (0.76-1.19) 1.07 (0.87-1.30) 








No. of participants2 22 30 27 24 
No. Vaccinated2 15 21 22 24 
     %  (95% CI) 68.2 (45.1-86.1) 70.0 (50.6-85.3) 81.5 (61.9-93.7) 100 (85.7-100.0)4 
Unadjusted      
     RR (95% CI) 1 (Reference) 1.03 (0.68-1.56) 1.20 (0.80-1.77) 1.46 (1.01-2.12) 
     P value  0.902 0.379 0.043 
Adjusted3     
     RR (95% CI) 1 (Reference) 1.04 (0.67-1.63) 1.21 (0.78-1.88) 1.49 (0.99-2.25) 






No. of participants2 22 28 25 24 
No. Vaccinated2 13 17 13 20 
     %  (95% CI) 59.1 (36.4-79.3) 60.7 (40.6-78.5) 52.0 (31.3-72.2) 83.3 (62.6-95.3) 
Unadjusted      
     RR (95% CI) 1 (Reference) 1.03 (0.62-1.71) 0.88 (0.52-1.50) 1.41 (0.91-2.19) 
     P value  0.917 0.637 0.128 
Adjusted3     
     RR (95% CI) 1 (Reference) 1.11 (0.67-1.86) 0.89 (0.52-1.53) 1.50 (0.93-2.41) 
     P value  0.677 0.675 0.099 
Abbreviations: RR, risk ratio; SMS, short message system; KSH, Kenyan Schilling 
1 85 KSH= 1 United States Dollar as of October 2014 
2  Participants must have been alive and not out migrated by the scheduled date of vaccination plus 2 weeks 
3 Adjusted for phone ownership, time to clinic, and region a priori 




Appendix 14. Unadjusted and adjusted risk ratios for vaccination coverage 
  Study Arm 
  Control SMS SMS + 75 
KSH1 








No. of participants2 22 29 27 24 
Vaccinated2     
     No. 21 26 24 24 
     %  (95% CI) 95.5 (77.2-99.9) 89.7 (72.6-97.8) 88.9 (70.8-97.6) 100 (85.8-100.0)5 
Unadjusted      
     RR (95% CI) 1 (Reference) 0.94 (0.83-1.06) 0.93 (0.80-1.07) 1.05 (0.96-1.14) 
     P value  0.322 0.341 0.288 
Adjusted3     
     RR (95% CI) 1 (Reference) 0.93 (0.81-1.08) 0.96 (0.80-1.14) 1.07 (0.94-1.22) 






No. of participants3 22 28 25 24 
Vaccinated3     
     No. 18 20 18 23 
     %  (95% CI) 81.8 (51.3-86.8) 71.4 (51.3-86.8) 72.0 (50.6-87.9) 95.8 (78.9-99.9)4 
Unadjusted      
     RR (95% CI) 1 (Reference) 0.87 (0.63-1.20) 0.88 (0.66-1.16) 1.17 (0.96-1.43) 
     P value  0.404 0.375 0.125 
Adjusted4     
     RR (95% CI) 1 (Reference) 0.94 (0.69-1.30) 0.92 (0.67-1.26) 1.26 (0.98-1.61) 
     P value  0.728 0.614 0.067 
Abbreviations: RR, risk ratio; SMS, short message system; KSH, Kenyan Schilling 
 
 
1 85 KSH= 1 United States Dollar as of October 2014 
2  Participants must have been alive and not out migrated by 24 weeks 
3  Participants must have been alive and not out migrated by 10 months (303 days) 
4 Adjusted for phone ownership, time to clinic, and region a priori 




Appendix 15. Immunization coverage within two weeks of scheduled date by study 
arm 
 
CAPTION: Immunization coverage within two weeks of vaccination appointment date 
calculated for pentavalent1, pentavalent2, pentavalent3, and measles vaccines.  
Appointment date for pentavalent1 was 42 days of age.  For pentavalent2, appointment 
date was calculated by adding 28 days (4 weeks) to date of pentavalent1 receipt.  For 
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